<div id="page0" style="width:595.3pt;height:793.7pt">
<p style="top:61.8pt;left:44.4pt;line-height:12.0pt"><span style="font-family:AdvOTd1f5cc91.B,serif;font-size:12.0pt">Systematic Review</span></p>
<p style="top:104.6pt;left:87.2pt;line-height:17.9pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:17.9pt">Low-Intensity Pulsed Ultrasound Augments Tendon,</span></p>
<p style="top:125.5pt;left:122.5pt;line-height:17.9pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:17.9pt">Ligament, and Bone</span><span style="font-family:AdvPS44A44B,serif;font-size:17.9pt">e</span><span style="font-family:AdvOTf93bf98f,serif;font-size:17.9pt">Soft Tissue Healing in</span></p>
<p style="top:146.4pt;left:103.6pt;line-height:17.9pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:17.9pt">Preclinical Animal Models: A Systematic Review</span></p>
<p style="top:175.1pt;left:56.4pt;line-height:12.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:12.0pt">Wilson C. Lai, M.D., Brenda C. Iglesias, B.A., Bryan J. Mark, M.D., and Dean Wang, M.D.</span></p>
<p style="top:237.8pt;left:44.4pt;line-height:9.5pt"><span style="font-family:AdvOTc307558e.B,serif;font-size:9.5pt">Purpose:</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.5pt"> To appraise the available animal and human studies investigating low-intensity pulsed ultrasound stimulation</span></p>
<p style="top:248.8pt;left:44.4pt;line-height:9.5pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.5pt">(LIPUS) on tendon, ligament, and bone</span><span style="font-family:AdvPS44A44B,serif;font-size:9.5pt">e</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.5pt">soft tissue (B-ST) junction healing.</span><span style="font-family:AdvOTc307558e.B,serif;font-size:9.5pt"> Methods:</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.5pt"> A systematic review of PUBMED,</span></p>
<p style="top:259.7pt;left:44.4pt;line-height:9.5pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.5pt">EMBASE, and the Cochrane Library was performed for animal and human studies investigating the effects of LIPUS on</span></p>
<p style="top:270.7pt;left:44.4pt;line-height:9.5pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.5pt">tendon, ligament, and B-ST junction healing. The systematic search was performed using the key term</span><span style="font-family:AdvOTf93bf98f+20,serif;font-size:9.5pt"> &#x201c;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.5pt">low intensity pulsed</span></p>
<p style="top:281.6pt;left:44.4pt;line-height:9.5pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.5pt">ultrasound</span><span style="font-family:AdvOTf93bf98f+20,serif;font-size:9.5pt">&#x201d;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.5pt"> and any of the following:</span><span style="font-family:AdvOTf93bf98f+20,serif;font-size:9.5pt"> &#x201c;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.5pt">tendon,</span><span style="font-family:AdvOTf93bf98f+20,serif;font-size:9.5pt">&#x201d; &#x201c;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.5pt">ligament,</span><span style="font-family:AdvOTf93bf98f+20,serif;font-size:9.5pt">&#x201d; &#x201c;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.5pt">tendon-bone,</span><span style="font-family:AdvOTf93bf98f+20,serif;font-size:9.5pt">&#x201d;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.5pt"> and</span><span style="font-family:AdvOTf93bf98f+20,serif;font-size:9.5pt"> &#x201c;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.5pt">bone-tendon.</span><span style="font-family:AdvOTf93bf98f+20,serif;font-size:9.5pt">&#x201d;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.5pt"> Inclusion criteria consisted</span></p>
<p style="top:292.6pt;left:44.4pt;line-height:9.5pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.5pt">of (1) randomized controlled trials assessing the effect of LIPUS on bone, tendon, and soft tissue in animals or humans and (2)</span></p>
<p style="top:303.6pt;left:44.4pt;line-height:9.5pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.5pt">English-language articles.</span><span style="font-family:AdvOTc307558e.B,serif;font-size:9.5pt"> Results:</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.5pt"> A total of 28 animal and 2 human studies met inclusion criteria. Animal studies utilized</span></p>
<p style="top:314.5pt;left:44.4pt;line-height:9.5pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.5pt">various models, including Achilles and patellar tendon transections, medial collateral ligament transections, and surgical repair</span></p>
<p style="top:325.5pt;left:44.4pt;line-height:9.5pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.5pt">of patellar tendon, rotator cuff tendon, and anterior cruciate ligament, to evaluate the effects of LIPUS. Animal studies</span></p>
<p style="top:336.4pt;left:44.4pt;line-height:9.5pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.5pt">demonstrated signi</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:9.5pt">&#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.5pt">cantly improved collagen content and organization, bone formation,</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:9.5pt"> &#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.5pt">brocartilage remodeling, and</span></p>
<p style="top:347.4pt;left:44.4pt;line-height:9.5pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.5pt">mechanical strength with LIPUS treatment compared with controls. In human trials, LIPUS treatment of chronic tendino-</span></p>
<p style="top:358.4pt;left:44.4pt;line-height:9.5pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.5pt">pathies did not improve clinical outcomes.</span><span style="font-family:AdvOTc307558e.B,serif;font-size:9.5pt"> Conclusions:</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.5pt"> In acute injury animal models, LIPUS augmented healing of acute</span></p>
<p style="top:369.3pt;left:44.4pt;line-height:9.5pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.5pt">tendon, ligament, and B-ST junction injuries through increased collagen content and organization; increased anti-</span></p>
<p style="top:380.3pt;left:44.4pt;line-height:9.5pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.5pt">in</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:9.5pt">&#xfb02;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.5pt">ammatory cellular signaling; and increased angiogenesis. However, in 2 human studies investigating chronic tendinop-</span></p>
<p style="top:391.3pt;left:44.4pt;line-height:9.5pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.5pt">athy, LIPUS did not lead to superior outcomes compared with controls.</span><span style="font-family:AdvOTc307558e.B,serif;font-size:9.5pt"> Clinical Relevance:</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.5pt"> Animal models suggest that</span></p>
<p style="top:402.2pt;left:44.4pt;line-height:9.5pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.5pt">LIPUS may be a promising noninvasive treatment modality for accelerating patient recovery after acute tendon and ligament</span></p>
<p style="top:413.2pt;left:44.4pt;line-height:9.5pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.5pt">injuries, as well as after surgical repair of B-ST junction injuries, but this has not been demonstrated in human studies.</span></p>
<p style="top:424.1pt;left:44.4pt;line-height:9.5pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.5pt">Randomized clinical trials evaluating LIPUS for acute tendon and ligament injuries are warranted.</span></p>
<p style="top:454.3pt;left:224.4pt;line-height:12.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:12.0pt">See commentary on page</span><span style="font-family:AdvOTc548c603.I,serif;font-size:12.0pt;color:#0a7fac"> 2334</span></p>
<p style="top:481.8pt;left:44.4pt;line-height:28.9pt"><span style="font-family:AdvOTc307558e.B,serif;font-size:28.9pt">L</span></p>
<p style="top:485.3pt;left:64.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">ow-intensity pulsed ultrasound stimulation (LIPUS)</span></p>
<p style="top:497.3pt;left:64.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">transmits mechanical energy transcutaneously as</span></p>
<p style="top:509.2pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">high-frequency acoustical pressure waves into biological</span></p>
<p style="top:521.1pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">tissues in order to stimulate healing.</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">1</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">Multiple studies</span></p>
<p style="top:533.1pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">have demonstrated the effects of LIPUS on bone,</span></p>
<p style="top:545.1pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">including increased angiogenesis and osteogenesis.</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">1</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt">,</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">2</span></sup></p>
<p style="top:557.0pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">LIPUS is a US Food and Drug Administration</span><span style="font-family:AdvPS44A44B,serif;font-size:10.0pt">e</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">approved</span></p>
<p style="top:485.3pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">treatment for the acceleration of bone healing in the</span></p>
<p style="top:497.3pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">setting of delayed and nonunion fractures.</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">3-10</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">LIPUS has</span></p>
<p style="top:509.2pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">also been shown to increase cell proliferation, cytokine</span></p>
<p style="top:521.1pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">production, and extracellular matrix synthesis in</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt"> &#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">bro-</span></p>
<p style="top:533.1pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">blasts and chondrocytes in vitro and in vivo in animal</span></p>
<p style="top:545.1pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">models.</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">11-15</span></sup></p>
<p style="top:557.0pt;left:313.9pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">Multiple animal studies have examined the effects of</span></p>
<p style="top:569.0pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">LIPUS on tendon, ligament, and bone</span><span style="font-family:AdvPS44A44B,serif;font-size:10.0pt">e</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">soft tissue (B-ST)</span></p>
<p style="top:581.0pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">junction healing. LIPUS has demonstrated potential for</span></p>
<p style="top:592.9pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">accelerating the healing of both acute and chronic</span></p>
<p style="top:604.9pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">tendon and ligament injuries in animal models, allowing</span></p>
<p style="top:616.8pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">for its potential application in the clinical setting.</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">16-18</span></sup></p>
<p style="top:628.7pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">Injured Achilles tendons treated with LIPUS in animal</span></p>
<p style="top:640.7pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">models have shown to exhibit signi</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt">&#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">cantly more mature</span></p>
<p style="top:652.7pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">collagen</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt"> &#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">bers, improved biomechanical properties, and</span></p>
<p style="top:664.6pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">increased rate of tissue regeneration compared with</span></p>
<p style="top:676.6pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">controls.</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">16-18</span></sup></p>
<p style="top:676.6pt;left:370.2pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">Studies</span></p>
<p style="top:676.6pt;left:409.8pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">in</span></p>
<p style="top:676.6pt;left:426.7pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">medial</span></p>
<p style="top:676.6pt;left:464.2pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">collateral</span></p>
<p style="top:676.6pt;left:511.7pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">ligament</span></p>
<p style="top:688.6pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">(MCL) transection rat models treated with LIPUS have</span></p>
<p style="top:700.5pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">demonstrated accelerated healing of ligaments with</span></p>
<p style="top:712.4pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">improved strength and stiffness just after 2 weeks.</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">19</span></sup></p>
<p style="top:594.5pt;left:52.4pt;line-height:8.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:8.0pt">From the Department of Orthopaedic Surgery, University of California</span></p>
<p style="top:604.4pt;left:44.4pt;line-height:8.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:8.0pt">Irvine, Orange, California, U.S.A. (W.C.L., B.J.M., D.W.) and David Geffen</span></p>
<p style="top:614.4pt;left:44.4pt;line-height:8.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:8.0pt">School of Medicine at UCLA, Los Angeles, California, U.S.A. (B.C.I.).</span></p>
<p style="top:624.3pt;left:52.4pt;line-height:8.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:8.0pt">The authors report that they have no con</span><span style="font-family:AdvOTc548c603.I+fb,serif;font-size:8.0pt">&#xfb02;</span><span style="font-family:AdvOTc548c603.I,serif;font-size:8.0pt">icts of interest in the authorship</span></p>
<p style="top:634.3pt;left:44.4pt;line-height:8.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:8.0pt">and publication of this article. Full ICMJE author disclosure forms are</span></p>
<p style="top:644.3pt;left:44.4pt;line-height:8.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:8.0pt">available for this article online, as</span><span style="font-family:AdvOTc548c603.I,serif;font-size:8.0pt;color:#0a7fac"> supplementary material</span><span style="font-family:AdvOTc548c603.I,serif;font-size:8.0pt">.</span></p>
<p style="top:654.3pt;left:52.4pt;line-height:8.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:8.0pt">Received May 16, 2020; accepted February 4, 2021.</span></p>
<p style="top:664.2pt;left:52.4pt;line-height:8.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:8.0pt">Address correspondence to Dean Wang, M.D., UCI Department of Ortho-</span></p>
<p style="top:674.2pt;left:44.4pt;line-height:8.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:8.0pt">paedic Surgery, 101 The City Drive S. Pavilion III, 2nd Floor, Orange, CA</span></p>
<p style="top:684.1pt;left:44.4pt;line-height:8.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:8.0pt">92868, U.S.A. E-mail:</span><span style="font-family:AdvOTc548c603.I,serif;font-size:8.0pt;color:#0a7fac"> deanwangmd@gmail.com</span></p>
<p style="top:694.1pt;left:52.4pt;line-height:8.0pt"><span style="font-family:AdvPSSym,serif;font-size:8.0pt">&#xfffd;</span><span style="font-family:AdvOTc548c603.I,serif;font-size:8.0pt"> 2021 by the Arthroscopy Association of North America</span></p>
<p style="top:704.0pt;left:52.4pt;line-height:8.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:8.0pt">0749-8063/20871/$36.00</span></p>
<p style="top:714.0pt;left:52.4pt;line-height:8.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:8.0pt;color:#0a7fac">https://doi.org/10.1016/j.arthro.2021.02.019</span></p>
<img style="position:absolute;transform:matrix(.3201046,0,-0,-.31858827,665.8774,108.30139)" src="data:image/png;base64,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">
<p style="top:747.3pt;left:44.4pt;line-height:11.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:11.0pt">2318</span></p>
<p style="top:749.7pt;left:123.1pt;line-height:8.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:8.0pt">Arthroscopy: The Journal of Arthroscopic and Related Surgery, Vol 37, No 7 (July), 2021: pp 2318-2333</span></p>


<p style="top:55.1pt;left:52.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">In addition, LIPUS has shown potential bene</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt">&#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">t for B-ST</span></p>
<p style="top:67.1pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">junction healing in anterior cruciate ligament (ACL)</span></p>
<p style="top:79.1pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">reconstruction, patellar tendon repair, and rotator cuff</span></p>
<p style="top:91.0pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">repair in animalmodels.</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">20-24</span></sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">Typically after surgical repair,</span></p>
<p style="top:103.0pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">the B-ST interface heals via development ofa</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt"> &#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">brovascular</span></p>
<p style="top:114.9pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">scar that is mechanically inferior and less effective in</span></p>
<p style="top:126.9pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">distributing loads compared with the native enthesis.</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">25-28</span></sup></p>
<p style="top:138.8pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">Thus, the use of LIPUS to improve B-ST junction healing</span></p>
<p style="top:150.8pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">may be a promising therapy in the postoperative setting.</span></p>
<p style="top:162.7pt;left:52.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">Although there is a vast body of literature demon-</span></p>
<p style="top:174.7pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">strating the positive effects of LIPUS on bone healing, the</span></p>
<p style="top:186.7pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">therapeutic effects of LIPUS on tendon, ligament, and B-</span></p>
<p style="top:198.6pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">ST junction healing are unclear. The purpose of this sys-</span></p>
<p style="top:210.6pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">tematic review was to appraise the available animal and</span></p>
<p style="top:222.5pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">human studies investigating LIPUS on tendon, ligament,</span></p>
<p style="top:234.4pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">and B-ST junction healing. We hypothesized that LIPUS</span></p>
<p style="top:246.4pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">treatment would induce positive effects on tendon, liga-</span></p>
<p style="top:258.4pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">ment, and B-ST junction healing through improved</span></p>
<p style="top:270.3pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">collagen</span></p>
<p style="top:270.3pt;left:89.2pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">formation</span></p>
<p style="top:270.3pt;left:141.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">and</span></p>
<p style="top:270.3pt;left:167.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">organization,</span></p>
<p style="top:270.3pt;left:232.6pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">resulting</span></p>
<p style="top:270.3pt;left:279.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">in</span></p>
<p style="top:282.3pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">improved biomechanical properties of these structures.</span></p>
<p style="top:310.6pt;left:141.4pt;line-height:12.0pt"><span style="font-family:AdvOTd1f5cc91.B,serif;font-size:12.0pt">Methods</span></p>
<p style="top:332.1pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTd1f5cc91.B,serif;font-size:10.0pt">Search Strategy</span></p>
<p style="top:344.0pt;left:52.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">A systematic review of the preclinical literature was</span></p>
<p style="top:356.0pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">conducted</span></p>
<p style="top:356.0pt;left:97.3pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">according</span></p>
<p style="top:356.0pt;left:147.1pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">to</span></p>
<p style="top:356.0pt;left:163.8pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">standard</span></p>
<p style="top:356.0pt;left:209.2pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">guidelines.</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">29</span></sup></p>
<p style="top:356.0pt;left:271.7pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">The</span></p>
<p style="top:368.0pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">PUBMED, EMBASE, and Cochrane Library databases</span></p>
<p style="top:379.9pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">were searched to identify studies examining the effects of</span></p>
<p style="top:391.9pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">LIPUS on tendon, ligament, and the B-ST junction heal-</span></p>
<p style="top:403.8pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">ing. The systematic search of electronic databases was</span></p>
<p style="top:415.8pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">performed in September 2020, using the key terms</span><span style="font-family:AdvOTf93bf98f+20,serif;font-size:10.0pt"> &#x201c;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">low</span></p>
<p style="top:427.8pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">intensity pulsed ultrasound,</span><span style="font-family:AdvOTf93bf98f+20,serif;font-size:10.0pt">&#x201d;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt"> with a combination of any</span></p>
<p style="top:439.7pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">of the following terms:</span><span style="font-family:AdvOTf93bf98f+20,serif;font-size:10.0pt"> &#x201c;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">tendon,</span><span style="font-family:AdvOTf93bf98f+20,serif;font-size:10.0pt">&#x201d; &#x201c;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">ligament,</span><span style="font-family:AdvOTf93bf98f+20,serif;font-size:10.0pt">&#x201d; &#x201c;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">tendon-</span></p>
<p style="top:451.6pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">bone,</span><span style="font-family:AdvOTf93bf98f+20,serif;font-size:10.0pt">&#x201d; &#x201c;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">bone-tendon,</span><span style="font-family:AdvOTf93bf98f+20,serif;font-size:10.0pt">&#x201d;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt"> and</span><span style="font-family:AdvOTf93bf98f+20,serif;font-size:10.0pt"> &#x201c;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">healing.</span><span style="font-family:AdvOTf93bf98f+20,serif;font-size:10.0pt">&#x201d;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt"> Additional studies</span></p>
<p style="top:463.6pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">were identi</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt">&#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">ed through reference review of the previ-</span></p>
<p style="top:475.6pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">ously queried articles. Inclusion criteria consisted of (1)</span></p>
<p style="top:487.5pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">animal studies with controls investigating the effects of</span></p>
<p style="top:499.5pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">LIPUS application on bone, tendon, and B-ST healing; (2)</span></p>
<p style="top:511.4pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">randomized controlled trials assessing the effect of LIPUS</span></p>
<p style="top:523.4pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">on bone, tendon, and soft tissue in humans; and (3)</span></p>
<p style="top:535.3pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">English-language articles. Exclusion criteria consisted of</span></p>
<p style="top:547.3pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">(1) studies examining the treatment effects of continuous,</span></p>
<p style="top:559.2pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">rather than pulsed, low-intensity ultrasound; (2) non-</span></p>
<p style="top:571.2pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">English-language studies; (3) studies discussing LIPUS</span></p>
<p style="top:583.2pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">effects on bone and fracture healing; (4) review papers;</span></p>
<p style="top:595.1pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">(5) supplements or addenda to original articles; and (6)</span></p>
<p style="top:607.1pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">conference abstracts. The effects of LIPUS were assessed</span></p>
<p style="top:619.1pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">based on signi</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt">&#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">cantly improved outcomes in the LIPUS-</span></p>
<p style="top:631.0pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">treated group compared with the control group, with</span></p>
<p style="top:642.9pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">improved healing de</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt">&#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">ned as superior histologic (i.e.,</span></p>
<p style="top:654.9pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">collagen content and organization) and biomechanical</span></p>
<p style="top:666.8pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">tissue properties in animal models.</span></p>
<p style="top:688.8pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTd1f5cc91.B,serif;font-size:10.0pt">Data Extraction</span></p>
<p style="top:700.7pt;left:52.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">Two reviewers independently screened the titles, ab-</span></p>
<p style="top:712.6pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">stract, and full-text for study inclusion. Discrepancies</span></p>
<p style="top:55.1pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">between the 2 independent reviewers were resolved by</span></p>
<p style="top:67.1pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">discussion or a third reviewer. Two reviewers then inde-</span></p>
<p style="top:79.1pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">pendently extracted data from each of the included</span></p>
<p style="top:91.0pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">studies, including journal/article information (i.e., au-</span></p>
<p style="top:103.0pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">thors, year of publication, journal), animal model and/or</span></p>
<p style="top:114.9pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">disease being investigated, sample size, procedure per-</span></p>
<p style="top:126.9pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">formed, LIPUS dosage and duration, control, and treat-</span></p>
<p style="top:138.8pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">ment outcomes.</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">30</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt;color:#0a7fac"> </span></sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt;color:#0a7fac">Fig 1</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt"> details the study selection and</span></p>
<p style="top:150.8pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">exclusion process performed in accordance with Preferred</span></p>
<p style="top:162.7pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">Reporting Items for Systematic Reviews and Meta-</span></p>
<p style="top:174.7pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">Analysis guidelines.</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">30</span></sup></p>
<p style="top:186.7pt;left:313.9pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">The initial search yielded 101 unique studies. After</span></p>
<p style="top:198.6pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">title review, 63 studies that focused on tendon, liga-</span></p>
<p style="top:210.6pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">ment, or the B-ST junction went on to abstract review.</span></p>
<p style="top:222.5pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">During abstract review, studies on the following topics</span></p>
<p style="top:234.4pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">were excluded: periodontal cells, osteoarthritis models,</span></p>
<p style="top:246.4pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">conferences abstracts, and review papers. During full-</span></p>
<p style="top:258.4pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">text review of the remaining 31 articles, 1 non-</span></p>
<p style="top:270.3pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">randomized human trial was excluded. Thirty studies</span></p>
<p style="top:282.3pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">ful</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt">&#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">lled the inclusion and exclusion criteria and were</span></p>
<p style="top:294.3pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">included in this review.</span></p>
<p style="top:316.1pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTd1f5cc91.B,serif;font-size:10.0pt">Appraisal of Bias</span></p>
<p style="top:328.1pt;left:313.9pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">Risk of bias in the randomized human studies was</span></p>
<p style="top:340.1pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">evaluated in accordance with the methods of the</span></p>
<p style="top:352.0pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">Cochrane Collaboration tool. This tool includes 5 bias do-</span></p>
<p style="top:364.0pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">mains:</span></p>
<p style="top:364.0pt;left:344.2pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">selection,</span></p>
<p style="top:364.0pt;left:393.9pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">performance,</span></p>
<p style="top:364.0pt;left:461.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">detection,</span></p>
<p style="top:364.0pt;left:512.7pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">attrition,</span></p>
<p style="top:376.0pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">reporting, and other potential biases as determined by the</span></p>
<p style="top:387.9pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">authors.</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">31</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">For each item, each author reviewed empirical</span></p>
<p style="top:399.8pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">evidence and assigned risk of bias as low risk, high risk, or</span></p>
<p style="top:411.8pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">indeterminate. Assessment of risk of bias was performed</span></p>
<p style="top:423.7pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">independently by 2 authors (W.L. and B.I.), and discrep-</span></p>
<p style="top:435.7pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">ancieswereresolvedby discussiontoreacha</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt">&#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">naldecision.</span></p>
<p style="top:447.7pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">Animal studies were assessed using the Systematic Review</span></p>
<p style="top:459.6pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">Centre for Laboratory Animal Experimentation risk of bias</span></p>
<p style="top:471.6pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">tool,</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">32</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">a validated method adapted from the Cochrane</span></p>
<p style="top:483.6pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">Collaboration tool for assessing risk of bias (</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt;color:#0a7fac">Appendix</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">).</span></p>
<p style="top:511.8pt;left:406.7pt;line-height:12.0pt"><span style="font-family:AdvOTd1f5cc91.B,serif;font-size:12.0pt">Results</span></p>
<p style="top:533.3pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTd1f5cc91.B,serif;font-size:10.0pt">Study Characteristics</span></p>
<p style="top:545.3pt;left:313.9pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">Thirty studies were included in this review: 11</span></p>
<p style="top:557.3pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">focused on tendon healing, 4 focused on ligament</span></p>
<p style="top:569.2pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">healing, and 15 focused on healing at the B-ST junc-</span></p>
<p style="top:581.2pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">tion. Two human tendon studies and 28 animal studies</span></p>
<p style="top:593.1pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">were identi</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt">&#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">ed. These studies examined the effects of</span></p>
<p style="top:605.1pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">LIPUS</span></p>
<p style="top:605.1pt;left:341.6pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">on</span></p>
<p style="top:605.1pt;left:361.8pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">patellar</span></p>
<p style="top:605.1pt;left:403.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">tendinopathy</span></p>
<p style="top:605.1pt;left:471.2pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">and</span></p>
<p style="top:605.1pt;left:496.3pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">lateral</span></p>
<p style="top:605.1pt;left:532.5pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">epi-</span></p>
<p style="top:617.0pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">condylitis. Animal tendon studies utilized profundus,</span></p>
<p style="top:629.0pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">Achilles, and patellar tendon models. Ligament studies</span></p>
<p style="top:640.9pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">focused on MCL-transection animal models. B-ST</span></p>
<p style="top:652.9pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">studies</span></p>
<p style="top:652.9pt;left:345.7pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">examined</span></p>
<p style="top:652.9pt;left:398.7pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">the</span></p>
<p style="top:652.9pt;left:422.5pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">effects</span></p>
<p style="top:652.9pt;left:459.7pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">of</span></p>
<p style="top:652.9pt;left:477.8pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">LIPUS</span></p>
<p style="top:652.9pt;left:514.3pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">on</span></p>
<p style="top:652.9pt;left:535.3pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">the</span></p>
<p style="top:664.9pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">patella</span><span style="font-family:AdvPS44A44B,serif;font-size:10.0pt">e</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">patellar tendon junction, infraspinatus tendon</span></p>
<p style="top:676.8pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">repair, extensor digitorum longus B-ST junction, and</span></p>
<p style="top:688.8pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">ACL reconstruction models. Sample sizes ranged from 8</span></p>
<p style="top:700.7pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">to 120 animals per study. End points for the studies</span></p>
<p style="top:712.7pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">were measured at postprocedure day 1 up to 18 weeks.</span></p>
<p style="top:31.6pt;left:184.5pt;line-height:9.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt">LIPUS FOR MUSCULOSKELETAL SOFT TISSUE HEALING</span></p>
<p style="top:30.0pt;left:525.4pt;line-height:11.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:11.0pt">2319</span></p>


<p style="top:473.6pt;left:52.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">Ultrasound frequencies used ranged from 1.0 to 3</span></p>
<p style="top:485.5pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">MHz, delivering 30 to 2,300 mW/cm</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt">2</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">of energy. All</span></p>
<p style="top:497.5pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">available B-ST junction animal studies used an intensity</span></p>
<p style="top:509.5pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">of 30 mW/cm</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt">2</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">of energy and</span><span style="font-family:AdvP4C4E74,serif;font-size:10.0pt"> &#xfffd;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">1.5 mHz. Length of</span></p>
<p style="top:521.4pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">LIPUS treatment ranged from 5- to 20-minute intervals</span></p>
<p style="top:533.3pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">once or twice daily. No complications from LIPUS</span></p>
<p style="top:545.3pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">treatment were reported in any animal or human</span></p>
<p style="top:557.3pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">studies analyzed.</span></p>
<p style="top:581.2pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTd1f5cc91.B,serif;font-size:10.0pt">Appraisal of Bias</span></p>
<p style="top:593.1pt;left:52.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">The human studies included in this review were Level</span></p>
<p style="top:605.1pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">I studies with low risk of selection, attrition, reporting, or</span></p>
<p style="top:617.0pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">other biases (</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt;color:#0a7fac">Appendix</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">). Among animal studies, we note</span></p>
<p style="top:629.0pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">the possibility of selection, performance, and detection</span></p>
<p style="top:640.9pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">bias in the included articles, as blinding of experimenters</span></p>
<p style="top:652.9pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">to animal treatment groups, treatment administration,</span></p>
<p style="top:664.9pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">and outcome analysis was not always reported.</span></p>
<p style="top:688.8pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTd1f5cc91.B,serif;font-size:10.0pt">Effects of LIPUS on Tendon Healing</span></p>
<p style="top:700.7pt;left:52.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">Two human studies were identi</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt">&#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">ed in this review</span></p>
<p style="top:712.7pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">(</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt;color:#0a7fac">Table 1</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">). Two randomized control trials were used to</span></p>
<p style="top:473.6pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">assess the potential use of LIPUS to treat chronic ten-</span></p>
<p style="top:485.5pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">dinopathies. D</span><span style="font-family:AdvOTf93bf98f+20,serif;font-size:10.0pt">&#x2019;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">Vaz et al.</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">33</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">performed a randomized,</span></p>
<p style="top:497.5pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">placebo-controlled trial with 48 patients. LIPUS was</span></p>
<p style="top:509.5pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">used to treat chronic lateral epicondylitis in 25 patients,</span></p>
<p style="top:521.4pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">while 23 were treated with sham ultrasound. LIPUS</span></p>
<p style="top:533.3pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">dosage was set at 30 mW/cm</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt">2</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">intensity at a 1.0-MHz</span></p>
<p style="top:545.3pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">signal, and patients self-administered treatment for 20</span></p>
<p style="top:557.3pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">minutes per day for 12 weeks. In LIPUS-treated groups,</span></p>
<p style="top:569.2pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">64% achieved at least 50% improvement in baseline</span></p>
<p style="top:581.2pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">elbow pain compared with 57% improvement in con-</span></p>
<p style="top:593.1pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">trol groups. However, this difference was not statisti-</span></p>
<p style="top:605.1pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">cally signi</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt">&#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">cant. Similarly, in another randomized,</span></p>
<p style="top:617.0pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">placebo-controlled trial, Warden et al.</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">34</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">used LIPUS to</span></p>
<p style="top:629.0pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">treat chronic patellar tendinopathy in 20 patients, while</span></p>
<p style="top:640.9pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">17 were treated with sham ultrasound. Treatment</span></p>
<p style="top:652.9pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">consisted of self-administered LIPUS at 100 mW/cm</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt">2</span></sup></p>
<p style="top:664.9pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">intensity at 1.0 MHz 20 minutes per day for 12 weeks.</span></p>
<p style="top:676.8pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">In this study, visual analog scales for both usual and</span></p>
<p style="top:688.8pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">worst tendon pain were signi</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt">&#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">cantly decreased in both</span></p>
<p style="top:700.7pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">groups (</span><span style="font-family:AdvOTc548c603.I,serif;font-size:10.0pt">P</span><span style="font-family:AdvP4C4E51,serif;font-size:10.0pt"> &lt;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt"> .01). This study demonstrated that LIPUS</span></p>
<p style="top:712.7pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">provided no additional bene</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt">&#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">t to exercise therapy for</span></p>
<p style="top:63.2pt;left:92.2pt;line-height:7.7pt"><span style="font-family:Calibri,sans-serif;font-size:7.7pt">Records identi&#xfb01;ed through Medline</span></p>
<p style="top:72.7pt;left:135.9pt;line-height:7.7pt"><span style="font-family:Calibri,sans-serif;font-size:7.7pt">(n = 77)</span></p>
<p style="top:203.9pt;left:49.8pt;line-height:8.4pt"><b><span style="font-family:Calibri,sans-serif;font-size:8.4pt">Screening</span></b></p>
<p style="top:378.0pt;left:49.8pt;line-height:8.4pt"><b><span style="font-family:Calibri,sans-serif;font-size:8.4pt">Included</span></b></p>
<p style="top:290.1pt;left:49.6pt;line-height:7.7pt"><b><span style="font-family:Calibri,sans-serif;font-size:7.7pt">Eligibility</span></b></p>
<p style="top:122.4pt;left:49.8pt;line-height:8.4pt"><b><span style="font-family:Calibri,sans-serif;font-size:8.4pt">Iden&#xfffd;&#xfb01;ca&#xfffd;on</span></b></p>
<p style="top:63.0pt;left:240.5pt;line-height:7.7pt"><span style="font-family:Calibri,sans-serif;font-size:7.7pt">Addi&#xfffd;onal records iden&#xfffd;&#xfb01;ed </span></p>
<p style="top:72.4pt;left:259.5pt;line-height:7.7pt"><span style="font-family:Calibri,sans-serif;font-size:7.7pt">through Embase</span></p>
<p style="top:81.8pt;left:273.2pt;line-height:7.7pt"><span style="font-family:Calibri,sans-serif;font-size:7.7pt">(n = 83)</span></p>
<p style="top:126.1pt;left:161.9pt;line-height:7.7pt"><span style="font-family:Calibri,sans-serif;font-size:7.7pt">Records a&#xfffd;er duplicates removed</span></p>
<p style="top:135.7pt;left:200.7pt;line-height:7.7pt"><span style="font-family:Calibri,sans-serif;font-size:7.7pt">(n = 101)</span></p>
<p style="top:182.6pt;left:185.9pt;line-height:7.7pt"><span style="font-family:Calibri,sans-serif;font-size:7.7pt">Titles screened</span></p>
<p style="top:192.1pt;left:195.5pt;line-height:7.7pt"><span style="font-family:Calibri,sans-serif;font-size:7.7pt">(n = 101)</span></p>
<p style="top:170.4pt;left:305.8pt;line-height:7.7pt"><span style="font-family:Calibri,sans-serif;font-size:7.7pt">Records excluded a&#xfffd;er &#xfffd;tle </span></p>
<p style="top:179.7pt;left:317.2pt;line-height:7.7pt"><span style="font-family:Calibri,sans-serif;font-size:7.7pt">screening: review or</span></p>
<p style="top:189.1pt;left:305.2pt;line-height:7.7pt"><span style="font-family:Calibri,sans-serif;font-size:7.7pt">supplement, non-so&#xfffd; &#xfffd;ssue </span></p>
<p style="top:198.5pt;left:305.2pt;line-height:7.7pt"><span style="font-family:Calibri,sans-serif;font-size:7.7pt">study, non-English language</span></p>
<p style="top:207.9pt;left:336.9pt;line-height:7.7pt"><span style="font-family:Calibri,sans-serif;font-size:7.7pt">(n = 38)</span></p>
<p style="top:257.8pt;left:181.4pt;line-height:7.7pt"><span style="font-family:Calibri,sans-serif;font-size:7.7pt">Abstracts screened </span></p>
<p style="top:267.3pt;left:199.2pt;line-height:7.7pt"><span style="font-family:Calibri,sans-serif;font-size:7.7pt">(n = 63)</span></p>
<p style="top:245.3pt;left:299.4pt;line-height:7.7pt"><span style="font-family:Calibri,sans-serif;font-size:7.7pt">Records excluded a&#xfffd;er abstract </span></p>
<p style="top:254.7pt;left:299.4pt;line-height:7.7pt"><span style="font-family:Calibri,sans-serif;font-size:7.7pt">screening: osteoarthri&#xfffd;s animal </span></p>
<p style="top:264.0pt;left:299.5pt;line-height:7.7pt"><span style="font-family:Calibri,sans-serif;font-size:7.7pt">model, in-vitro or ex vivo study, </span></p>
<p style="top:273.4pt;left:316.2pt;line-height:7.7pt"><span style="font-family:Calibri,sans-serif;font-size:7.7pt">conference abstracts</span></p>
<p style="top:282.8pt;left:337.9pt;line-height:7.7pt"><span style="font-family:Calibri,sans-serif;font-size:7.7pt">(n =32)</span></p>
<p style="top:321.7pt;left:171.7pt;line-height:7.7pt"><span style="font-family:Calibri,sans-serif;font-size:7.7pt">Full-text ar&#xfffd;cles assessed</span></p>
<p style="top:331.1pt;left:191.8pt;line-height:7.7pt"><span style="font-family:Calibri,sans-serif;font-size:7.7pt">for eligibility</span></p>
<p style="top:340.6pt;left:199.3pt;line-height:7.7pt"><span style="font-family:Calibri,sans-serif;font-size:7.7pt">(n = 31)</span></p>
<p style="top:391.9pt;left:176.2pt;line-height:7.7pt"><span style="font-family:Calibri,sans-serif;font-size:7.7pt">Ar&#xfffd;cles included in this </span></p>
<p style="top:401.3pt;left:201.8pt;line-height:7.7pt"><span style="font-family:Calibri,sans-serif;font-size:7.7pt">review</span></p>
<p style="top:410.8pt;left:199.6pt;line-height:7.7pt"><span style="font-family:Calibri,sans-serif;font-size:7.7pt">(n =  30)</span></p>
<p style="top:324.6pt;left:299.8pt;line-height:7.7pt"><span style="font-family:Calibri,sans-serif;font-size:7.7pt">Full-text ar&#xfffd;cles excluded: non-</span></p>
<p style="top:334.0pt;left:311.3pt;line-height:7.7pt"><span style="font-family:Calibri,sans-serif;font-size:7.7pt">randomized human trial</span></p>
<p style="top:343.5pt;left:338.9pt;line-height:7.7pt"><span style="font-family:Calibri,sans-serif;font-size:7.7pt">(n = 1)</span></p>
<p style="top:118.5pt;left:309.9pt;line-height:7.7pt"><span style="font-family:Calibri,sans-serif;font-size:7.7pt;color:#ff0101">Addi&#xfffd;onal records iden&#xfffd;&#xfb01;ed </span></p>
<p style="top:127.9pt;left:314.6pt;line-height:7.7pt"><span style="font-family:Calibri,sans-serif;font-size:7.7pt;color:#ff0101">through Cochrane Library</span></p>
<p style="top:137.3pt;left:343.5pt;line-height:7.7pt"><span style="font-family:Calibri,sans-serif;font-size:7.7pt;color:#ff0101">(n =10)</span></p>
<p style="top:220.6pt;left:416.9pt;line-height:9.0pt"><span style="font-family:AdvOTc307558e.B,serif;font-size:9.0pt">Fig</span></p>
<p style="top:220.6pt;left:438.7pt;line-height:9.0pt"><span style="font-family:AdvOTc307558e.B,serif;font-size:9.0pt">1.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt"> Preclinical</span></p>
<p style="top:220.6pt;left:499.1pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">studies</span></p>
<p style="top:220.6pt;left:534.7pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">and</span></p>
<p style="top:231.6pt;left:416.9pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">clinical evidence on low-intensity</span></p>
<p style="top:242.6pt;left:416.9pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">pulsed</span></p>
<p style="top:242.6pt;left:450.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">ultrasound</span></p>
<p style="top:242.6pt;left:500.4pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">for</span></p>
<p style="top:242.6pt;left:519.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">tendon,</span></p>
<p style="top:253.5pt;left:416.9pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">ligament, and bone-tendon junc-</span></p>
<p style="top:264.4pt;left:416.9pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">tion healing.</span></p>
<p style="top:30.0pt;left:44.4pt;line-height:11.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:11.0pt">2320</span></p>
<p style="top:31.6pt;left:263.7pt;line-height:9.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt">W. C. LAI ET AL.</span></p>


<p style="top:55.1pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">chronic patellar tendinopathy compared with placebo</span></p>
<p style="top:67.1pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">control.</span></p>
<p style="top:79.1pt;left:313.9pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">Nine preclinical animal studies investigating the ef-</span></p>
<p style="top:91.0pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">fects of LIPUS on tendon healing were identi</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt">&#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">ed</span></p>
<p style="top:103.0pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">(</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt;color:#0a7fac">Table 2</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">). One of the</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt"> &#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">rst pulsed ultrasound studies by</span></p>
<p style="top:114.9pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">Roberts et al.</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">35</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">used a tenotomized profundus tendon</span></p>
<p style="top:126.9pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">in a rabbit model and ultrasound intensity of 800 mW/</span></p>
<p style="top:138.8pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">cm</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt">2</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">at a 1.1-MHz frequency. Tendons treated with</span></p>
<p style="top:150.8pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">pulsed ultrasound at this intensity did not heal, whereas</span></p>
<p style="top:162.7pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">untreated control tendons healed, illustrating a poten-</span></p>
<p style="top:174.7pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">tially damaging effect of higher-intensity pulsed ultra-</span></p>
<p style="top:186.7pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">sound treatment. Similarly, Larsen et al.</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">36</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">assessed</span></p>
<p style="top:198.6pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">LIPUS treatment in the Achilles tendon of New Zealand</span></p>
<p style="top:210.6pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">rabbits at varying intensities of 0 (control), 50, 100, 200,</span></p>
<p style="top:222.5pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">500, 750, 1,000, and 2,000 mW/cm</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt">2</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">at a 3-MHz fre-</span></p>
<p style="top:234.4pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">quency. In this study, increasing intensity of sonication</span></p>
<p style="top:246.4pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">decreased the stiffness and collagen content in the</span></p>
<p style="top:258.4pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">repaired tendons. They found that pulsed ultrasound</span></p>
<p style="top:270.3pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">did not improve the biomechanical properties of the</span></p>
<p style="top:282.3pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">healing Achilles tendon and that extensibility of ten-</span></p>
<p style="top:294.3pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">dons was higher in the group treated with 2,000 vs 50</span></p>
<p style="top:306.2pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">mW/cm</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt">2</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">(</span><span style="font-family:AdvOTc548c603.I,serif;font-size:10.0pt">P</span><span style="font-family:AdvP4C4E51,serif;font-size:10.0pt"> &lt;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt"> .01).</span></p>
<p style="top:318.2pt;left:313.9pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">In contrast, studies that used lower ultrasound in-</span></p>
<p style="top:330.1pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">tensities more consistently reported bene</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt">&#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">cial tendon-</span></p>
<p style="top:342.1pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">healing effects. da Cunha et al.</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">16</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">used an intensity of</span></p>
<p style="top:354.0pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">500 mW/cm</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt">2</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">pulsed ultrasound in a rat Achilles</span></p>
<p style="top:366.0pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">tenotomy model. At 15 days postoperatively, LIPUS-</span></p>
<p style="top:377.9pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">treated Achilles tendons showed increased synthesis</span></p>
<p style="top:389.9pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">and collagen</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt"> &#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">bril organization compared with mock-</span></p>
<p style="top:401.9pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">sonicated controls and continuous ultrasound treat-</span></p>
<p style="top:413.8pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">ment (</span><span style="font-family:AdvOTc548c603.I,serif;font-size:10.0pt">P</span><span style="font-family:AdvP4C4E74,serif;font-size:10.0pt"> &#xbc;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt"> .001). In the same rat model, Kosaka et al.</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">14</span></sup></p>
<p style="top:425.7pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">found that LIPUS treatment at 45 mW/cm</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt">2</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">signi</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt">&#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">cantly</span></p>
<p style="top:437.7pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">increased COX-2 and EP4R in the in</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt">&#xfb02;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">ammatory period</span></p>
<p style="top:449.7pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">and increased collagen I and III, as well as transforming</span></p>
<p style="top:461.6pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">groeth factor (TGF)</span><span style="font-family:AdvPS44A44B,serif;font-size:10.0pt">e</span><span style="font-family:AdvPS3F4C13,serif;font-size:10.7pt">b</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">1 messenger RNA expression,</span></p>
<p style="top:473.6pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">during the repair and reconstitution process after 2</span></p>
<p style="top:485.5pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">weeks (</span><span style="font-family:AdvOTc548c603.I,serif;font-size:10.0pt">P</span><span style="font-family:AdvP4C4E51,serif;font-size:10.0pt"> &lt;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt"> .05). The LIPUS treatment group experi-</span></p>
<p style="top:497.5pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">enced accelerated tendon repair and increased thick-</span></p>
<p style="top:509.5pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">ness of collagen I</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt"> &#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">brils compared with controls.</span></p>
<p style="top:521.4pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">Similarly, Aiyegbusi et al.</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">37</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">found that LIPUS-treated</span></p>
<p style="top:533.3pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">Achilles tendons of rabbits showed a higher popula-</span></p>
<p style="top:545.3pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">tion of tenoblasts and volume fraction of collagen</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt"> &#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">brils</span></p>
<p style="top:557.3pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">compared with control tendons. Jeremias J&#xfa;nior et al.</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">17</span></sup></p>
<p style="top:569.2pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">further examined Achilles tendon strength in 28 rats</span></p>
<p style="top:581.2pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">after undergoing tenotomy and tenorrhaphy. After a</span></p>
<p style="top:593.1pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">4-week treatment period with LIPUS, the repaired</span></p>
<p style="top:605.1pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">tendons demonstrated signi</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt">&#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">cantly greater ultimate</span></p>
<p style="top:617.0pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">load (</span><span style="font-family:AdvOTc548c603.I,serif;font-size:10.0pt">P</span><span style="font-family:AdvP4C4E74,serif;font-size:10.0pt"> &#xbc;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt"> .005) and mean tensile strength (</span><span style="font-family:AdvOTc548c603.I,serif;font-size:10.0pt">P</span><span style="font-family:AdvP4C4E74,serif;font-size:10.0pt"> &#xbc;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt"> .019)</span></p>
<p style="top:629.0pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">compared with controls, similar to the</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt"> &#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">ndings of</span></p>
<p style="top:640.9pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">Yeung et al.</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">18</span></sup></p>
<p style="top:652.9pt;left:313.9pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">With regards to temporal application, LIPUS treat-</span></p>
<p style="top:664.9pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">ment during the granulation phase of healing seems to</span></p>
<p style="top:676.8pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">be more effective than when it is applied during the</span></p>
<p style="top:688.8pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">remodeling phase. Fu et al.</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">38</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt">,</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">39</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">discovered that rats</span></p>
<p style="top:700.7pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">treated with 2 weeks of LIPUS immediately after</span></p>
<p style="top:712.7pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">patellar tendon injury demonstrated improved collagen</span></p>
<p style="top:713.5pt;left:42.7pt;line-height:9.0pt"><span style="font-family:AdvOTc307558e.B,serif;font-size:9.0pt">Table 1.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt"> Human Studies Comparing LIPUS to Controls for Tendon Healing</span></p>
<p style="top:710.9pt;left:62.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Author and</span></p>
<p style="top:698.3pt;left:72.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Year</span></p>
<p style="top:649.3pt;left:72.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Journal</span></p>
<p style="top:602.0pt;left:62.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">No. of</span></p>
<p style="top:605.4pt;left:72.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Subjects</span></p>
<p style="top:548.2pt;left:72.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Condition Treated</span></p>
<p style="top:439.0pt;left:72.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">LIPUS Dosage</span></p>
<p style="top:352.0pt;left:72.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">LIPUS Duration</span></p>
<p style="top:259.6pt;left:72.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Control</span></p>
<p style="top:165.5pt;left:72.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Outcome</span></p>
<p style="top:79.7pt;left:62.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Level of</span></p>
<p style="top:81.6pt;left:72.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Evidence</span></p>
<p style="top:714.2pt;left:83.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Warden et al.</span></p>
<p style="top:706.3pt;left:92.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">(2008)</span><span style="font-family:AdvOTf93bf98f,serif;font-size:5.6pt;color:#0a7fac">34</span></p>
<p style="top:658.4pt;left:83.7pt;line-height:8.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:8.0pt">Rheumatology</span></p>
<p style="top:650.4pt;left:93.7pt;line-height:8.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:8.0pt">(Oxford)</span></p>
<p style="top:595.5pt;left:83.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">37</span></p>
<p style="top:568.7pt;left:83.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Patellar tendinopathy</span></p>
<p style="top:455.7pt;left:82.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">1.0 MHz, 100 mW/cm</span><span style="font-family:AdvOTf93bf98f,serif;font-size:5.6pt">2</span></p>
<p style="top:365.1pt;left:83.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">20 min/d,</span></p>
<p style="top:357.1pt;left:93.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">7 d/wk for 12 weeks</span></p>
<p style="top:275.3pt;left:83.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Mock sonication</span></p>
<p style="top:209.2pt;left:83.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">In patients with chronic patellar</span></p>
<p style="top:201.2pt;left:93.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">tendinopathy, visual analog</span></p>
<p style="top:201.2pt;left:103.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">scale scores improved in both</span></p>
<p style="top:201.2pt;left:113.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">the placebo and LIPUS-treated</span></p>
<p style="top:201.2pt;left:123.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">groups with no signi</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:8.0pt">&#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">cant</span></p>
<p style="top:201.2pt;left:133.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">difference between the 2</span></p>
<p style="top:201.2pt;left:143.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">groups. LIPUS may not provide</span></p>
<p style="top:201.2pt;left:153.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">additional bene</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:8.0pt">&#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">t over placebo</span></p>
<p style="top:201.2pt;left:163.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">treatment.</span></p>
<p style="top:66.9pt;left:83.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">I</span></p>
<p style="top:714.2pt;left:173.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">D</span><span style="font-family:AdvOTf93bf98f+20,serif;font-size:8.0pt">&#x2019;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Vaz et al.</span></p>
<p style="top:706.3pt;left:181.9pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">(2006)</span><span style="font-family:AdvOTf93bf98f,serif;font-size:5.6pt;color:#0a7fac">33</span></p>
<p style="top:658.4pt;left:173.4pt;line-height:8.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:8.0pt">Rheumatology</span></p>
<p style="top:595.5pt;left:173.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">48</span></p>
<p style="top:568.7pt;left:173.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Common extensor</span><span style="font-family:AdvPS44A44B,serif;font-size:8.0pt">e</span><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">supinator</span></p>
<p style="top:560.8pt;left:183.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">tendinopathy</span></p>
<p style="top:455.7pt;left:171.9pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">1.5 MHz, 30 mW/cm</span><span style="font-family:AdvOTf93bf98f,serif;font-size:5.6pt">2</span></p>
<p style="top:365.1pt;left:173.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">20 min/d, 12 weeks</span></p>
<p style="top:275.3pt;left:173.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Mock sonication</span></p>
<p style="top:209.2pt;left:173.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">In LIPUS-treated groups, 64%</span></p>
<p style="top:201.2pt;left:183.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">achieved at least 50%</span></p>
<p style="top:201.2pt;left:193.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">improvement in baseline elbow</span></p>
<p style="top:201.2pt;left:203.0pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">pain score compared with 57%</span></p>
<p style="top:201.2pt;left:213.0pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">in control groups, but this</span></p>
<p style="top:201.2pt;left:222.9pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">difference was not signi</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:8.0pt">&#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">cant.</span></p>
<p style="top:66.9pt;left:173.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">I</span></p>
<p style="top:708.3pt;left:235.9pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">LIPUS, low-intensity pulsed ultrasound.</span></p>
<p style="top:31.6pt;left:184.5pt;line-height:9.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt">LIPUS FOR MUSCULOSKELETAL SOFT TISSUE HEALING</span></p>
<p style="top:30.0pt;left:525.4pt;line-height:11.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:11.0pt">2321</span></p>


<p style="top:713.5pt;left:42.7pt;line-height:9.0pt"><span style="font-family:AdvOTc307558e.B,serif;font-size:9.0pt">Table 2.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt"> Studies Comparing LIPUS to Controls for Tendon Healing</span></p>
<p style="top:714.2pt;left:72.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Author and Year</span></p>
<p style="top:628.4pt;left:72.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Journal</span></p>
<p style="top:571.9pt;left:62.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">No. of</span></p>
<p style="top:575.5pt;left:72.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Animals</span></p>
<p style="top:526.8pt;left:72.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Animal Type</span></p>
<p style="top:436.9pt;left:72.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Model</span></p>
<p style="top:369.7pt;left:72.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">LIPUS Dosage</span></p>
<p style="top:292.4pt;left:72.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">LIPUS Duration</span></p>
<p style="top:200.4pt;left:72.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Control</span></p>
<p style="top:113.7pt;left:72.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Outcome</span></p>
<p style="top:714.2pt;left:83.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Aiyegbusi et al.</span></p>
<p style="top:706.3pt;left:92.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">(2012)</span><span style="font-family:AdvOTf93bf98f,serif;font-size:5.6pt;color:#0a7fac">37</span></p>
<p style="top:644.8pt;left:83.7pt;line-height:8.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:8.0pt">Connect Tissue Res</span></p>
<p style="top:565.4pt;left:83.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">45</span></p>
<p style="top:540.6pt;left:83.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Sprague Dawley rats</span></p>
<p style="top:453.2pt;left:83.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Achilles tendon</span></p>
<p style="top:447.2pt;left:93.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">crush injury</span></p>
<p style="top:383.2pt;left:82.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">1 MHz, 500 mW/cm</span><span style="font-family:AdvOTf93bf98f,serif;font-size:5.6pt">2</span></p>
<p style="top:293.2pt;left:83.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">5 min/d starting</span></p>
<p style="top:293.8pt;left:93.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">POD1 for 6 days</span></p>
<p style="top:300.5pt;left:103.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">with 1 day of rest for</span></p>
<p style="top:297.6pt;left:113.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">14 days; end point</span></p>
<p style="top:295.9pt;left:123.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">POD14 or POD30</span></p>
<p style="top:210.7pt;left:83.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">No treatment</span></p>
<p style="top:145.4pt;left:83.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">LIPUS resulted in a</span></p>
<p style="top:137.5pt;left:93.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">signi</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:8.0pt">&#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">cant increase in</span></p>
<p style="top:137.5pt;left:103.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">tenocyte population at</span></p>
<p style="top:137.5pt;left:113.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">POD14, and a higher</span></p>
<p style="top:137.5pt;left:123.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">population of tenoblasts</span></p>
<p style="top:137.5pt;left:133.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">at POD30 day compared</span></p>
<p style="top:137.5pt;left:143.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">with normal tendons</span></p>
<p style="top:137.5pt;left:153.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">and an increase in</span></p>
<p style="top:137.5pt;left:163.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">collagen</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:8.0pt"> &#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">bers compared</span></p>
<p style="top:137.5pt;left:173.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">with controls.</span></p>
<p style="top:714.2pt;left:183.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Jeremias J&#xfa;nior</span></p>
<p style="top:706.3pt;left:191.9pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">et al. (2011)</span><span style="font-family:AdvOTf93bf98f,serif;font-size:5.6pt;color:#0a7fac">17</span></p>
<p style="top:645.9pt;left:183.3pt;line-height:8.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:8.0pt">J Orthop Sports PT</span></p>
<p style="top:565.4pt;left:183.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">28</span></p>
<p style="top:523.1pt;left:183.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Wistar rats</span></p>
<p style="top:457.7pt;left:183.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Achilles tenotomy</span></p>
<p style="top:443.9pt;left:193.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">and repair</span></p>
<p style="top:383.2pt;left:181.9pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">1 MHz, 100 mW/cm</span><span style="font-family:AdvOTf93bf98f,serif;font-size:5.6pt">2</span></p>
<p style="top:293.2pt;left:183.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">5 min/d starting</span></p>
<p style="top:298.1pt;left:193.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">POD1 until POD28</span></p>
<p style="top:216.1pt;left:183.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Mock sonication</span></p>
<p style="top:145.4pt;left:183.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">LIPUS treatment</span></p>
<p style="top:137.5pt;left:193.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">demonstrated</span></p>
<p style="top:137.5pt;left:203.0pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">signi</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:8.0pt">&#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">cantly greater</span></p>
<p style="top:137.5pt;left:213.0pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">ultimate load (</span><span style="font-family:AdvOTc548c603.I,serif;font-size:8.0pt">P</span><span style="font-family:AdvP4C4E74,serif;font-size:8.0pt"> &#xbc;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt"> .005)</span></p>
<p style="top:137.5pt;left:222.9pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">and mean tensile</span></p>
<p style="top:137.5pt;left:232.9pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">strength (</span><span style="font-family:AdvOTc548c603.I,serif;font-size:8.0pt">P</span><span style="font-family:AdvP4C4E74,serif;font-size:8.0pt"> &#xbc;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt"> .019)</span></p>
<p style="top:137.5pt;left:242.9pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">compared with controls.</span></p>
<p style="top:137.5pt;left:252.9pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">No signi</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:8.0pt">&#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">cant difference</span></p>
<p style="top:137.5pt;left:262.8pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">was found in cross-</span></p>
<p style="top:137.5pt;left:272.8pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">sectional area and</span></p>
<p style="top:137.5pt;left:282.8pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">energy absorption.</span></p>
<p style="top:714.2pt;left:292.7pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Kosaka et al.</span></p>
<p style="top:706.3pt;left:301.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">(2011)</span><span style="font-family:AdvOTf93bf98f,serif;font-size:5.6pt;color:#0a7fac">14</span></p>
<p style="top:641.7pt;left:292.9pt;line-height:8.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:8.0pt">W Indian Med J</span></p>
<p style="top:565.4pt;left:292.7pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">98</span></p>
<p style="top:540.6pt;left:292.7pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Sprague Dawley rats</span></p>
<p style="top:457.7pt;left:292.7pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Achilles tenotomy</span></p>
<p style="top:384.0pt;left:291.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">1.5 MHz, 45 mW/cm</span><span style="font-family:AdvOTf93bf98f,serif;font-size:5.6pt">2</span></p>
<p style="top:296.5pt;left:292.7pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">20 min/d, starting</span></p>
<p style="top:274.9pt;left:302.7pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">POD0</span></p>
<p style="top:210.1pt;left:292.7pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Contralateral</span></p>
<p style="top:215.4pt;left:302.7pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">nontreated limb</span></p>
<p style="top:145.4pt;left:292.7pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">LIPUS treatment</span></p>
<p style="top:137.5pt;left:302.7pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">accelerated repair of</span></p>
<p style="top:137.5pt;left:312.6pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Achilles tendon</span></p>
<p style="top:137.5pt;left:322.6pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">compared with</span></p>
<p style="top:137.5pt;left:332.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">untreated groups on</span></p>
<p style="top:137.5pt;left:342.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">electron microscopy.</span></p>
<p style="top:137.5pt;left:352.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">COX-2 and EP4 were</span></p>
<p style="top:137.5pt;left:362.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">overexpressed with</span></p>
<p style="top:137.5pt;left:372.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">LIPUS treatment in the</span></p>
<p style="top:137.5pt;left:382.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">in</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:8.0pt">&#xfb02;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">ammatory period.</span></p>
<p style="top:137.5pt;left:392.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">TGF-</span><span style="font-family:AdvPS3F4C13,serif;font-size:8.5pt">b</span><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">1 expression was</span></p>
<p style="top:137.5pt;left:402.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">markedly induced in</span></p>
<p style="top:137.5pt;left:412.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">LIPUS-treated groups,</span></p>
<p style="top:137.5pt;left:422.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">followed by collagen I</span></p>
<p style="top:137.5pt;left:432.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">and II expression in the</span></p>
<p style="top:137.5pt;left:442.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">repair and reconstitution</span></p>
<p style="top:137.5pt;left:452.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">process.</span></p>
<p style="top:87.0pt;left:468.7pt;line-height:7.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt">(continued)</span></p>
<p style="top:30.0pt;left:44.4pt;line-height:11.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:11.0pt">2322</span></p>
<p style="top:31.6pt;left:263.7pt;line-height:9.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt">W. C. LAI ET AL.</span></p>


<p style="top:713.5pt;left:42.8pt;line-height:9.0pt"><span style="font-family:AdvOTc307558e.B,serif;font-size:9.0pt">Table 2.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt"> Continued</span></p>
<p style="top:714.2pt;left:72.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Author and Year</span></p>
<p style="top:628.4pt;left:72.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Journal</span></p>
<p style="top:571.9pt;left:62.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">No. of</span></p>
<p style="top:575.5pt;left:72.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Animals</span></p>
<p style="top:526.8pt;left:72.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Animal Type</span></p>
<p style="top:436.9pt;left:72.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Model</span></p>
<p style="top:369.7pt;left:72.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">LIPUS Dosage</span></p>
<p style="top:292.4pt;left:72.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">LIPUS Duration</span></p>
<p style="top:200.4pt;left:72.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Control</span></p>
<p style="top:113.7pt;left:72.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Outcome</span></p>
<p style="top:714.2pt;left:82.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Fu et al. (2010)</span><span style="font-family:AdvOTf93bf98f,serif;font-size:5.6pt;color:#0a7fac">38</span></p>
<p style="top:645.9pt;left:83.9pt;line-height:8.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:8.0pt">J Orthop Sports PT</span></p>
<p style="top:565.4pt;left:83.7pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">78</span></p>
<p style="top:540.6pt;left:83.7pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Sprague Dawley rats</span></p>
<p style="top:448.4pt;left:83.7pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Central third</span></p>
<p style="top:452.6pt;left:93.6pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">patellar tendon</span></p>
<p style="top:440.1pt;left:103.6pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">removal</span></p>
<p style="top:379.6pt;left:83.7pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">1.5 MHz, 150 mW/</span></p>
<p style="top:352.1pt;left:92.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">cm</span><span style="font-family:AdvOTf93bf98f,serif;font-size:5.6pt">2</span></p>
<p style="top:299.6pt;left:83.7pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">20 min/d on POD4,</span></p>
<p style="top:280.8pt;left:93.6pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">14, or 28</span></p>
<p style="top:216.1pt;left:83.7pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Mock sonication</span></p>
<p style="top:145.4pt;left:83.7pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">LIPUS increased COL1A1</span></p>
<p style="top:137.5pt;left:93.6pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">and COL3A1 mRNA in</span></p>
<p style="top:137.5pt;left:103.6pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">healing patellar tendons</span></p>
<p style="top:137.5pt;left:113.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">when administered on</span></p>
<p style="top:137.5pt;left:123.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">POD4 or POD14. LIPUS</span></p>
<p style="top:137.5pt;left:133.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">enhanced collagen</span></p>
<p style="top:137.5pt;left:143.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">synthesis in vivo only</span></p>
<p style="top:137.5pt;left:153.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">during the granulation</span></p>
<p style="top:137.5pt;left:163.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">phase.</span></p>
<p style="top:714.2pt;left:172.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Fu et al. (2008)</span><span style="font-family:AdvOTf93bf98f,serif;font-size:5.6pt;color:#0a7fac">39</span></p>
<p style="top:624.7pt;left:173.5pt;line-height:8.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:8.0pt">AJSM</span></p>
<p style="top:565.4pt;left:173.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">60</span></p>
<p style="top:540.8pt;left:173.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Sprague-Dawley rats</span></p>
<p style="top:448.4pt;left:173.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Central third</span></p>
<p style="top:452.6pt;left:183.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">patellar tendon</span></p>
<p style="top:440.1pt;left:193.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">removal</span></p>
<p style="top:381.0pt;left:172.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">1 MHz, 30 mW/cm</span><span style="font-family:AdvOTf93bf98f,serif;font-size:5.6pt">2</span></p>
<p style="top:285.6pt;left:173.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">20 min/d, 5</span></p>
<p style="top:296.6pt;left:183.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">consecutive d/wk,</span></p>
<p style="top:297.1pt;left:193.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">starting POD1, 14,</span></p>
<p style="top:300.5pt;left:203.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">or 28 and treated for</span></p>
<p style="top:293.3pt;left:213.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">2, 4, or 6 weeks</span></p>
<p style="top:216.1pt;left:173.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Mock sonication</span></p>
<p style="top:145.4pt;left:173.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">LIPUS treatment improved</span></p>
<p style="top:137.5pt;left:183.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">mechanical strength and</span></p>
<p style="top:137.5pt;left:193.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">collagen alignment in</span></p>
<p style="top:137.5pt;left:203.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">healing tendons only</span></p>
<p style="top:137.5pt;left:213.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">when applied during the</span></p>
<p style="top:137.5pt;left:223.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">early stages of healing or</span></p>
<p style="top:137.5pt;left:233.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">the</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:8.0pt"> &#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">rst 2 weeks</span></p>
<p style="top:137.5pt;left:243.0pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">postoperatively.</span></p>
<p style="top:137.5pt;left:253.0pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Extension of treatment</span></p>
<p style="top:137.5pt;left:263.0pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">beyond 2 weeks did not</span></p>
<p style="top:137.5pt;left:272.9pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">lead to further</span></p>
<p style="top:137.5pt;left:282.9pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">improvement of these</span></p>
<p style="top:137.5pt;left:292.8pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">effects.</span></p>
<p style="top:714.2pt;left:302.8pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Yeung et al.</span></p>
<p style="top:706.3pt;left:311.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">(2006)</span><span style="font-family:AdvOTf93bf98f,serif;font-size:5.6pt;color:#0a7fac">18</span></p>
<p style="top:635.8pt;left:303.1pt;line-height:8.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:8.0pt">J Orthop Res</span></p>
<p style="top:565.4pt;left:302.8pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">48</span></p>
<p style="top:540.6pt;left:302.8pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Sprague Dawley rats</span></p>
<p style="top:439.5pt;left:302.8pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Achilles</span></p>
<p style="top:451.6pt;left:312.8pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">hemitenotomy</span></p>
<p style="top:383.2pt;left:301.6pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">1 MHz, 500 mW/cm</span><span style="font-family:AdvOTf93bf98f,serif;font-size:5.6pt">2</span></p>
<p style="top:295.7pt;left:302.8pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">5 min/d, 3 times/</span></p>
<p style="top:300.5pt;left:312.8pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">week, starting POD1</span></p>
<p style="top:293.9pt;left:322.7pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">for 2 or 4 weeks</span></p>
<p style="top:216.1pt;left:302.8pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Mock sonication</span></p>
<p style="top:145.4pt;left:302.8pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">LIPUS-treated tendons</span></p>
<p style="top:137.5pt;left:312.8pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">after 2 or 4 weeks had</span></p>
<p style="top:137.5pt;left:322.7pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">signi</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:8.0pt">&#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">cantly higher</span></p>
<p style="top:137.5pt;left:332.7pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">ultimate tensile strength</span></p>
<p style="top:137.5pt;left:342.7pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">and stiffness (</span><span style="font-family:AdvOTc548c603.I,serif;font-size:8.0pt">P</span><span style="font-family:AdvP4C4E51,serif;font-size:8.0pt"> &lt;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt"> .05).</span></p>
<p style="top:137.5pt;left:352.6pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">LIPUS-treated tendons</span></p>
<p style="top:137.5pt;left:362.6pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">demonstrated more</span></p>
<p style="top:137.5pt;left:372.6pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">mature denser scar tissue</span></p>
<p style="top:137.5pt;left:382.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">and better aligned</span></p>
<p style="top:137.5pt;left:392.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">collagen</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:8.0pt"> &#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">ber bundles,</span></p>
<p style="top:137.5pt;left:402.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">especially after 4 weeks.</span></p>
<p style="top:87.0pt;left:419.1pt;line-height:7.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt">(continued)</span></p>
<p style="top:31.6pt;left:184.5pt;line-height:9.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt">LIPUS FOR MUSCULOSKELETAL SOFT TISSUE HEALING</span></p>
<p style="top:30.0pt;left:525.4pt;line-height:11.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:11.0pt">2323</span></p>


<p style="top:713.5pt;left:42.8pt;line-height:9.0pt"><span style="font-family:AdvOTc307558e.B,serif;font-size:9.0pt">Table 2.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt"> Continued</span></p>
<p style="top:714.2pt;left:72.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Author and Year</span></p>
<p style="top:628.4pt;left:72.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Journal</span></p>
<p style="top:571.9pt;left:62.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">No. of</span></p>
<p style="top:575.5pt;left:72.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Animals</span></p>
<p style="top:526.8pt;left:72.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Animal Type</span></p>
<p style="top:436.9pt;left:72.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Model</span></p>
<p style="top:369.7pt;left:72.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">LIPUS Dosage</span></p>
<p style="top:292.4pt;left:72.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">LIPUS Duration</span></p>
<p style="top:200.4pt;left:72.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Control</span></p>
<p style="top:113.7pt;left:72.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Outcome</span></p>
<p style="top:714.2pt;left:83.7pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Larsen et al.</span></p>
<p style="top:706.3pt;left:92.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">(2005)</span><span style="font-family:AdvOTf93bf98f,serif;font-size:5.6pt;color:#0a7fac">36</span></p>
<p style="top:634.5pt;left:83.9pt;line-height:8.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:8.0pt">Acta Orthop</span></p>
<p style="top:565.4pt;left:83.7pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">72</span></p>
<p style="top:540.3pt;left:83.7pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">New Zealand rabbits</span></p>
<p style="top:457.7pt;left:83.7pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Achilles tenotomy</span></p>
<p style="top:443.9pt;left:93.6pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">and repair</span></p>
<p style="top:381.0pt;left:83.7pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">3 MHz; 0 (controls),</span></p>
<p style="top:377.5pt;left:93.6pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">50, 100, 200, 500,</span></p>
<p style="top:384.0pt;left:103.6pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">750, 1,000, and 2,000</span></p>
<p style="top:352.7pt;left:113.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">mW</span></p>
<p style="top:279.9pt;left:83.7pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">5 min/d,</span></p>
<p style="top:300.3pt;left:93.6pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">consecutively for 10</span></p>
<p style="top:272.4pt;left:103.6pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">days</span></p>
<p style="top:216.1pt;left:83.7pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Mock sonication</span></p>
<p style="top:145.4pt;left:83.7pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Stiffness and collagen</span></p>
<p style="top:137.5pt;left:93.6pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">content declined with</span></p>
<p style="top:137.5pt;left:103.6pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">increasing intensities of</span></p>
<p style="top:137.5pt;left:113.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">ultrasound. Extensibility</span></p>
<p style="top:137.5pt;left:123.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">of the healing tendons</span></p>
<p style="top:137.5pt;left:133.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">was greater at higher</span></p>
<p style="top:137.5pt;left:143.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">intensity. There was no</span></p>
<p style="top:137.5pt;left:153.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">signi</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:8.0pt">&#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">cant effect on the</span></p>
<p style="top:137.5pt;left:163.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">load at rupture and</span></p>
<p style="top:137.5pt;left:173.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">normalized load at</span></p>
<p style="top:137.5pt;left:183.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">rupture of ultrasound-</span></p>
<p style="top:137.5pt;left:193.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">treated healing tendons</span></p>
<p style="top:137.5pt;left:203.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">compared with controls.</span></p>
<p style="top:714.2pt;left:213.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">da Cunha et al.</span></p>
<p style="top:706.3pt;left:221.9pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">(2001)</span><span style="font-family:AdvOTf93bf98f,serif;font-size:5.6pt;color:#0a7fac">16</span></p>
<p style="top:648.7pt;left:213.4pt;line-height:8.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:8.0pt">Ultrasound Med Biol</span></p>
<p style="top:565.4pt;left:213.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">30</span></p>
<p style="top:523.1pt;left:213.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Wistar rats</span></p>
<p style="top:457.7pt;left:213.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Achilles tenotomy</span></p>
<p style="top:383.2pt;left:211.9pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">1 MHz, 500 mW/cm</span><span style="font-family:AdvOTf93bf98f,serif;font-size:5.6pt">2</span></p>
<p style="top:294.3pt;left:213.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">5 min/d, starting</span></p>
<p style="top:299.5pt;left:223.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">POD1 until POD 14</span></p>
<p style="top:214.8pt;left:213.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Mock-sonicated</span></p>
<p style="top:216.8pt;left:223.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">tenotomized and</span></p>
<p style="top:215.9pt;left:233.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">nontenotomized</span></p>
<p style="top:201.1pt;left:243.0pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">tendons</span></p>
<p style="top:145.4pt;left:213.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">LIPUS-treated tendons</span></p>
<p style="top:137.5pt;left:223.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">during the</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:8.0pt"> &#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">rst 14 days</span></p>
<p style="top:137.5pt;left:233.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">of healing demonstrated</span></p>
<p style="top:137.5pt;left:243.0pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">improved arrangement,</span></p>
<p style="top:137.5pt;left:253.0pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">aggregation state, and</span></p>
<p style="top:137.5pt;left:263.0pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">molecular order of</span></p>
<p style="top:137.5pt;left:272.9pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">collagen</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:8.0pt"> &#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">brils compared</span></p>
<p style="top:137.5pt;left:282.9pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">with controls and</span></p>
<p style="top:137.5pt;left:292.8pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">continuous ultrasound</span></p>
<p style="top:137.5pt;left:302.8pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">treatment.</span></p>
<p style="top:714.3pt;left:312.8pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Roberts et al.</span></p>
<p style="top:706.3pt;left:321.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">(1982)</span><span style="font-family:AdvOTf93bf98f,serif;font-size:5.6pt;color:#0a7fac">35</span></p>
<p style="top:624.0pt;left:313.1pt;line-height:8.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:8.0pt">Hand</span></p>
<p style="top:565.4pt;left:312.8pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">14</span></p>
<p style="top:540.3pt;left:312.8pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">New Zealand rabbits</span></p>
<p style="top:443.8pt;left:312.8pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Profundus</span></p>
<p style="top:442.7pt;left:322.7pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">tenotomy</span></p>
<p style="top:379.6pt;left:312.8pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">1.1 MHz, 800 mW/</span></p>
<p style="top:352.1pt;left:321.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">cm</span><span style="font-family:AdvOTf93bf98f,serif;font-size:5.6pt">2</span></p>
<p style="top:300.2pt;left:312.8pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">5 min/d, 5 d/wk for</span></p>
<p style="top:279.1pt;left:322.7pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">6 weeks</span></p>
<p style="top:204.6pt;left:312.8pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Untreated</span></p>
<p style="top:209.2pt;left:322.7pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">contralateral</span></p>
<p style="top:201.1pt;left:332.7pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">tendons</span></p>
<p style="top:145.4pt;left:312.8pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">None of the tendons</span></p>
<p style="top:137.5pt;left:322.7pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">treated with ultrasound</span></p>
<p style="top:137.5pt;left:332.7pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">healed compared with</span></p>
<p style="top:137.5pt;left:342.7pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">untreated controls.</span></p>
<p style="top:708.3pt;left:355.6pt;line-height:8.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:8.0pt">AJSM</span><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">,</span><span style="font-family:AdvOTc548c603.I,serif;font-size:8.0pt"> American Journal of Sports Medicine</span><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">; LIPUS, low-intensity pulsed ultrasound; mRNA, messenger RNA; POD, postoperative day; TGF-</span><span style="font-family:AdvPS3F4C13,serif;font-size:8.5pt">b</span><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">1, transforming growth factor</span><span style="font-family:AdvPS3F4C13,serif;font-size:8.5pt"> b</span><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">1.</span></p>
<p style="top:30.0pt;left:44.4pt;line-height:11.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:11.0pt">2324</span></p>
<p style="top:31.6pt;left:263.7pt;line-height:9.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt">W. C. LAI ET AL.</span></p>


<p style="top:713.5pt;left:58.4pt;line-height:9.0pt"><span style="font-family:AdvOTc307558e.B,serif;font-size:9.0pt">Table 3.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt"> Animal Studies Comparing LIPUS to Controls for Ligament Healing</span></p>
<p style="top:714.2pt;left:88.0pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Author and Year</span></p>
<p style="top:638.2pt;left:88.0pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Journal</span></p>
<p style="top:582.2pt;left:78.0pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">No.</span></p>
<p style="top:595.3pt;left:88.0pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">of Animals</span></p>
<p style="top:537.4pt;left:88.0pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Animal Type</span></p>
<p style="top:447.8pt;left:88.0pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Model</span></p>
<p style="top:378.5pt;left:88.0pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">LIPUS Dosage</span></p>
<p style="top:297.7pt;left:88.0pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">LIPUS Duration</span></p>
<p style="top:211.4pt;left:88.0pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Control</span></p>
<p style="top:122.7pt;left:88.0pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Outcome</span></p>
<p style="top:714.2pt;left:99.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Warden et al.</span></p>
<p style="top:706.3pt;left:107.8pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">(2006)</span><span style="font-family:AdvOTf93bf98f,serif;font-size:5.6pt;color:#0a7fac">19</span></p>
<p style="top:634.5pt;left:99.4pt;line-height:8.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:8.0pt">AJSM</span></p>
<p style="top:580.5pt;left:99.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">60</span></p>
<p style="top:551.2pt;left:99.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Sprague Dawley rats</span></p>
<p style="top:470.7pt;left:99.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">MCL transection of</span></p>
<p style="top:462.2pt;left:109.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">bilateral knees</span></p>
<p style="top:395.1pt;left:95.6pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">1.0 MHz, 100 mW/ cm</span><span style="font-family:AdvOTf93bf98f,serif;font-size:5.6pt">2</span><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt"> 20 min/d, 5 d/wk for</span></p>
<p style="top:303.6pt;left:109.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">2, 4, and 12 weeks</span></p>
<p style="top:227.1pt;left:99.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Mock sonication At 2 weeks, LIPUS-treated</span></p>
<p style="top:155.4pt;left:109.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">ligaments were 34.2%</span></p>
<p style="top:155.4pt;left:119.0pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">stronger, were 27.0% stiffer,</span></p>
<p style="top:155.4pt;left:129.0pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">and had 54.4% higher energy</span></p>
<p style="top:155.4pt;left:139.0pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">to failure compared with</span></p>
<p style="top:155.4pt;left:149.0pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">controls. No signi</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:8.0pt">&#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">cant</span></p>
<p style="top:155.4pt;left:158.9pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">differences were found</span></p>
<p style="top:155.4pt;left:168.9pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">between treated and control</span></p>
<p style="top:155.4pt;left:178.8pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">ligaments at 4 and 12 weeks.</span></p>
<p style="top:714.2pt;left:188.8pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Leung et al.</span></p>
<p style="top:706.3pt;left:197.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">(2005)</span><span style="font-family:AdvOTf93bf98f,serif;font-size:5.6pt;color:#0a7fac">41</span></p>
<p style="top:642.9pt;left:189.1pt;line-height:8.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:8.0pt">Ultrasound</span></p>
<p style="top:639.3pt;left:199.0pt;line-height:8.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:8.0pt">Med Biol</span></p>
<p style="top:580.5pt;left:188.8pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">36</span></p>
<p style="top:551.2pt;left:188.8pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Sprague Dawley rats</span></p>
<p style="top:470.7pt;left:188.8pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">MCL transection of</span></p>
<p style="top:462.2pt;left:198.7pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">bilateral knees</span></p>
<p style="top:394.8pt;left:188.8pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">3.0 MHz, 0, 500, 2,300</span></p>
<p style="top:369.8pt;left:197.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">mW/cm</span><span style="font-family:AdvOTf93bf98f,serif;font-size:5.6pt">2</span></p>
<p style="top:304.6pt;left:188.8pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">5 min/d for 1, 5, or</span></p>
<p style="top:283.4pt;left:198.7pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">10 days</span></p>
<p style="top:227.1pt;left:188.8pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Mock sonication Ultrasound treatment in high-</span></p>
<p style="top:155.4pt;left:198.7pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">dose application enhances</span></p>
<p style="top:155.4pt;left:208.7pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">ligament repair by</span></p>
<p style="top:155.4pt;left:218.7pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">upregulating expression of</span></p>
<p style="top:155.4pt;left:228.6pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">TGF-</span><span style="font-family:AdvPS3F4C13,serif;font-size:8.5pt">b</span><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">1 after treatment for 5</span></p>
<p style="top:155.4pt;left:238.6pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">and 10 days. Treatment at 10</span></p>
<p style="top:155.4pt;left:248.6pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">days had higher expression of</span></p>
<p style="top:155.4pt;left:258.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">TGF-</span><span style="font-family:AdvPS3F4C13,serif;font-size:8.5pt">b</span><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">1 than at 5 days.</span></p>
<p style="top:714.3pt;left:268.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Sparrow et al.</span></p>
<p style="top:706.3pt;left:277.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">(2004)</span><span style="font-family:AdvOTf93bf98f,serif;font-size:5.6pt;color:#0a7fac">40</span></p>
<p style="top:634.5pt;left:268.7pt;line-height:8.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:8.0pt">AJSM</span></p>
<p style="top:580.5pt;left:268.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">21</span></p>
<p style="top:550.9pt;left:268.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">New Zealand rabbits</span></p>
<p style="top:470.7pt;left:268.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">MCL transection of</span></p>
<p style="top:462.2pt;left:278.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">bilateral knees</span></p>
<p style="top:395.1pt;left:267.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">1.0 MHz, 300 mW/ cm</span><span style="font-family:AdvOTf93bf98f,serif;font-size:5.6pt">2</span></p>
<p style="top:298.4pt;left:268.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">10 min/d, every</span></p>
<p style="top:300.6pt;left:278.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">other day, 6 total</span></p>
<p style="top:288.7pt;left:288.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">treatments</span></p>
<p style="top:227.1pt;left:268.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Mock sonication At 3 and 6 weeks</span></p>
<p style="top:155.4pt;left:278.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">postoperatively, LIPUS-</span></p>
<p style="top:155.4pt;left:288.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">treated ligaments had a higher</span></p>
<p style="top:155.4pt;left:298.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">proportion of type I collagen</span></p>
<p style="top:155.4pt;left:308.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">compared with controls. At 6</span></p>
<p style="top:155.4pt;left:318.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">weeks, LIPUS-treated</span></p>
<p style="top:155.4pt;left:328.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">ligaments were larger, with</span></p>
<p style="top:155.4pt;left:338.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">higher ultimate load, ultimate</span></p>
<p style="top:155.4pt;left:348.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">displacement, and energy</span></p>
<p style="top:155.4pt;left:358.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">absorption compared with</span></p>
<p style="top:155.4pt;left:368.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">controls. No signi</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:8.0pt">&#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">cant</span></p>
<p style="top:155.4pt;left:378.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">biomechanical differences</span></p>
<p style="top:155.4pt;left:388.0pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">were observed at 3 weeks.</span></p>
<p style="top:714.2pt;left:398.0pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Takakura et al.</span></p>
<p style="top:706.3pt;left:406.7pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">(2002)</span><span style="font-family:AdvOTf93bf98f,serif;font-size:5.6pt;color:#0a7fac">12</span></p>
<p style="top:645.9pt;left:398.3pt;line-height:8.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:8.0pt">J Ultrasound</span></p>
<p style="top:631.7pt;left:408.2pt;line-height:8.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:8.0pt">Med</span></p>
<p style="top:580.5pt;left:398.0pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">13</span></p>
<p style="top:551.2pt;left:398.0pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Sprague Dawley rats</span></p>
<p style="top:470.7pt;left:398.0pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">MCL transection of</span></p>
<p style="top:462.2pt;left:408.0pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">bilateral knees</span></p>
<p style="top:393.0pt;left:396.7pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">1.5 MHz, 30 mW/cm</span><span style="font-family:AdvOTf93bf98f,serif;font-size:5.6pt">2</span></p>
<p style="top:295.9pt;left:398.0pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">20 min/d until</span></p>
<p style="top:301.1pt;left:408.0pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">POD12 or POD21</span></p>
<p style="top:215.6pt;left:398.0pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Untreated</span></p>
<p style="top:163.4pt;left:398.0pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">At POD12, LIPUS-treated</span></p>
<p style="top:155.4pt;left:408.0pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">ligaments demonstrated</span></p>
<p style="top:155.4pt;left:417.9pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">superior mechanical</span></p>
<p style="top:155.4pt;left:427.9pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">properties compared with</span></p>
<p style="top:155.4pt;left:437.9pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">controls in ultimate load,</span></p>
<p style="top:155.4pt;left:447.8pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">stiffness, and energy</span></p>
<p style="top:155.4pt;left:457.8pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">absorption (</span><span style="font-family:AdvOTc548c603.I,serif;font-size:8.0pt">P</span><span style="font-family:AdvP4C4E51,serif;font-size:8.0pt"> &lt;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt"> .05). There</span></p>
<p style="top:155.4pt;left:467.7pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">was no difference at POD21.</span></p>
<p style="top:155.4pt;left:477.7pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Mean</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:8.0pt"> &#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">bril diameter was</span></p>
<p style="top:155.4pt;left:487.6pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">signi</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:8.0pt">&#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">cantly larger with LIPUS</span></p>
<p style="top:155.4pt;left:497.6pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">treatment than on the control</span></p>
<p style="top:155.4pt;left:507.6pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">side (</span><span style="font-family:AdvOTc548c603.I,serif;font-size:8.0pt">P</span><span style="font-family:AdvP4C4E51,serif;font-size:8.0pt"> &lt;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt"> .05).</span></p>
<p style="top:708.3pt;left:520.5pt;line-height:8.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:8.0pt">AJSM</span><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">,</span><span style="font-family:AdvOTc548c603.I,serif;font-size:8.0pt"> American Journal of Sports Medicine</span><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">; LIPUS, low-intensity pulsed ultrasound; MCL, medial collateral ligament; POD, postoperative day; TGF-</span><span style="font-family:AdvPS3F4C13,serif;font-size:8.5pt">b</span><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">1, transforming growth factor</span><span style="font-family:AdvPS3F4C13,serif;font-size:8.5pt"> b</span><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">1.</span></p>
<p style="top:31.6pt;left:184.5pt;line-height:9.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt">LIPUS FOR MUSCULOSKELETAL SOFT TISSUE HEALING</span></p>
<p style="top:30.0pt;left:525.4pt;line-height:11.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:11.0pt">2325</span></p>


<p style="top:55.1pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">alignment and increased strength but not when LIPUS</span></p>
<p style="top:67.1pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">was applied after the initial 2-week injury period.</span></p>
<p style="top:91.0pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTd1f5cc91.B,serif;font-size:10.0pt">Effects of LIPUS on Ligament Healing</span></p>
<p style="top:103.0pt;left:52.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">Four preclinical animal studies investigating the effects</span></p>
<p style="top:114.9pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">of LIPUS in MCL transection models were identi</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt">&#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">ed</span></p>
<p style="top:126.9pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">(</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt;color:#0a7fac">Table3</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">).Ina rat model, Takakura etal.</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">12</span></sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">found improved</span></p>
<p style="top:138.8pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">mechanical properties in LIPUS-treated MCLs compared</span></p>
<p style="top:150.8pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">with untreated contralateral MCLs at 12 days post-</span></p>
<p style="top:162.7pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">operatively. Specimens from the LIPUS-treated knees had</span></p>
<p style="top:174.7pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">a signi</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt">&#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">cantly higher mean ultimate load (21.6</span><span style="font-family:AdvP4C4E74,serif;font-size:10.0pt"> &#xfffd;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt"> 2.0 N)</span></p>
<p style="top:186.7pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">compared with untreated contralateral knees (17.8</span><span style="font-family:AdvP4C4E74,serif;font-size:10.0pt"> &#xfffd;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt"> 0.9</span></p>
<p style="top:198.6pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">N) along with greater stiffness, mean energy absorption,</span></p>
<p style="top:210.6pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">and mean</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt"> &#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">bril diameter (</span><span style="font-family:AdvOTc548c603.I,serif;font-size:10.0pt">P</span><span style="font-family:AdvP4C4E51,serif;font-size:10.0pt"> &lt;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt"> .05). No difference was</span></p>
<p style="top:222.5pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">found in mechanical properties at 3 weeks post-</span></p>
<p style="top:234.4pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">operatively. Similarly, Warden et al.</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">19</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">showed that rats</span></p>
<p style="top:246.4pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">with transected MCLs treated with LIPUS for 2 weeks</span></p>
<p style="top:258.4pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">were 34.2% stronger, were 27.0% stiffer, and absorbed</span></p>
<p style="top:270.3pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">54.4% more energy before failure than controls, but there</span></p>
<p style="top:282.3pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">was no difference in these properties at 4 and 12 weeks of</span></p>
<p style="top:294.3pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">treatment. In addition, Sparrow et al.</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">40</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">also showed that</span></p>
<p style="top:306.2pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">LIPUS-treated ligaments demonstrated superior ultimate</span></p>
<p style="top:318.2pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">load and energy absorption compared with the sham-</span></p>
<p style="top:330.1pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">treated controls at 6 weeks. The cross-sectional areas of</span></p>
<p style="top:342.1pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">ligament scars were larger, and the proportion of type I</span></p>
<p style="top:354.0pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">collagen was greater in LIPUS-treated ligaments.</span></p>
<p style="top:366.0pt;left:52.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">Leung et al.</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">41</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">suggested that LIPUS could lead to liga-</span></p>
<p style="top:377.9pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">ment healing by promoting upregulation of TGF-</span><span style="font-family:AdvPS3F4C13,serif;font-size:10.7pt">b</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">1</span></p>
<p style="top:389.9pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">during the in</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt">&#xfb02;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">ammation and proliferation phases of soft</span></p>
<p style="top:401.9pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">tissue healing. This study used transected MCLs in rat</span></p>
<p style="top:413.8pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">models at varying intensities (0, 500, and 2,300 mW/cm</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt">2</span></sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">)</span></p>
<p style="top:425.7pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">to assess the healing ligament. Their study demonstrated</span></p>
<p style="top:437.7pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">that TGF-</span><span style="font-family:AdvPS3F4C13,serif;font-size:10.7pt">b</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">1 was signi</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt">&#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">cantly elevated at 5 days and 10</span></p>
<p style="top:449.7pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">days after ultrasound treatment in their high-dose group,</span></p>
<p style="top:461.6pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">with elevation being highest at 10 days.</span></p>
<p style="top:485.5pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTd1f5cc91.B,serif;font-size:10.0pt">Effect of LIPUS on the B-ST Junction</span></p>
<p style="top:497.5pt;left:52.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">Fifteen preclinical animal studies investigating the</span></p>
<p style="top:509.5pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">effects of LIPUS on B-ST junction healing were identi-</span></p>
<p style="top:521.4pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt">&#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">ed (</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt;color:#0a7fac">Table 4</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">).</span></p>
<p style="top:543.3pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTd1f5cc91.B,serif;font-size:10.0pt">Cellular Effects</span></p>
<p style="top:555.3pt;left:52.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">Several animal studies have noted increased vascularity</span></p>
<p style="top:567.2pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">in LIPUS-treated B-ST junctions. Lu et al.</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">13</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">demonstrated</span></p>
<p style="top:579.2pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">that early vascular endothelial growth factor (VEGF)</span></p>
<p style="top:591.1pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">upregulation plays a role in healing at the patella</span><span style="font-family:AdvPS44A44B,serif;font-size:10.0pt">e</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">patellar</span></p>
<p style="top:603.1pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">tendon junction in rabbits. At 4 weeks postoperatively,</span></p>
<p style="top:615.0pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">chondrocytes and osteoblasts in woven bone expressed</span></p>
<p style="top:627.0pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">signi</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt">&#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">cantly more VEGF on immunohistologic staining in</span></p>
<p style="top:639.0pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">the LIPUS group compared with controls (</span><span style="font-family:AdvOTc548c603.I,serif;font-size:10.0pt">P</span><span style="font-family:AdvP4C4E51,serif;font-size:10.0pt"> &lt;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt"> .05).</span></p>
<p style="top:650.9pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">Similarly, after ACL reconstruction in sheep, Walsh</span></p>
<p style="top:662.9pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">et al.</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">20</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">found increased vascularity and angiogenesis at 3,</span></p>
<p style="top:674.8pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">6, and 12 weeks postoperatively at the B-ST junction in</span></p>
<p style="top:686.7pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">femoral and tibial bone tunnels compared with untreated</span></p>
<p style="top:698.7pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">controls. In an ovine rotator cuff tear model, Lovric et al.</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">22</span></sup></p>
<p style="top:710.7pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">further demonstrated signi</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt">&#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">cantly increased protein</span></p>
<p style="top:55.1pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">expression of VEGF (</span><span style="font-family:AdvOTc548c603.I,serif;font-size:10.0pt">P</span><span style="font-family:AdvP4C4E74,serif;font-size:10.0pt"> &#xbc;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt"> .038), RUNX2 (</span><span style="font-family:AdvOTc548c603.I,serif;font-size:10.0pt">P</span><span style="font-family:AdvP4C4E74,serif;font-size:10.0pt"> &#xbc;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt"> .02), and</span></p>
<p style="top:67.1pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">Smad4 (</span><span style="font-family:AdvOTc548c603.I,serif;font-size:10.0pt">P</span><span style="font-family:AdvP4C4E74,serif;font-size:10.0pt"> &#xbc;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt"> .05) in the rotator cuff B-ST junction 4 weeks</span></p>
<p style="top:79.1pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">postoperatively in LIPUS treatment groups.</span></p>
<p style="top:91.0pt;left:313.9pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">Several studies have demonstrated that LIPUS has a role</span></p>
<p style="top:103.0pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">in the regulation of growth factors and cytokines at the</span></p>
<p style="top:114.9pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">B-ST junction. Results from this study indicated that at</span></p>
<p style="top:126.9pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">postoperative day (POD) 0, TGF-</span><span style="font-family:AdvPS3F4C13,serif;font-size:10.7pt">b</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">1 was upregulated in a</span></p>
<p style="top:138.8pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">bimodal distribution (POD0 and POD14).</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">42</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">Lu et al.</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">43</span></sup></p>
<p style="top:150.8pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">showed that LIPUS has an anti-in</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt">&#xfb02;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">ammatory role in the</span></p>
<p style="top:162.7pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">process of B-ST junction healing. At the inferior</span></p>
<p style="top:174.7pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">pole</span><span style="font-family:AdvPS44A44B,serif;font-size:10.0pt">e</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">patellar tendon junction, messenger RNA expres-</span></p>
<p style="top:186.7pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">sion of TGF-</span><span style="font-family:AdvPS3F4C13,serif;font-size:10.7pt">b</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">1 and interleukin (IL) 10, which has anti-</span></p>
<p style="top:198.6pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">in</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt">&#xfb02;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">ammatory effects, was signi</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt">&#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">cantly higher in the</span></p>
<p style="top:210.6pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">LIPUS-treated groups compared with placebo-treated</span></p>
<p style="top:222.5pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">controls at 4, 8, and 16 weeks (</span><span style="font-family:AdvOTc548c603.I,serif;font-size:10.0pt">P</span><span style="font-family:AdvP4C4E51,serif;font-size:10.0pt"> &lt;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt"> .05). In contrast,</span></p>
<p style="top:234.4pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">expression of proin</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt">&#xfb02;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">ammatory cytokines, tumor necrosis</span></p>
<p style="top:246.4pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">factor</span><span style="font-family:AdvPS44A44B,serif;font-size:10.0pt">e</span><span style="font-family:AdvPS3F4C13,serif;font-size:10.7pt">a</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt"> and IL-1</span><span style="font-family:AdvPS3F4C13,serif;font-size:10.7pt">b</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">, were lower compared with placebo-</span></p>
<p style="top:258.4pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">treated specimens. Gene expression of in</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt">&#xfb02;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">ammatory</span></p>
<p style="top:270.3pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">cytokine IL-6 in LIPUS groups was also signi</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt">&#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">cantly lower</span></p>
<p style="top:282.3pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">at week 4 (</span><span style="font-family:AdvOTc548c603.I,serif;font-size:10.0pt">P</span><span style="font-family:AdvP4C4E51,serif;font-size:10.0pt"> &lt;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt"> .05).</span></p>
<p style="top:304.2pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTd1f5cc91.B,serif;font-size:10.0pt">Bone Formation at the B-ST Junction</span></p>
<p style="top:316.1pt;left:313.9pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">Among</span></p>
<p style="top:316.1pt;left:355.8pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">the</span></p>
<p style="top:316.1pt;left:379.6pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">reviewed</span></p>
<p style="top:316.1pt;left:429.1pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">studies,</span></p>
<p style="top:316.1pt;left:471.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">LIPUS</span></p>
<p style="top:316.1pt;left:507.2pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">promoted</span></p>
<p style="top:328.1pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">increased bone formation at the B-ST junction after</span></p>
<p style="top:340.1pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">surgery compared with controls (</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt;color:#0a7fac">Table 4</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">). Studies of the</span></p>
<p style="top:352.0pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">distal pole</span><span style="font-family:AdvPS44A44B,serif;font-size:10.0pt">e</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">patellar tendon junction of a rabbit patel-</span></p>
<p style="top:364.0pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">lectomy model showed that bone formation was higher</span></p>
<p style="top:376.0pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">in the LIPUS-treated groups compared with untreated</span></p>
<p style="top:387.9pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">groups at 8, 12, 16, and 18 weeks after patellec-</span></p>
<p style="top:399.8pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">tomy.</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">21</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt">,</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">23</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt">,</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">43-47</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">In one study by Qin et al.,</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">21</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">bone for-</span></p>
<p style="top:411.8pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">mation was 2.6 and 3.0 times greater in the LIPUS group</span></p>
<p style="top:423.7pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">compared with the control group at 8 and 16 weeks after</span></p>
<p style="top:435.7pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">patellectomy, respectively. In addition, in an ovine ro-</span></p>
<p style="top:447.7pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">tator cuff repair model, Lovric et al.</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">22</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">found that LIPUS-</span></p>
<p style="top:459.6pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">treated groups demonstrated a thicker region of woven</span></p>
<p style="top:471.6pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">bone with increased osteoblast activity at the B-ST</span></p>
<p style="top:483.6pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">interface in the initial phase of healing. A recent study by</span></p>
<p style="top:495.5pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">Chen et al.</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">48</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">found that a combination of LIPUS and</span></p>
<p style="top:507.4pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">adipose-derived stem cells led to greater bone formation.</span></p>
<p style="top:519.4pt;left:313.9pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">Bone mineral density (BMD) is also increased with</span></p>
<p style="top:531.3pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">LIPUS treatment at the B-ST junction. Lovric et al.</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">22</span></sup></p>
<p style="top:543.3pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">demonstrated that at 4 weeks postoperatively, BMD at</span></p>
<p style="top:555.3pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">the footprint of the rotator cuff repair was signi</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt">&#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">cantly</span></p>
<p style="top:567.2pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">higher in the LIPUS-treated group (</span><span style="font-family:AdvOTc548c603.I,serif;font-size:10.0pt">P</span><span style="font-family:AdvP4C4E51,serif;font-size:10.0pt"> &lt;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt"> .01). Further-</span></p>
<p style="top:579.2pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">more, in the rabbit postpatellectomy model, multiple</span></p>
<p style="top:591.1pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">authors have demonstrated that LIPUS enhances BMD</span></p>
<p style="top:603.1pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">at the B-ST junction at 6, 8, and 12 weeks post-</span></p>
<p style="top:615.0pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">operatively compared with controls.</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">21</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt">,</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">45</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt">,</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">47</span></sup></p>
<p style="top:627.0pt;left:313.9pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">Last, LIPUS treatment at the B-ST junction has been</span></p>
<p style="top:639.0pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">associated with accelerated bone remodeling and for-</span></p>
<p style="top:650.9pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">mation of new trabecular bone.</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">24</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt">,</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">38</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">The histologic</span></p>
<p style="top:662.9pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">assessment by Lu et al.</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">24</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">of LIPUS-treated patellectomy</span></p>
<p style="top:674.8pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">rabbit models showed formation of irregular woven</span></p>
<p style="top:686.7pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">bone as early as 8 weeks postpatellectomy with overall</span></p>
<p style="top:698.7pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">eventual progression to more mature bone compared</span></p>
<p style="top:710.7pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">with control groups.</span></p>
<p style="top:30.0pt;left:44.4pt;line-height:11.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:11.0pt">2326</span></p>
<p style="top:31.6pt;left:263.7pt;line-height:9.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt">W. C. LAI ET AL.</span></p>


<p style="top:713.5pt;left:42.7pt;line-height:9.0pt"><span style="font-family:AdvOTc307558e.B,serif;font-size:9.0pt">Table 4.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt"> Animal Studies Comparing LIPUS to Controls for Bone</span><span style="font-family:AdvPS44A44B,serif;font-size:9.0pt">e</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">Soft Tissue Junction Healing</span></p>
<p style="top:714.2pt;left:72.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Author and Year</span></p>
<p style="top:630.8pt;left:72.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Journal</span></p>
<p style="top:576.9pt;left:62.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">No. of</span></p>
<p style="top:580.5pt;left:72.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Animals Animal Type</span></p>
<p style="top:461.9pt;left:72.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Model</span></p>
<p style="top:387.2pt;left:72.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">LIPUS Dosage</span></p>
<p style="top:311.3pt;left:72.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">LIPUS Duration</span></p>
<p style="top:227.8pt;left:72.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Control</span></p>
<p style="top:131.6pt;left:72.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Outcome</span></p>
<p style="top:714.2pt;left:83.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Chen et al.</span></p>
<p style="top:706.3pt;left:92.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">(2019)</span><span style="font-family:AdvOTf93bf98f,serif;font-size:5.6pt;color:#0a7fac">48</span></p>
<p style="top:627.1pt;left:83.7pt;line-height:8.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:8.0pt">AJSM</span></p>
<p style="top:572.6pt;left:83.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">112</span></p>
<p style="top:546.8pt;left:83.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">New Zealand</span></p>
<p style="top:535.2pt;left:93.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">rabbits</span></p>
<p style="top:494.8pt;left:83.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Partial patellectomy with</span></p>
<p style="top:489.2pt;left:93.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">patellar tendon repair</span></p>
<p style="top:401.5pt;left:82.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">1.5 mHz, 30 mW/cm</span><span style="font-family:AdvOTf93bf98f,serif;font-size:5.6pt">2</span></p>
<p style="top:315.4pt;left:83.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">20 min/d, starting</span></p>
<p style="top:317.5pt;left:93.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">POD3 until 8 or 16</span></p>
<p style="top:294.4pt;left:103.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">weeks</span></p>
<p style="top:243.5pt;left:83.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Mock sonication Autologous ASC transplantation</span></p>
<p style="top:173.3pt;left:93.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">stimulated with LIPUS increased</span></p>
<p style="top:173.3pt;left:103.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">bone formation, regenerated</span></p>
<p style="top:173.3pt;left:113.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:8.0pt">&#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">brocartilage, and led to higher</span></p>
<p style="top:173.3pt;left:123.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">failure load and stiffness compared</span></p>
<p style="top:173.3pt;left:133.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">with LIPUS- or ASC-treated group.</span></p>
<p style="top:714.2pt;left:142.0pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Lu et al. (2018)</span><span style="font-family:AdvOTf93bf98f,serif;font-size:5.6pt;color:#0a7fac">46</span></p>
<p style="top:643.1pt;left:143.5pt;line-height:8.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:8.0pt">Am J Phys Med</span></p>
<p style="top:629.7pt;left:153.5pt;line-height:8.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:8.0pt">Rehabil</span></p>
<p style="top:572.6pt;left:143.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">120</span></p>
<p style="top:546.8pt;left:143.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">New Zealand</span></p>
<p style="top:535.2pt;left:153.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">rabbits</span></p>
<p style="top:494.8pt;left:143.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Partial patellectomy with</span></p>
<p style="top:492.1pt;left:153.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">patella</span><span style="font-family:AdvPS44A44B,serif;font-size:8.0pt">e</span><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">patellar tendon</span></p>
<p style="top:461.0pt;left:163.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">repair</span></p>
<p style="top:401.7pt;left:142.0pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">1.5 MHz, 30 mW/cm</span><span style="font-family:AdvOTf93bf98f,serif;font-size:5.6pt">2</span></p>
<p style="top:312.8pt;left:143.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">20-min duration</span></p>
<p style="top:319.0pt;left:153.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">with 2 groups: daily</span></p>
<p style="top:308.7pt;left:163.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">or twice daily.</span></p>
<p style="top:316.7pt;left:173.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Starting POD7 and</span></p>
<p style="top:319.4pt;left:183.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">up to 8 or 16 weeks</span></p>
<p style="top:243.5pt;left:143.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Mock sonication LIPUS treatment twice a day was</span></p>
<p style="top:173.3pt;left:153.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">more effective than once-a-day</span></p>
<p style="top:173.3pt;left:163.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">treatment on BSTJ healing,</span></p>
<p style="top:173.3pt;left:173.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">showing increased bone formation,</span></p>
<p style="top:173.3pt;left:183.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:8.0pt">&#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">brocartilage regeneration, and</span></p>
<p style="top:173.3pt;left:193.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">biomechanical properties.</span></p>
<p style="top:714.2pt;left:201.8pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Lu et al. (2016)</span><span style="font-family:AdvOTf93bf98f,serif;font-size:5.6pt;color:#0a7fac">50</span></p>
<p style="top:627.1pt;left:203.3pt;line-height:8.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:8.0pt">AJSM</span></p>
<p style="top:572.6pt;left:203.0pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">112</span></p>
<p style="top:546.8pt;left:203.0pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">New Zealand</span></p>
<p style="top:535.2pt;left:213.0pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">rabbits</span></p>
<p style="top:494.8pt;left:203.0pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Partial patellectomy with</span></p>
<p style="top:489.2pt;left:213.0pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">patellar tendon repair</span></p>
<p style="top:401.7pt;left:201.8pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">1.5 MHz, 30 mW/cm</span><span style="font-family:AdvOTf93bf98f,serif;font-size:5.6pt">2</span></p>
<p style="top:315.4pt;left:203.0pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">20 min/d, starting</span></p>
<p style="top:318.4pt;left:213.0pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">on POD0, POD7, or</span></p>
<p style="top:316.9pt;left:222.9pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">POD14 until 8 and</span></p>
<p style="top:300.1pt;left:232.9pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">16 weeks</span></p>
<p style="top:243.5pt;left:203.0pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Mock sonication LIPUS-treated groups improved</span></p>
<p style="top:173.3pt;left:213.0pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">biomechanical properties at the</span></p>
<p style="top:173.3pt;left:222.9pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">BSTJ. LIPUS initiated at POD7 was</span></p>
<p style="top:173.3pt;left:232.9pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">more effective than initiating at</span></p>
<p style="top:173.3pt;left:242.9pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">POD0 or POD14, as demonstrated</span></p>
<p style="top:173.3pt;left:252.9pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">by increased stiffness, ultimate</span></p>
<p style="top:173.3pt;left:262.8pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">strength, bone volume, and bone</span></p>
<p style="top:173.3pt;left:272.8pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">mineral content.</span></p>
<p style="top:714.2pt;left:281.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Lu et al. (2016)</span><span style="font-family:AdvOTf93bf98f,serif;font-size:5.6pt;color:#0a7fac">43</span></p>
<p style="top:638.3pt;left:283.0pt;line-height:8.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:8.0pt">J Orthop Res</span></p>
<p style="top:570.4pt;left:282.8pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">36</span></p>
<p style="top:546.8pt;left:282.8pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">New Zealand</span></p>
<p style="top:535.2pt;left:292.7pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">rabbits</span></p>
<p style="top:494.8pt;left:282.8pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Partial patellectomy with</span></p>
<p style="top:489.2pt;left:292.7pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">patellar tendon repair</span></p>
<p style="top:401.7pt;left:279.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">1.5 MHz, 30 mW/cm</span><span style="font-family:AdvOTf93bf98f,serif;font-size:5.6pt">2</span><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt"> 20 min/d, starting 2</span></p>
<p style="top:294.4pt;left:292.7pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">weeks</span></p>
<p style="top:310.3pt;left:302.7pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">postoperatively</span></p>
<p style="top:314.5pt;left:312.6pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">until 4, 8, and 16</span></p>
<p style="top:294.4pt;left:322.6pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">weeks</span></p>
<p style="top:243.5pt;left:282.8pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Mock sonication LIPUS treatment resulted in greater</span></p>
<p style="top:173.3pt;left:292.7pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">mRNA expression of anti-</span></p>
<p style="top:173.3pt;left:302.7pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">in</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:8.0pt">&#xfb02;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">ammatory cytokines TGF-</span><span style="font-family:AdvPS3F4C13,serif;font-size:8.5pt">b</span><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">1</span></p>
<p style="top:173.3pt;left:312.6pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">and IL-10 compared with controls</span></p>
<p style="top:173.3pt;left:322.6pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">at 4, 8, and 16 weeks. Expression of</span></p>
<p style="top:173.3pt;left:332.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">proin</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:8.0pt">&#xfb02;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">ammatory cytokines, TNF-</span><span style="font-family:AdvPS3F4C13,serif;font-size:8.5pt">a</span></p>
<p style="top:173.3pt;left:342.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">and IL-1</span><span style="font-family:AdvPS3F4C13,serif;font-size:8.5pt">b</span><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">, was lower at 4 and 8</span></p>
<p style="top:173.3pt;left:352.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">weeks compared with controls.</span></p>
<p style="top:173.3pt;left:362.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">IL-6 mRNA expression in LIPUS</span></p>
<p style="top:173.3pt;left:372.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">groups was also lower at 4 weeks.</span></p>
<p style="top:173.3pt;left:382.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">LIPUS treatment also resulted in</span></p>
<p style="top:173.3pt;left:392.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">higher failure load, ultimate</span></p>
<p style="top:173.3pt;left:402.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">strength, and energy at failure</span></p>
<p style="top:173.3pt;left:412.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">compared with controls at 4, 8, and</span></p>
<p style="top:173.3pt;left:422.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">16 weeks.</span></p>
<p style="top:714.2pt;left:430.9pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Lu et al. (2015)</span><span style="font-family:AdvOTf93bf98f,serif;font-size:5.6pt;color:#0a7fac">24</span></p>
<p style="top:633.3pt;left:432.4pt;line-height:8.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:8.0pt">PLoS One</span></p>
<p style="top:570.4pt;left:432.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">24</span></p>
<p style="top:546.8pt;left:432.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">New Zealand</span></p>
<p style="top:535.2pt;left:442.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">rabbits</span></p>
<p style="top:494.8pt;left:432.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Partial patellectomy with</span></p>
<p style="top:489.2pt;left:442.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">patellar tendon repair</span></p>
<p style="top:401.7pt;left:430.9pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">1.5 MHz, 30 mW/cm</span><span style="font-family:AdvOTf93bf98f,serif;font-size:5.6pt">2</span></p>
<p style="top:315.4pt;left:432.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">20 min/d, starting</span></p>
<p style="top:317.5pt;left:442.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">POD7 until 8 or 16</span></p>
<p style="top:294.4pt;left:452.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">weeks</span></p>
<p style="top:243.5pt;left:432.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Mock sonication LIPUS accelerated bone formation</span></p>
<p style="top:173.3pt;left:442.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">and remodeling of new trabecular</span></p>
<p style="top:173.3pt;left:452.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">bone during the BSTJ healing</span></p>
<p style="top:173.3pt;left:462.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">process compared with controls, as</span></p>
<p style="top:173.3pt;left:472.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">evidenced by 3-dimensional</span></p>
<p style="top:173.3pt;left:482.0pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">visualization of new trabecular</span></p>
<p style="top:173.3pt;left:492.0pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">bone on micro-CT.</span></p>
<p style="top:87.0pt;left:508.6pt;line-height:7.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt">(continued)</span></p>
<p style="top:31.6pt;left:184.5pt;line-height:9.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt">LIPUS FOR MUSCULOSKELETAL SOFT TISSUE HEALING</span></p>
<p style="top:30.0pt;left:525.4pt;line-height:11.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:11.0pt">2327</span></p>


<p style="top:713.5pt;left:42.8pt;line-height:9.0pt"><span style="font-family:AdvOTc307558e.B,serif;font-size:9.0pt">Table 4.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt"> Continued</span></p>
<p style="top:714.2pt;left:72.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Author and Year</span></p>
<p style="top:630.8pt;left:72.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Journal</span></p>
<p style="top:576.9pt;left:62.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">No. of</span></p>
<p style="top:580.5pt;left:72.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Animals Animal Type</span></p>
<p style="top:461.9pt;left:72.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Model</span></p>
<p style="top:387.2pt;left:72.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">LIPUS Dosage</span></p>
<p style="top:311.3pt;left:72.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">LIPUS Duration</span></p>
<p style="top:227.8pt;left:72.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Control</span></p>
<p style="top:131.6pt;left:72.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Outcome</span></p>
<p style="top:714.2pt;left:83.7pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Hu et al.</span></p>
<p style="top:706.3pt;left:92.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">(2013)</span><span style="font-family:AdvOTf93bf98f,serif;font-size:5.6pt;color:#0a7fac">45</span></p>
<p style="top:638.3pt;left:83.9pt;line-height:8.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:8.0pt">J Orthop Res</span></p>
<p style="top:570.4pt;left:83.7pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">20</span></p>
<p style="top:546.8pt;left:83.7pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">New Zealand</span></p>
<p style="top:535.2pt;left:93.6pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">rabbits</span></p>
<p style="top:494.8pt;left:83.7pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Partial patellectomy with</span></p>
<p style="top:489.2pt;left:93.6pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">patellar tendon repair</span></p>
<p style="top:401.7pt;left:82.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">1.5 MHz, 30 mW/cm</span><span style="font-family:AdvOTf93bf98f,serif;font-size:5.6pt">2</span></p>
<p style="top:314.1pt;left:83.7pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">LIPUS: 20 min/d,</span></p>
<p style="top:317.7pt;left:93.6pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">starting POD3 until</span></p>
<p style="top:299.0pt;left:103.6pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">6 weeks.</span></p>
<p style="top:313.7pt;left:113.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">FES: 30 min/d, 5</span></p>
<p style="top:309.6pt;left:123.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">times/wk for 6</span></p>
<p style="top:313.4pt;left:133.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">weeks, starting 6</span></p>
<p style="top:294.4pt;left:143.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">weeks</span></p>
<p style="top:310.3pt;left:153.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">postoperatively</span></p>
<p style="top:232.0pt;left:83.7pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Untreated</span></p>
<p style="top:181.3pt;left:83.7pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">LIPUS treatment alone, late FES, or</span></p>
<p style="top:173.3pt;left:93.6pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">LIPUS</span><span style="font-family:AdvP4C4E74,serif;font-size:8.0pt"> &#xfe;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt"> late FES demonstrated</span></p>
<p style="top:173.3pt;left:103.6pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">increased area and bone mineral</span></p>
<p style="top:173.3pt;left:113.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">content of new bone, improved</span></p>
<p style="top:173.3pt;left:123.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">remodeling of newly formed bone/</span></p>
<p style="top:173.3pt;left:133.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:8.0pt">&#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">brocartilage zone, and improved</span></p>
<p style="top:173.3pt;left:143.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">failure load and ultimate strength of</span></p>
<p style="top:173.3pt;left:153.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">the BSTJ compared with untreated</span></p>
<p style="top:173.3pt;left:163.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">controls. LIPUS alone improved</span></p>
<p style="top:173.3pt;left:173.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">ultimate strength (LIPUS: 7.24</span><span style="font-family:AdvP4C4E74,serif;font-size:8.0pt"> &#xfffd;</span></p>
<p style="top:173.3pt;left:183.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">1.58 MPa vs control: 4.20</span><span style="font-family:AdvP4C4E74,serif;font-size:8.0pt"> &#xfffd;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt"> 0.69</span></p>
<p style="top:173.3pt;left:193.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">MPa,</span><span style="font-family:AdvOTc548c603.I,serif;font-size:8.0pt"> P</span><span style="font-family:AdvP4C4E51,serif;font-size:8.0pt"> &lt;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt"> .05).</span></p>
<p style="top:714.3pt;left:203.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Lovric et al.</span></p>
<p style="top:706.3pt;left:211.9pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">(2013)</span><span style="font-family:AdvOTf93bf98f,serif;font-size:5.6pt;color:#0a7fac">22</span></p>
<p style="top:645.1pt;left:203.5pt;line-height:8.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:8.0pt">Knee Surg Sports</span></p>
<p style="top:649.0pt;left:213.4pt;line-height:8.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:8.0pt">Traumatol Arthrosc</span></p>
<p style="top:568.2pt;left:203.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">8</span></p>
<p style="top:538.3pt;left:203.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Wethers</span></p>
<p style="top:489.5pt;left:203.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Infraspinatous tendon</span></p>
<p style="top:486.8pt;left:213.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">complex injury with</span></p>
<p style="top:474.8pt;left:223.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">tendon repair</span></p>
<p style="top:401.7pt;left:201.9pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">1.5 MHz, 30 mW/cm</span><span style="font-family:AdvOTf93bf98f,serif;font-size:5.6pt">2</span></p>
<p style="top:316.0pt;left:203.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">20 min/d, 5 d/wk,</span></p>
<p style="top:307.5pt;left:213.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">until 4 weeks</span></p>
<p style="top:232.0pt;left:203.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Untreated</span></p>
<p style="top:181.3pt;left:203.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">LIPUS upregulates growth factor</span></p>
<p style="top:173.3pt;left:213.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">expression (Smad 4, VEGF, and</span></p>
<p style="top:173.3pt;left:223.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">RUNX2), improves bone-tendon</span></p>
<p style="top:173.3pt;left:233.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">integration, and increases BMD at</span></p>
<p style="top:173.3pt;left:243.0pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">the rotator cuff repair footprint</span></p>
<p style="top:173.3pt;left:253.0pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">compared with untreated controls.</span></p>
<p style="top:714.2pt;left:261.7pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Lu et al. (2009)</span><span style="font-family:AdvOTf93bf98f,serif;font-size:5.6pt;color:#0a7fac">49</span></p>
<p style="top:635.9pt;left:263.2pt;line-height:8.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:8.0pt">Orthopedics</span></p>
<p style="top:570.4pt;left:263.0pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">20</span></p>
<p style="top:546.8pt;left:263.0pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">New Zealand</span></p>
<p style="top:535.2pt;left:272.9pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">rabbits</span></p>
<p style="top:484.8pt;left:263.0pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Extensor digitorum</span></p>
<p style="top:495.0pt;left:272.9pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">longus transplantation to</span></p>
<p style="top:486.4pt;left:282.9pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">proximal tibial bone</span></p>
<p style="top:462.2pt;left:292.8pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">tunnel</span></p>
<p style="top:401.7pt;left:259.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">1.0 MHz, 48 mW/cm</span><span style="font-family:AdvOTf93bf98f,serif;font-size:5.6pt">2</span><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt"> 20 min/d until 1, 3,</span></p>
<p style="top:309.7pt;left:272.9pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">6, or 12 weeks</span></p>
<p style="top:243.5pt;left:263.0pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Mock sonication LIPUS-treated BSTJ demonstrated</span></p>
<p style="top:173.3pt;left:272.9pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">denser granulation tissue and</span></p>
<p style="top:173.3pt;left:282.9pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">increased tensile strength during</span></p>
<p style="top:173.3pt;left:292.8pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">the early stages of healing. LIPUS</span></p>
<p style="top:173.3pt;left:302.8pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">treatment also exhibited new bone</span></p>
<p style="top:173.3pt;left:312.8pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">formation compared with mock-</span></p>
<p style="top:173.3pt;left:322.7pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">treated controls.</span></p>
<p style="top:714.2pt;left:329.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Lu et al. (2009)</span><span style="font-family:AdvOTf93bf98f,serif;font-size:5.6pt;color:#0a7fac">47</span><span style="font-family:AdvOTc548c603.I,serif;font-size:8.0pt"> Conf Proc IEEE Eng</span></p>
<p style="top:638.2pt;left:342.9pt;line-height:8.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:8.0pt">Med Biol Soc</span></p>
<p style="top:570.4pt;left:332.7pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">24</span></p>
<p style="top:546.8pt;left:332.7pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">New Zealand</span></p>
<p style="top:535.2pt;left:342.7pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">rabbits</span></p>
<p style="top:494.8pt;left:332.7pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Partial patellectomy with</span></p>
<p style="top:489.2pt;left:342.7pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">patellar tendon repair</span></p>
<p style="top:401.5pt;left:331.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">1.5 mHz, 30 mW/cm</span><span style="font-family:AdvOTf93bf98f,serif;font-size:5.6pt">2</span></p>
<p style="top:315.4pt;left:332.7pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">20 min/d, starting</span></p>
<p style="top:319.4pt;left:342.7pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">POD3, until 6, 12, or</span></p>
<p style="top:300.1pt;left:352.6pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">18 weeks</span></p>
<p style="top:232.0pt;left:332.7pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Untreated</span></p>
<p style="top:181.3pt;left:332.7pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">LIPUS treatment showed higher</span></p>
<p style="top:173.3pt;left:342.7pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">BMD at week 6 and increased new</span></p>
<p style="top:173.3pt;left:352.6pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">bone and stiffness of tissues at the</span></p>
<p style="top:173.3pt;left:362.6pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">BSTJ compared with controls at</span></p>
<p style="top:173.3pt;left:372.6pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">week 18.</span></p>
<p style="top:714.2pt;left:382.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Papatheodorou</span></p>
<p style="top:706.3pt;left:391.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">et al. (2009)</span><span style="font-family:AdvOTf93bf98f,serif;font-size:5.6pt;color:#0a7fac">42</span></p>
<p style="top:643.6pt;left:382.8pt;line-height:8.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:8.0pt">Ultrasound Med</span></p>
<p style="top:623.8pt;left:392.7pt;line-height:8.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:8.0pt">Biol</span></p>
<p style="top:570.4pt;left:382.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">52</span></p>
<p style="top:546.8pt;left:382.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">New Zealand</span></p>
<p style="top:535.2pt;left:392.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">rabbits</span></p>
<p style="top:481.8pt;left:382.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">ACL excision and</span></p>
<p style="top:494.2pt;left:392.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">reconstruction with long</span></p>
<p style="top:491.6pt;left:402.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">digital extensor tendon</span></p>
<p style="top:466.6pt;left:412.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">autograft</span></p>
<p style="top:398.5pt;left:381.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">1 MHz, 30 mW/cm</span><span style="font-family:AdvOTf93bf98f,serif;font-size:5.6pt">2</span></p>
<p style="top:315.4pt;left:382.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">20 min/d, starting</span></p>
<p style="top:319.4pt;left:392.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">POD1 until POD1, 2,</span></p>
<p style="top:317.4pt;left:402.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">5, 7, 9, 12, 14, and</span></p>
<p style="top:287.9pt;left:412.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">21</span></p>
<p style="top:232.0pt;left:382.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Untreated</span></p>
<p style="top:181.3pt;left:382.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Transosseous LIPUS treatment led to</span></p>
<p style="top:173.3pt;left:392.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">faster healing rate of the BSTJ and</span></p>
<p style="top:173.3pt;left:402.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">stable graft incorporation within</span></p>
<p style="top:173.3pt;left:412.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">the tibial bone tunnel compared</span></p>
<p style="top:173.3pt;left:422.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">with the control group. LIPUS</span></p>
<p style="top:173.3pt;left:432.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">induced upregulation of biglycan</span></p>
<p style="top:173.3pt;left:442.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">and collagen I gene, while TGF-</span><span style="font-family:AdvPS3F4C13,serif;font-size:8.5pt">b</span><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">1</span></p>
<p style="top:173.3pt;left:452.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">expression exhibited a bimodal</span></p>
<p style="top:173.3pt;left:462.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">pro</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:8.0pt">&#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">le.</span></p>
<p style="top:87.0pt;left:478.8pt;line-height:7.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt">(continued)</span></p>
<p style="top:30.0pt;left:44.4pt;line-height:11.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:11.0pt">2328</span></p>
<p style="top:31.6pt;left:263.7pt;line-height:9.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt">W. C. LAI ET AL.</span></p>


<p style="top:713.5pt;left:42.8pt;line-height:9.0pt"><span style="font-family:AdvOTc307558e.B,serif;font-size:9.0pt">Table 4.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt"> Continued</span></p>
<p style="top:714.2pt;left:72.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Author and Year</span></p>
<p style="top:630.8pt;left:72.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Journal</span></p>
<p style="top:576.9pt;left:62.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">No. of</span></p>
<p style="top:580.5pt;left:72.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Animals Animal Type</span></p>
<p style="top:461.9pt;left:72.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Model</span></p>
<p style="top:387.2pt;left:72.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">LIPUS Dosage</span></p>
<p style="top:311.3pt;left:72.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">LIPUS Duration</span></p>
<p style="top:227.8pt;left:72.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Control</span></p>
<p style="top:131.6pt;left:72.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Outcome</span></p>
<p style="top:714.2pt;left:82.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Lu et al. (2008)</span><span style="font-family:AdvOTf93bf98f,serif;font-size:5.6pt;color:#0a7fac">13</span></p>
<p style="top:643.6pt;left:83.9pt;line-height:8.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:8.0pt">Ultrasound Med</span></p>
<p style="top:623.8pt;left:93.8pt;line-height:8.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:8.0pt">Biol</span></p>
<p style="top:570.4pt;left:83.7pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">64</span></p>
<p style="top:546.8pt;left:83.7pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">New Zealand</span></p>
<p style="top:535.2pt;left:93.6pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">rabbits</span></p>
<p style="top:494.8pt;left:83.7pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Partial patellectomy with</span></p>
<p style="top:489.2pt;left:93.6pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">patellar tendon repair</span></p>
<p style="top:401.7pt;left:82.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">1.5 MHz, 30 mW/cm</span><span style="font-family:AdvOTf93bf98f,serif;font-size:5.6pt">2</span></p>
<p style="top:316.0pt;left:83.7pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">5 d/wk, 20 min/d,</span></p>
<p style="top:317.7pt;left:93.6pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">starting POD3 until</span></p>
<p style="top:309.5pt;left:103.6pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">2, 4, 8, and 16</span></p>
<p style="top:294.4pt;left:113.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">weeks</span></p>
<p style="top:232.0pt;left:83.7pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Untreated</span></p>
<p style="top:181.3pt;left:83.7pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">LIPUS treatment accelerated early</span></p>
<p style="top:173.3pt;left:93.6pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">angiogenesis by upregulating</span></p>
<p style="top:173.3pt;left:103.6pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">VEGF, leading to subsequent</span></p>
<p style="top:173.3pt;left:113.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">chondrogenesis during BSTJ</span></p>
<p style="top:173.3pt;left:123.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">healing. LIPUS treatment led to</span></p>
<p style="top:173.3pt;left:133.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">thicker</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:8.0pt"> &#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">brocartilage zone and</span></p>
<p style="top:173.3pt;left:143.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">larger cartilaginous metaplasia at</span></p>
<p style="top:173.3pt;left:153.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">BSTJ.</span></p>
<p style="top:714.2pt;left:163.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Walsh et al.</span></p>
<p style="top:706.3pt;left:172.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">(2007)</span><span style="font-family:AdvOTf93bf98f,serif;font-size:5.6pt;color:#0a7fac">20</span></p>
<p style="top:636.4pt;left:163.6pt;line-height:8.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:8.0pt">Arthroscopy</span></p>
<p style="top:570.4pt;left:163.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">89</span></p>
<p style="top:538.3pt;left:163.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Wethers</span></p>
<p style="top:481.8pt;left:163.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">ACL excision and</span></p>
<p style="top:494.2pt;left:173.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">reconstruction with long</span></p>
<p style="top:491.6pt;left:183.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">digital extensor tendon</span></p>
<p style="top:466.6pt;left:193.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">autograft</span></p>
<p style="top:401.5pt;left:162.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">1.5 mHz, 30 mW/cm</span><span style="font-family:AdvOTf93bf98f,serif;font-size:5.6pt">2</span></p>
<p style="top:314.6pt;left:163.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">20 min/d, treated</span></p>
<p style="top:318.5pt;left:173.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">daily until 3, 6, and</span></p>
<p style="top:300.1pt;left:183.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">12 weeks</span></p>
<p style="top:232.0pt;left:163.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Untreated</span></p>
<p style="top:181.3pt;left:163.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">LIPUS appears to improve healing at</span></p>
<p style="top:173.3pt;left:173.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">the BSTJ for soft tissue grafts as</span></p>
<p style="top:173.3pt;left:183.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">evidenced by greater peak load,</span></p>
<p style="top:173.3pt;left:193.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">increased bone organization,</span></p>
<p style="top:173.3pt;left:203.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">vascularity and angiogenesis, and a</span></p>
<p style="top:173.3pt;left:213.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">more mature BSTJ compared with</span></p>
<p style="top:173.3pt;left:223.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">untreated controls.</span></p>
<p style="top:714.2pt;left:231.8pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Lu et al. (2006)</span><span style="font-family:AdvOTf93bf98f,serif;font-size:5.6pt;color:#0a7fac">44</span></p>
<p style="top:627.1pt;left:233.3pt;line-height:8.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:8.0pt">AJSM</span></p>
<p style="top:570.4pt;left:233.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">48</span></p>
<p style="top:546.8pt;left:233.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">New Zealand</span></p>
<p style="top:535.2pt;left:243.0pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">rabbits</span></p>
<p style="top:494.8pt;left:233.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Partial patellectomy with</span></p>
<p style="top:489.2pt;left:243.0pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">patellar tendon repair</span></p>
<p style="top:401.7pt;left:231.8pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">1.5 MHz, 30 mW/cm</span><span style="font-family:AdvOTf93bf98f,serif;font-size:5.6pt">2</span></p>
<p style="top:315.4pt;left:233.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">20 min/d, starting</span></p>
<p style="top:317.0pt;left:243.0pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">POD3 until 2, 4, 8,</span></p>
<p style="top:305.2pt;left:253.0pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">or 16 weeks</span></p>
<p style="top:243.5pt;left:233.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Mock sonication LIPUS treatment accelerated repair at</span></p>
<p style="top:173.3pt;left:243.0pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">the BSTJ via increased new bone</span></p>
<p style="top:173.3pt;left:253.0pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">formation, advanced bone</span></p>
<p style="top:173.3pt;left:263.0pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">remodeling, and</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:8.0pt"> &#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">brocartilage</span></p>
<p style="top:173.3pt;left:272.9pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">regeneration. LIPUS treatment</span></p>
<p style="top:173.3pt;left:282.9pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">resulted in 35.1% higher failure</span></p>
<p style="top:173.3pt;left:292.8pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">load and 35.0% higher ultimate</span></p>
<p style="top:173.3pt;left:302.8pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">strength compared with controls at</span></p>
<p style="top:173.3pt;left:312.8pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">16 weeks.</span></p>
<p style="top:714.2pt;left:322.7pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Qin et al.</span></p>
<p style="top:706.3pt;left:331.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">(2006)</span><span style="font-family:AdvOTf93bf98f,serif;font-size:5.6pt;color:#0a7fac">23</span></p>
<p style="top:638.7pt;left:323.0pt;line-height:8.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:8.0pt">Clin Biomech</span></p>
<p style="top:640.9pt;left:333.0pt;line-height:8.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:8.0pt">(Bristol, Avon)</span></p>
<p style="top:570.4pt;left:322.7pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">16</span></p>
<p style="top:546.8pt;left:322.7pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">New Zealand</span></p>
<p style="top:535.2pt;left:332.7pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">rabbits</span></p>
<p style="top:494.8pt;left:322.7pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Partial patellectomy with</span></p>
<p style="top:489.2pt;left:332.7pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">patellar tendon repair</span></p>
<p style="top:401.5pt;left:321.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">1.5 mHz, 30 mW/cm</span><span style="font-family:AdvOTf93bf98f,serif;font-size:5.6pt">2</span></p>
<p style="top:315.4pt;left:322.7pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">20 min/d, starting</span></p>
<p style="top:319.4pt;left:332.7pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">POD3, up to 8 or 16</span></p>
<p style="top:294.4pt;left:342.7pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">weeks</span></p>
<p style="top:232.0pt;left:322.7pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Untreated</span></p>
<p style="top:181.3pt;left:322.7pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">LIPUS treatment resulted in 3 times</span></p>
<p style="top:173.3pt;left:332.7pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">greater bone formation and 20%</span></p>
<p style="top:173.3pt;left:342.7pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">increase in matrix hardness of new</span></p>
<p style="top:173.3pt;left:352.6pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">bone compared with untreated</span></p>
<p style="top:173.3pt;left:362.6pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">controls at week 16.</span></p>
<p style="top:714.2pt;left:372.6pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Qin et al.</span></p>
<p style="top:706.3pt;left:381.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">(2006)</span><span style="font-family:AdvOTf93bf98f,serif;font-size:5.6pt;color:#0a7fac">21</span></p>
<p style="top:643.6pt;left:372.8pt;line-height:8.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:8.0pt">Ultrasound Med</span></p>
<p style="top:623.8pt;left:382.8pt;line-height:8.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:8.0pt">Biol</span></p>
<p style="top:570.4pt;left:372.6pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">32</span></p>
<p style="top:546.8pt;left:372.6pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">New Zealand</span></p>
<p style="top:535.2pt;left:382.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">rabbits</span></p>
<p style="top:494.8pt;left:372.6pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Partial patellectomy with</span></p>
<p style="top:489.2pt;left:382.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">patellar tendon repair</span></p>
<p style="top:401.5pt;left:371.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">1.5 mHz, 30 mW/cm</span><span style="font-family:AdvOTf93bf98f,serif;font-size:5.6pt">2</span></p>
<p style="top:316.0pt;left:372.6pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">20 min/d, 5 d/wk,</span></p>
<p style="top:317.7pt;left:382.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">starting POD3 until</span></p>
<p style="top:311.5pt;left:392.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">8 and 16 weeks</span></p>
<p style="top:232.0pt;left:372.6pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Untreated</span></p>
<p style="top:181.3pt;left:372.6pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">LIPUS treatment resulted in 2.6 and</span></p>
<p style="top:173.3pt;left:382.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">3.0 times greater size of new bone</span></p>
<p style="top:173.3pt;left:392.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">compared with controls at weeks 8</span></p>
<p style="top:173.3pt;left:402.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">and 16, respectively. LIPUS group</span></p>
<p style="top:173.3pt;left:412.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">showed higher BMD at week 8</span></p>
<p style="top:173.3pt;left:422.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">than controls.</span></p>
<p style="top:708.3pt;left:435.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">ACL, anterior cruciate ligament;</span><span style="font-family:AdvOTc548c603.I,serif;font-size:8.0pt"> AJSM</span><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">,</span><span style="font-family:AdvOTc548c603.I,serif;font-size:8.0pt"> American Journal of Sports Medicine</span><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">; ASC, adipose-derived stromal cell; BMD, bone mineral density; BSTJ, bone</span><span style="font-family:AdvPS44A44B,serif;font-size:8.0pt">e</span><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">soft tissue junction; CT, computer</span></p>
<p style="top:714.2pt;left:445.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">tomography; FES, functional electrical stimulation; LIPUS, low-intensity pulsed ultrasound; mRNA, messenger RNA; POD, postoperative day; TGF-</span><span style="font-family:AdvPS3F4C13,serif;font-size:8.5pt">b</span><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">1, transforming growth factor</span><span style="font-family:AdvPS3F4C13,serif;font-size:8.5pt"> b</span><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">1; TNF-</span><span style="font-family:AdvPS3F4C13,serif;font-size:8.5pt">a</span><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">,</span></p>
<p style="top:714.3pt;left:455.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">tumor necrosis factor</span><span style="font-family:AdvPS44A44B,serif;font-size:8.0pt">e</span><span style="font-family:AdvPS3F4C13,serif;font-size:8.5pt">a</span><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">; VEGF, vascular endothelial growth factor.</span></p>
<p style="top:31.6pt;left:184.5pt;line-height:9.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt">LIPUS FOR MUSCULOSKELETAL SOFT TISSUE HEALING</span></p>
<p style="top:30.0pt;left:525.4pt;line-height:11.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:11.0pt">2329</span></p>


<p style="top:55.1pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTd1f5cc91.B,serif;font-size:10.0pt">Collagen Organization at the B-ST Junction</span></p>
<p style="top:67.1pt;left:52.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">Several studies reported superior collagen organiza-</span></p>
<p style="top:79.1pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">tion with LIPUS treatment at the B-ST junction. Qin</span></p>
<p style="top:91.0pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">et al.</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">21</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">and Lu et al.</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">43</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">both demonstrated improved</span></p>
<p style="top:103.0pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">collagen alignment and cross-sectional area of the B-ST</span></p>
<p style="top:114.9pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">junction</span></p>
<p style="top:114.9pt;left:89.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">within the LIPUS treatment</span></p>
<p style="top:114.9pt;left:234.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">group after</span></p>
<p style="top:126.9pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">patellectomy. Lovric et al.</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">22</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">and Walsh et al.</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">20</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">also both</span></p>
<p style="top:138.8pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">found that LIPUS-treated ovine rotator cuff repairs and</span></p>
<p style="top:150.8pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">intra-articular ACL reconstructions in sheep produced</span></p>
<p style="top:162.7pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">earlier Sharpey</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt"> &#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">bers and a more mature continuous B-</span></p>
<p style="top:174.7pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">ST interface compared with untreated controls. The</span></p>
<p style="top:186.7pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">control group demonstrated a discontinuous B-ST</span></p>
<p style="top:198.6pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">interface and some discrete Sharpey</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt"> &#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">bers much later</span></p>
<p style="top:210.6pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">than</span></p>
<p style="top:210.6pt;left:72.9pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">the</span></p>
<p style="top:210.6pt;left:95.2pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">LIPUS-treated</span></p>
<p style="top:210.6pt;left:164.9pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">group</span></p>
<p style="top:210.6pt;left:198.9pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">at</span></p>
<p style="top:210.6pt;left:215.2pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">week</span></p>
<p style="top:210.6pt;left:247.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">26</span></p>
<p style="top:210.6pt;left:266.1pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">post-</span></p>
<p style="top:222.5pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">operatively.</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">20</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">In addition, Lu et al.</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">49</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">demonstrated</span></p>
<p style="top:234.4pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">increased collagen</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt"> &#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">bers as early as 3 weeks after</span></p>
<p style="top:246.4pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">initiation of LIPUS treatment at the extensor digitorum</span></p>
<p style="top:258.4pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">longus tendon</span><span style="font-family:AdvPS44A44B,serif;font-size:10.0pt">e</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">tibial interface in a rabbit model.</span></p>
<p style="top:280.3pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTd1f5cc91.B,serif;font-size:10.0pt">Fibrocartilage Remodeling at the B-ST Junction</span></p>
<p style="top:292.3pt;left:52.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">At the cartilaginous zone, LIPUS treatment advanced</span></p>
<p style="top:304.2pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">remodeling at the distal pole</span><span style="font-family:AdvPS44A44B,serif;font-size:10.0pt">e</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">patellar tendon junction</span></p>
<p style="top:316.1pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">in</span></p>
<p style="top:316.1pt;left:61.3pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">partial</span></p>
<p style="top:316.1pt;left:97.3pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">patellectomy</span></p>
<p style="top:316.1pt;left:161.7pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">rabbit</span></p>
<p style="top:316.1pt;left:195.2pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">models.</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">13</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt">,</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">44</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt">,</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">46</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt">,</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">50</span></sup></p>
<p style="top:316.1pt;left:276.5pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">Lu</span></p>
<p style="top:328.1pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">et al.</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">13</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">found regeneration of the</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt"> &#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">brocartilage layer</span></p>
<p style="top:340.1pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">and a larger</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt"> &#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">eld of cartilaginous metaplasia at the</span></p>
<p style="top:352.0pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">patella</span><span style="font-family:AdvPS44A44B,serif;font-size:10.0pt">e</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">patellar tendon healing junction at 8 and 16</span></p>
<p style="top:364.0pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">weeks after patellectomy in LIPUS treatment groups. By</span></p>
<p style="top:376.0pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">week 8, LIPUS-treated samples showed cartilage-like</span></p>
<p style="top:387.9pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">tissue at the patella</span><span style="font-family:AdvPS44A44B,serif;font-size:10.0pt">e</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">patellar tendon osteotomy site</span></p>
<p style="top:399.8pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">with larger, more mature cartilage cells compared with</span></p>
<p style="top:411.8pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">the untreated controls.</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">43</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">In addition, other authors</span></p>
<p style="top:423.7pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">have found increased Vickers hardness of new</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt"> &#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">bro-</span></p>
<p style="top:435.7pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">cartilage tissue and improved remodeling of the</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt"> &#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">bro-</span></p>
<p style="top:447.7pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">cartilage zone after patellectomy in LIPUS-treated</span></p>
<p style="top:459.6pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">partial-patellectomy rabbits.</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">23</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt">,</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">45</span></sup></p>
<p style="top:481.5pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTd1f5cc91.B,serif;font-size:10.0pt">Mechanical Properties at the B-ST Junction</span></p>
<p style="top:493.5pt;left:52.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">In rabbit patellectomy model studies, Lu et al.</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">43</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt">,</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">44</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">and</span></p>
<p style="top:505.4pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">Hu et al.</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">45</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">showed that failure load, ultimate strength,</span></p>
<p style="top:517.4pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">and energy at failure of the patella</span><span style="font-family:AdvPS44A44B,serif;font-size:10.0pt">e</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">patellar tendon</span></p>
<p style="top:529.4pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">junction were signi</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt">&#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">cantly higher in LIPUS groups than</span></p>
<p style="top:541.3pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">control groups (</span><span style="font-family:AdvOTc548c603.I,serif;font-size:10.0pt">P</span><span style="font-family:AdvP4C4E51,serif;font-size:10.0pt"> &lt;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt"> .05)</span><span style="font-family:AdvOTc548c603.I,serif;font-size:10.0pt">.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt"> For example, Lu et al.</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">44</span></sup></p>
<p style="top:553.3pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">demonstrated a 35.1% higher failure load and 35.0%</span></p>
<p style="top:565.3pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">higher ultimate strength in LIPUS-treated groups at 16</span></p>
<p style="top:577.2pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">weeks. In addition, in a ovine rotator cuff tear model,</span></p>
<p style="top:589.1pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">Walsh et al.</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">20</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">demonstrated that LIPUS treatment</span></p>
<p style="top:601.1pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">resulted in a greater peak load and stiffness compared</span></p>
<p style="top:613.0pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">with controls. Lu et al.</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">49</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">found similar results with</span></p>
<p style="top:625.0pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">LIPUS treatment, resulting in higher maximal tensile</span></p>
<p style="top:637.0pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">strength at 2 weeks at the tendon-tibial interface using</span></p>
<p style="top:648.9pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">transplanted extensor digitorum tendons in a rabbit</span></p>
<p style="top:660.9pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">model.</span></p>
<p style="top:687.2pt;left:135.3pt;line-height:12.0pt"><span style="font-family:AdvOTd1f5cc91.B,serif;font-size:12.0pt">Discussion</span></p>
<p style="top:700.7pt;left:52.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">In acute injury animal models, LIPUS augmented</span></p>
<p style="top:712.7pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">healing of acute tendon, ligament, and B-ST junction</span></p>
<p style="top:55.1pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">injuries, while LIPUS demonstrated no bene</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt">&#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">t for</span></p>
<p style="top:67.1pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">chronic tendinopathies in humans in 2 studies. In acute</span></p>
<p style="top:79.1pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">tendon and ligament injury animal models, LIPUS</span></p>
<p style="top:91.0pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">markedly increased collagen content and organization,</span></p>
<p style="top:103.0pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">correlating with improved biomechanical properties. At</span></p>
<p style="top:114.9pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">the B-ST junction in animals, LIPUS treatment demon-</span></p>
<p style="top:126.9pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">strated increased TGF-</span><span style="font-family:AdvPS3F4C13,serif;font-size:10.7pt">b</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">1 and anti-in</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt">&#xfb02;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">ammatory cellular</span></p>
<p style="top:138.8pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">signaling, angiogenesis, bone formation, and improved</span></p>
<p style="top:150.8pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt">&#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">brocartilage remodeling, resulting in improved failure</span></p>
<p style="top:162.7pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">loads at the interface.</span></p>
<p style="top:174.7pt;left:313.9pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">The body of literature from animal models suggests that</span></p>
<p style="top:186.7pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">LIPUS treatment improves tendon, ligament, and B-ST</span></p>
<p style="top:198.6pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">junction healing through anabolic and angiogenic growth</span></p>
<p style="top:210.6pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">factor signaling, which is similar to the effects observed in</span></p>
<p style="top:222.5pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">healing bone. In vitro studies demonstrate that LIPUS</span></p>
<p style="top:234.4pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">treatment increases levels of bone morphogenetic pro-</span></p>
<p style="top:246.4pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">tein-2, -4, and -7 and VEGF production as well as phos-</span></p>
<p style="top:258.4pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">phorylation of Smad1,</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">51-53</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">and these effects occur in vivo</span></p>
<p style="top:270.3pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">as well.</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">13</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt">,</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">20</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt">,</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">22</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">Furthermore, LIPUS may promote an</span></p>
<p style="top:282.3pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">environment for healing by increasing vascularity and the</span></p>
<p style="top:294.3pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">expression of anti-in</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt">&#xfb02;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">ammatory cytokines and down-</span></p>
<p style="top:306.2pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">regulating proin</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt">&#xfb02;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">ammatory cytokines.</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">43</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">The molecular</span></p>
<p style="top:318.2pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">mechanisms by which LIPUS accelerates Achilles tendon</span></p>
<p style="top:330.1pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">repair are not well understood but are thought to be</span></p>
<p style="top:342.1pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">related to COX-2 and EP4 expression in the in</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt">&#xfb02;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">ammatory</span></p>
<p style="top:354.0pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">period and increased collagen expression via TGF-</span><span style="font-family:AdvPS3F4C13,serif;font-size:10.7pt">b</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">1</span></p>
<p style="top:366.0pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">signaling. EP4 seems to be an important receptor not only</span></p>
<p style="top:377.9pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">for mediating in</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt">&#xfb02;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">ammation but also for repairing</span></p>
<p style="top:389.9pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">tissues.</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">14</span></sup></p>
<p style="top:401.9pt;left:313.9pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">Review of the available studies demonstrated that the</span></p>
<p style="top:413.8pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">effects of LIPUS on healing ligaments and tendons differ</span></p>
<p style="top:425.7pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">based on timing and dosage.</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">24</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt">,</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">48</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt">,</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">50</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">Lu et al.</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">50</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">found that</span></p>
<p style="top:437.7pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">ultimate strength, stiffness, and bone formation were</span></p>
<p style="top:449.7pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">superior when LIPUS was started on POD7 compared</span></p>
<p style="top:461.6pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">with POD0 in a rabbit patellectomy model. LIPUS may</span></p>
<p style="top:473.6pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">modulate growth factor and cytokine expression at the</span></p>
<p style="top:485.5pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">B-ST junction. Maintaining the initial native in</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt">&#xfb02;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">amma-</span></p>
<p style="top:497.5pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">tory phase during acute tendon and ligament injury is</span></p>
<p style="top:509.5pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">important to allow for secretion of cytokines and growth</span></p>
<p style="top:521.4pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">factors to initiate the healing process, and application of</span></p>
<p style="top:533.3pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">LIPUS, which has anti-in</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt">&#xfb02;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">ammatory effects, may be</span></p>
<p style="top:545.3pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">better suited during the reparative and remodeling</span></p>
<p style="top:557.3pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">stages. These patterns are also seen in animal studies that</span></p>
<p style="top:569.2pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">demonstrate that early administration of nonsteroidal</span></p>
<p style="top:581.2pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">anti-in</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt">&#xfb02;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">ammatory</span></p>
<p style="top:581.2pt;left:398.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">drugs</span></p>
<p style="top:581.2pt;left:435.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">inhibits</span></p>
<p style="top:581.2pt;left:479.6pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">B-ST</span></p>
<p style="top:581.2pt;left:513.6pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">junction</span></p>
<p style="top:593.1pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">healing.</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">54</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt">,</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">55</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">Given the variability in healing noted across</span></p>
<p style="top:605.1pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">postoperative time periods, these studies stress the need</span></p>
<p style="top:617.0pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">to elucidate an ideal treatment window for application of</span></p>
<p style="top:629.0pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">LIPUS. Lu et al.</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">46</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">also demonstrated that effects of LIPUS</span></p>
<p style="top:640.9pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">on bone formation are frequency dependent, with</span></p>
<p style="top:652.9pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">twice-daily dosing resulting in increased bone formation.</span></p>
<p style="top:664.9pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">Bone formation has been shown to be an essential step</span></p>
<p style="top:676.8pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">in B-ST junction healing, and the increased density of</span></p>
<p style="top:688.8pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">the trabecular network allows for greater invasion of the</span></p>
<p style="top:700.7pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">tendon</span></p>
<p style="top:700.7pt;left:347.1pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt">&#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">brous</span></p>
<p style="top:700.7pt;left:387.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">tissue</span></p>
<p style="top:700.7pt;left:421.9pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">and</span></p>
<p style="top:700.7pt;left:448.5pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">improved</span></p>
<p style="top:700.7pt;left:500.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">mechanical</span></p>
<p style="top:712.7pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">strength of the B-ST interface.</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">56-58</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">Further, restoration</span></p>
<p style="top:30.0pt;left:44.4pt;line-height:11.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:11.0pt">2330</span></p>
<p style="top:31.6pt;left:263.7pt;line-height:9.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt">W. C. LAI ET AL.</span></p>


<p style="top:55.1pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">of the</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt"> &#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">brocartilage transition zone between bone and</span></p>
<p style="top:67.1pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">tendon/ligament is thought to be important in reducing</span></p>
<p style="top:79.1pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">B-ST junction failure.</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">56</span></sup></p>
<p style="top:91.0pt;left:52.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">There was signi</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt">&#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">cant heterogeneity with regards to the</span></p>
<p style="top:103.0pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">LIPUS dosage and tendon injury model among the animal</span></p>
<p style="top:114.9pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">studies reviewed. As a result, the evidence for LIPUS</span></p>
<p style="top:126.9pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">treatment for tendinous injuries remains weak.This study</span></p>
<p style="top:138.8pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">search found only 2 randomized control trials investi-</span></p>
<p style="top:150.8pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">gating LIPUS treatment in humans. LIPUS-treated and</span></p>
<p style="top:162.7pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">control groups for chronic tendinopathies demonstrated</span></p>
<p style="top:174.7pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">similar improvement inpainscoresfrombaseline, withno</span></p>
<p style="top:186.7pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">signi</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt">&#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">cant differences between groups, which may be due</span></p>
<p style="top:198.6pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">to the chronic nature of tendinopathies in comparison to</span></p>
<p style="top:210.6pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">the acute nature of tendon rupture models used in the</span></p>
<p style="top:222.5pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">animal studies.</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">33</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt">,</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">34</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">It is important to note that in these</span></p>
<p style="top:234.4pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">studies, LIPUS treatment was administered for chronic</span></p>
<p style="top:246.4pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">tendinopathies</span></p>
<p style="top:246.4pt;left:118.8pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">or</span></p>
<p style="top:246.4pt;left:138.3pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">after</span></p>
<p style="top:246.4pt;left:168.3pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt">&#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">rst-line</span></p>
<p style="top:246.4pt;left:215.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">treatments</span></p>
<p style="top:246.4pt;left:271.7pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">had</span></p>
<p style="top:258.4pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">failed.</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">33</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt">,</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">59</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">For instance, treatment with LIPUS for chronic</span></p>
<p style="top:270.3pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">lateral epicondylitis was initiated only after patients had at</span></p>
<p style="top:282.3pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">least 6 weeks of symptoms and failed anti-in</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt">&#xfb02;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">ammatory</span></p>
<p style="top:294.3pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">medications or corticosteroid injections.</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">33</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">In contrast,</span></p>
<p style="top:306.2pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">the animal studies collected in this review investigated the</span></p>
<p style="top:318.2pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">effects of LIPUS in acute surgical injury models, likely</span></p>
<p style="top:330.1pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">representing a different clinical scenario. LIPUS dosage</span></p>
<p style="top:342.1pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">and duration will likely differ depending on the pathol-</span></p>
<p style="top:354.0pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">ogy, thickness, and properties of the tissue, as well as the</span></p>
<p style="top:366.0pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">species being treated. Animal models do not always</span></p>
<p style="top:377.9pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">correlate with human conditions. In addition to the dis-</span></p>
<p style="top:389.9pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">crepancies between chronic tendinopathies in humans</span></p>
<p style="top:401.9pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">and surgical acute injury models in animal models as</span></p>
<p style="top:413.8pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">aforementioned, rodents have robust healing potential,</span></p>
<p style="top:425.7pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">reduced healing time, and ability to produce vitamin C to</span></p>
<p style="top:437.7pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">facilitate collagen synthesis compared with humans.</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">60</span></sup></p>
<p style="top:449.7pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">One of the main de</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt">&#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">ciencies of the many translational</span></p>
<p style="top:461.6pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">animal models utilized to investigate therapies is that they</span></p>
<p style="top:473.6pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">use an acute intervention to study tissues typically</span></p>
<p style="top:485.5pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">affected by a chronic, degenerative process.</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">61</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">Because</span></p>
<p style="top:497.5pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">LIPUS has demonstrated anti-in</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt">&#xfb02;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">ammatory cellular ef-</span></p>
<p style="top:509.5pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">fects, it may have limited bene</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt">&#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">t for chronic, degenerative</span></p>
<p style="top:521.4pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">tendinopathies for which in</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt">&#xfb02;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">ammation is not generally</span></p>
<p style="top:533.3pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">present or present at low levels.</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">12</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt">,</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">38</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt">,</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">40</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">However, given</span></p>
<p style="top:545.3pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">the existing evidence of histologic and biomechanical</span></p>
<p style="top:557.3pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">strength improvement in Achilles tendon animal models,</span></p>
<p style="top:569.2pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">the refractory nature of chronic tendinopathy, and rela-</span></p>
<p style="top:581.2pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">tive safety of LIPUS, further investigation of the effects of</span></p>
<p style="top:593.1pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">LIPUS on tendinopathy and tendon healing is warranted.</span></p>
<p style="top:605.1pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">Furthermore, thissystematicreviewcan help guide future</span></p>
<p style="top:617.0pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">human studies on the clinical application of LIPUS, such</span></p>
<p style="top:629.0pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">as treatment for acute tendon and ligament injuries (e.g.,</span></p>
<p style="top:640.9pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">acute MCL knee injuries) or after surgical repair.</span></p>
<p style="top:664.9pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTd1f5cc91.B,serif;font-size:10.0pt">Limitations</span></p>
<p style="top:676.8pt;left:52.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">There are several limitations of this review. First, the</span></p>
<p style="top:688.8pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">de</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt">&#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">nition of LIPUS is not consistent in the current</span></p>
<p style="top:700.7pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">literature, with some considering low-dose intensity to</span></p>
<p style="top:712.7pt;left:44.4pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">be</span><span style="font-family:AdvP4C4E51,serif;font-size:10.0pt"> &lt;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">1 W/cm</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt">2</span></sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">.</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:7.0pt;color:#0a7fac">62</span></sup><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">The intensity and dosage also differed</span></p>
<p style="top:55.1pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">across the various studies, limiting potential for gener-</span></p>
<p style="top:67.1pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">alization across multiple studies. Furthermore, there</span></p>
<p style="top:79.1pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">was a paucity of human clinical evidence, as there were</span></p>
<p style="top:91.0pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">only 2 randomized controlled trials to draw from for</span></p>
<p style="top:103.0pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">chronic tendinopathy. Finally, negative results are not</span></p>
<p style="top:114.9pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">often published, and therefore, there may be inherent</span></p>
<p style="top:126.9pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">publication bias in the studies examined in this review.</span></p>
<p style="top:151.2pt;left:392.9pt;line-height:12.0pt"><span style="font-family:AdvOTd1f5cc91.B,serif;font-size:12.0pt">Conclusions</span></p>
<p style="top:164.7pt;left:313.9pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">In acute injury animal models, LIPUS augmented</span></p>
<p style="top:176.7pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">healing of acute tendon, ligament, and B-ST junction</span></p>
<p style="top:188.6pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">injuries through increased collagen content and organi-</span></p>
<p style="top:200.6pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">zation, increased anti-in</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:10.0pt">&#xfb02;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">ammatory cellular signaling,</span></p>
<p style="top:212.6pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">and increased angiogenesis. However, in 2 human</span></p>
<p style="top:224.5pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">studies investigating chronic tendinopathy, LIPUS did</span></p>
<p style="top:236.4pt;left:306.0pt;line-height:10.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:10.0pt">not lead to superior outcomes compared with controls.</span></p>
<p style="top:260.7pt;left:395.4pt;line-height:12.0pt"><span style="font-family:AdvOTd1f5cc91.B,serif;font-size:12.0pt">References</span></p>
<p style="top:275.1pt;left:310.9pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">1.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> Rubin C, Bolander M, Ryaby JP, Hadjiargyrou M. The use</span></p>
<p style="top:286.1pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">of low-intensity ultrasound to accelerate the healing of</span></p>
<p style="top:297.0pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">fractures.</span><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac"> J Bone Joint Surg Am</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> 2001;83:259-270</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">.</span></p>
<p style="top:308.0pt;left:310.9pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">2.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> Leung KS, Cheung WH, Zhang C, Lee KM, Lo HK. Low</span></p>
<p style="top:318.9pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">intensity pulsed ultrasound stimulates osteogenic activity</span></p>
<p style="top:329.9pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">of human periosteal cells.</span><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac"> Clin Orthop Relat Res</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> 2004:</span></p>
<p style="top:340.9pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">253-259</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">.</span></p>
<p style="top:351.8pt;left:310.9pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">3.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> Kristiansen TK, Ryaby JP, McCabe J, Frey JJ, Roe LR.</span></p>
<p style="top:362.8pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">Accelerated healing of distal radial fractures with the use</span></p>
<p style="top:373.7pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">of speci</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:9.0pt;color:#0a7fac">&#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">c, low-intensity ultrasound: A multicenter, pro-</span></p>
<p style="top:384.7pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">spective, randomized, double-blind, placebo-controlled</span></p>
<p style="top:395.7pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">study.</span><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac"> J Bone Joint Surg Am</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> 1997;79:961-973</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">.</span></p>
<p style="top:406.6pt;left:310.9pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">4.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> Heckman JD, Ryaby JP, McCabe J, Frey JJ, Kilcoyne RF.</span></p>
<p style="top:417.6pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">Acceleration of tibial fracture-healing by non-invasive,</span></p>
<p style="top:428.5pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">low-intensity pulsed ultrasound.</span><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac"> J Bone Joint Surg Am</span></p>
<p style="top:439.5pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">1994;76:26-34</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">.</span></p>
<p style="top:450.4pt;left:310.9pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">5.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> El-Mowa</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:9.0pt;color:#0a7fac">&#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> H, Mohsen M. The effect of low-intensity</span></p>
<p style="top:461.4pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">pulsed ultrasound on callus maturation in tibial distrac-</span></p>
<p style="top:472.4pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">tion osteogenesis.</span><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac"> Int Orthop</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> 2005;29:121-124</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">.</span></p>
<p style="top:483.3pt;left:310.9pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">6.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> Azuma Y, Ito M, Harada Y, Takagi H, Ohta T, Jingushi S.</span></p>
<p style="top:494.3pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">Low-intensity pulsed ultrasound accelerates rat femoral</span></p>
<p style="top:505.3pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">fracture healing by acting on the various cellular reactions</span></p>
<p style="top:516.2pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">in the fracture callus.</span><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac"> J Bone Miner Res</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> 2001;16:671-680</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">.</span></p>
<p style="top:527.2pt;left:310.9pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">7.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> Freeman TA, Patel P, Parvizi J, Antoci V, Shapiro IM.</span></p>
<p style="top:538.2pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">Micro-CT analysis with multiple thresholds allows detec-</span></p>
<p style="top:549.1pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">tion of bone formation and resorption during ultrasound-</span></p>
<p style="top:560.0pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">treated fracture healing.</span><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac"> J Orthop Res</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> 2009;27:673-679</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">.</span></p>
<p style="top:571.0pt;left:310.9pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">8.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> Wang</span></p>
<p style="top:571.0pt;left:352.9pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">SJ,</span></p>
<p style="top:571.0pt;left:372.1pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">Lewallen</span></p>
<p style="top:571.0pt;left:416.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">DG,</span></p>
<p style="top:571.0pt;left:439.3pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">Bolander</span></p>
<p style="top:571.0pt;left:483.4pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">ME,</span></p>
<p style="top:571.0pt;left:507.5pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">Chao</span></p>
<p style="top:571.0pt;left:536.3pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">EY,</span></p>
<p style="top:582.0pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">Ilstrup DM, Greenleaf JF. Low intensity ultrasound</span></p>
<p style="top:592.9pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">treatment increases strength in a rat femoral fracture</span></p>
<p style="top:603.9pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">model.</span><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac"> J Orthop Res</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> 1994;12:40-47</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">.</span></p>
<p style="top:614.9pt;left:310.9pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">9.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> Gebauer D, Mayr E, Orthner E, Ryaby JP. Low-intensity</span></p>
<p style="top:625.8pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">pulsed ultrasound: Effects on nonunions.</span><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac"> Ultrasound Med</span></p>
<p style="top:636.7pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac">Biol</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> 2005;31:1391-1402</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">.</span></p>
<p style="top:647.7pt;left:306.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">10.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> Dijkman BG, Sprague S, Bhandari M. Low-intensity</span></p>
<p style="top:658.7pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">pulsed ultrasound: Nonunions.</span><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac"> Indian J Orthop</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> 2009;43:</span></p>
<p style="top:669.6pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">141-148</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">.</span></p>
<p style="top:680.6pt;left:306.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">11.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> Cook SD, Salkeld SL, Popich-Patron LS, Ryaby JP,</span></p>
<p style="top:691.6pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">Jones DG, Barrack RL. Improved cartilage repair after</span></p>
<p style="top:702.5pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">treatment with low-intensity pulsed ultrasound.</span><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac"> Clin</span></p>
<p style="top:713.4pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac">Orthop Relat Res</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> 2001:S231-S243</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">.</span></p>
<p style="top:31.6pt;left:184.5pt;line-height:9.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt">LIPUS FOR MUSCULOSKELETAL SOFT TISSUE HEALING</span></p>
<p style="top:30.0pt;left:525.4pt;line-height:11.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:11.0pt">2331</span></p>


<p style="top:55.2pt;left:44.4pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">12.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> Takakura Y, Matsui N, Yoshiya S, et al. Low-intensity</span></p>
<p style="top:66.2pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">pulsed ultrasound enhances early healing of medial</span></p>
<p style="top:77.2pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">collateral ligament injuries in rats.</span><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac"> J Ultrasound Med</span></p>
<p style="top:88.1pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">2002;21:283-288</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">.</span></p>
<p style="top:99.1pt;left:44.4pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">13.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> Lu H, Qin L, Cheung W, Lee K, Wong W, Leung K. Low-</span></p>
<p style="top:110.0pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">intensity</span></p>
<p style="top:110.0pt;left:101.8pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">pulsed</span></p>
<p style="top:110.0pt;left:135.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">ultrasound</span></p>
<p style="top:110.0pt;left:185.3pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">accelerated</span></p>
<p style="top:110.0pt;left:236.9pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">bone-tendon</span></p>
<p style="top:121.0pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">junction healing through regulation of vascular endo-</span></p>
<p style="top:132.0pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">thelial growth factor expression and cartilage formation.</span></p>
<p style="top:142.9pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac">Ultrasound Med Biol</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> 2008;34:1248-1260</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">.</span></p>
<p style="top:153.9pt;left:44.4pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">14.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> Kosaka T, Masaoka T, Yamamoto K. Possible molecular</span></p>
<p style="top:164.8pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">mechanism of promotion of repair of acute Achilles</span></p>
<p style="top:175.8pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">tendon rupture by low intensity-pulsed ultrasound treat-</span></p>
<p style="top:186.8pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">ment in a rat model.</span><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac"> West Indian Med J</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> 2011;60:263-268</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">.</span></p>
<p style="top:197.7pt;left:44.4pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">15.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> Zhang Z, Huckle J, Francomano CA, Spencer RG. The</span></p>
<p style="top:208.7pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">in</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:9.0pt;color:#0a7fac">&#xfb02;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">uence of pulsed low-intensity ultrasound on matrix</span></p>
<p style="top:219.7pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">production of chondrocytes at different stages of differ-</span></p>
<p style="top:230.6pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">entiation: an explant study.</span><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac"> Ultrasound Med Biol</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> 2002;28:</span></p>
<p style="top:241.5pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">1547-1553</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">.</span></p>
<p style="top:252.5pt;left:44.4pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">16.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> da Cunha A, Parizotto NA, Vidal BeC. The effect of ther-</span></p>
<p style="top:263.5pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">apeutic ultrasound on repair of the achilles tendon (tendo</span></p>
<p style="top:274.4pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">calcaneus) of the rat.</span><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac"> Ultrasound Med Biol</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> 2001;27:</span></p>
<p style="top:285.4pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">1691-1696</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">.</span></p>
<p style="top:296.4pt;left:44.4pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">17.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> Jeremias J&#xfa;nior SL, Camanho GL, Bassit ACF, Forgas A,</span></p>
<p style="top:307.3pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">Ingham SJM, Abdalla RJ. Low-intensity pulsed ultra-</span></p>
<p style="top:318.2pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">sound accelerates healing in rat calcaneus tendon injuries.</span></p>
<p style="top:329.2pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac">J Orthop Sports Phys Ther</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> 2011;41:526-531</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">.</span></p>
<p style="top:340.2pt;left:44.4pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">18.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> Yeung CK, Guo X, Ng YF. Pulsed ultrasound treatment</span></p>
<p style="top:351.1pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">accelerates the repair of Achilles tendon rupture in rats.</span></p>
<p style="top:362.1pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac">J Orthop Res</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> 2006;24:193-201</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">.</span></p>
<p style="top:373.1pt;left:44.4pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">19.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> Warden</span></p>
<p style="top:373.1pt;left:101.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">SJ,</span></p>
<p style="top:373.1pt;left:122.7pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">Avin</span></p>
<p style="top:373.1pt;left:151.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">KG,</span></p>
<p style="top:373.1pt;left:176.7pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">Beck</span></p>
<p style="top:373.1pt;left:205.8pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">EM,</span></p>
<p style="top:373.1pt;left:231.9pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">DeWolf</span></p>
<p style="top:373.1pt;left:271.8pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">ME,</span></p>
<p style="top:384.0pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">Hagemeier MA, Martin KM. Low-intensity pulsed ultra-</span></p>
<p style="top:394.9pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">sound accelerates and a nonsteroidal anti-in</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:9.0pt;color:#0a7fac">&#xfb02;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">ammatory</span></p>
<p style="top:405.9pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">drug delays knee ligament healing.</span><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac"> Am J Sports Med</span></p>
<p style="top:416.9pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">2006;34:1094-1102</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">.</span></p>
<p style="top:427.8pt;left:44.4pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">20.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> Walsh WR, Stephens P, Vizesi F, Bruce W, Huckle J, Yu Y.</span></p>
<p style="top:438.8pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">Effects of low-intensity pulsed ultrasound on tendon-</span></p>
<p style="top:449.8pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">bone healing in an intra-articular sheep knee model.</span></p>
<p style="top:460.7pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac">Arthroscopy</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> 2007;23:197-204</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">.</span></p>
<p style="top:471.7pt;left:44.4pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">21.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> Qin L, Lu H, Fok P, et al. Low-intensity pulsed ultrasound</span></p>
<p style="top:482.6pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">accelerates osteogenesis at bone-tendon healing junction.</span></p>
<p style="top:493.6pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac">Ultrasound Med Biol</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> 2006;32:1905-1911</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">.</span></p>
<p style="top:504.5pt;left:44.4pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">22.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> Lovric V, Ledger M, Goldberg J, et al. The effects of low-</span></p>
<p style="top:515.5pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">intensity pulsed ultrasound on tendon-bone healing in a</span></p>
<p style="top:526.5pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">transosseous-equivalent sheep rotator cuff model.</span><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac"> Knee</span></p>
<p style="top:537.4pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac">Surg Sports Traumatol Arthrosc</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> 2013;21:466-475</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">.</span></p>
<p style="top:548.4pt;left:44.4pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">23.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> Qin L, Fok P, Lu H, Shi S, Leng Y, Leung K. Low intensity</span></p>
<p style="top:559.3pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">pulsed ultrasound increases the matrix hardness of the</span></p>
<p style="top:570.3pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">healing tissues at bone-tendon insertion: A partial patel-</span></p>
<p style="top:581.3pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">lectomy model in rabbits.</span><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac"> Clin Biomech (Bristol, Avon)</span></p>
<p style="top:592.2pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">2006;21:387-394</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">.</span></p>
<p style="top:603.2pt;left:44.4pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">24.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> Lu H, Zheng C, Wang Z, Chen C, Chen H, Hu J. Effects of</span></p>
<p style="top:614.2pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">low-intensity pulsed ultrasound on new trabecular bone</span></p>
<p style="top:625.1pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">during bone-tendon junction healing in a rabbit model: A</span></p>
<p style="top:636.1pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">synchrotron radiation micro-CT study.</span><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac"> PLoS One</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> 2015;10:</span></p>
<p style="top:647.0pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">e0124724</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">.</span></p>
<p style="top:658.0pt;left:44.4pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">25.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> Palesy PD. Tendon and ligament insertions</span><span style="font-family:AdvPS44A44B,serif;font-size:9.0pt;color:#0a7fac">d</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">a possible</span></p>
<p style="top:668.9pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">source</span></p>
<p style="top:668.9pt;left:96.2pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">of</span></p>
<p style="top:668.9pt;left:114.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">musculoskeletal</span></p>
<p style="top:668.9pt;left:188.3pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">pain.</span></p>
<p style="top:668.9pt;left:218.3pt;line-height:9.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac">Cranio</span></p>
<p style="top:668.9pt;left:252.9pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">1997;15:</span></p>
<p style="top:679.9pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">194-202</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">.</span></p>
<p style="top:690.9pt;left:44.4pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">26.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> Wong MW, Qin L, Tai JK, Lee SK, Leung KS, Chan KM.</span></p>
<p style="top:701.8pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">Engineered allogeneic chondrocyte pellet for reconstruc-</span></p>
<p style="top:712.8pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">tion of</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:9.0pt;color:#0a7fac"> &#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">brocartilage zone at bone-tendon junction</span><span style="font-family:AdvPS44A44B,serif;font-size:9.0pt;color:#0a7fac">d</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">a</span></p>
<p style="top:55.2pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">preliminary histological observation.</span><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac"> J Biomed Mater Res B</span></p>
<p style="top:66.2pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac">Appl Biomater</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> 2004;70:362-367</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">.</span></p>
<p style="top:77.2pt;left:306.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">27.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> Qin L, Leung KS, Chan CW, Fu LK, Rosier R. Enlarge-</span></p>
<p style="top:88.1pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">ment of remaining patella after partial patellectomy in</span></p>
<p style="top:99.1pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">rabbits.</span><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac"> Med Sci Sports Exerc</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> 1999;31:502-506</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">.</span></p>
<p style="top:110.0pt;left:306.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">28.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> Kinneberg KR, Galloway MT, Butler DL, Shearn JT. The</span></p>
<p style="top:121.0pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">native cell population does not contribute to central-third</span></p>
<p style="top:131.9pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">graft healing at 6, 12, or 26 weeks in the rabbit patellar</span></p>
<p style="top:142.9pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">tendon.</span><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac"> J Orthop Res</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> 2013;31:638-644</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">.</span></p>
<p style="top:153.9pt;left:306.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">29.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> Harris JD, Quatman CE, Manring MM, Siston RA,</span></p>
<p style="top:164.8pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">Flanigan DC. How to write a systematic review.</span><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac"> Am J</span></p>
<p style="top:175.8pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac">Sports Med</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> 2014;42:2761-2768</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">.</span></p>
<p style="top:186.8pt;left:306.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">30.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA</span></p>
<p style="top:197.7pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">Group. Preferred reporting items for systematic reviews</span></p>
<p style="top:208.7pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">and meta-analyses: The PRISMA statement.</span><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac"> PLoS Med</span></p>
<p style="top:219.6pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">2009;6:e1000097</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">.</span></p>
<p style="top:230.6pt;left:306.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">31.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> Higgins JPT, Altman DG, G&#xf8;tzsche PC, et al. The Cochrane</span></p>
<p style="top:241.5pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">Collaboration</span><span style="font-family:AdvOTf93bf98f+20,serif;font-size:9.0pt;color:#0a7fac">&#x2019;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">s tool for assessing risk of bias in rando-</span></p>
<p style="top:252.5pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">mised trials.</span><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac"> BMJ</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> 2011;343:d5928</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">.</span></p>
<p style="top:263.5pt;left:306.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">32.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> Hooijmans CR, Rovers MM, de Vries RBM, Leenaars M,</span></p>
<p style="top:274.4pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">Ritskes-Hoitinga M, Langendam MW. SYRCLE</span><span style="font-family:AdvOTf93bf98f+20,serif;font-size:9.0pt;color:#0a7fac">&#x2019;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">s risk of</span></p>
<p style="top:285.4pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">bias tool for animal studies.</span><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac"> BMC Med Res Methodol</span></p>
<p style="top:296.4pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">2014;14:43</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">.</span></p>
<p style="top:307.3pt;left:306.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">33.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> D</span><span style="font-family:AdvOTf93bf98f+20,serif;font-size:9.0pt;color:#0a7fac">&#x2019;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">Vaz AP, Ostor AJ, Speed CA, et al. Pulsed low-intensity</span></p>
<p style="top:318.2pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">ultrasound therapy for chronic lateral epicondylitis: A</span></p>
<p style="top:329.2pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">randomized</span></p>
<p style="top:329.2pt;left:379.2pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">controlled</span></p>
<p style="top:329.2pt;left:429.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">trial.</span></p>
<p style="top:329.2pt;left:458.3pt;line-height:9.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac">Rheumatology</span></p>
<p style="top:329.2pt;left:519.6pt;line-height:9.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac">(Oxford)</span></p>
<p style="top:340.2pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">2006;45:566-570</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">.</span></p>
<p style="top:351.1pt;left:306.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">34.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> Warden SJ, Metcalf BR, Kiss ZS, et al. Low-intensity</span></p>
<p style="top:362.1pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">pulsed ultrasound for chronic patellar tendinopathy: A</span></p>
<p style="top:373.1pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">randomized, double-blind, placebo-controlled trial.</span><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac"> Rheu-</span></p>
<p style="top:384.0pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac">matology (Oxford)</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> 2008;47:467-471</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">.</span></p>
<p style="top:394.9pt;left:306.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">35.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> Roberts M, Rutherford JH, Harris D. The effect of ultra-</span></p>
<p style="top:405.9pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">sound on</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:9.0pt;color:#0a7fac"> &#xfb02;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">exor tendon repairs in the rabbit.</span><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac"> Hand</span></p>
<p style="top:416.9pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">1982;14:17-20</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">.</span></p>
<p style="top:427.8pt;left:306.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">36.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> Larsen A, Kristensen G, Thorlacius-Ussing O, Oxlund H.</span></p>
<p style="top:438.8pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">The in</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:9.0pt;color:#0a7fac">&#xfb02;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">uence of ultrasound on the mechanical properties</span></p>
<p style="top:449.8pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">of healing tendons in rabbits.</span><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac"> Acta Orthop</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> 2005;76:</span></p>
<p style="top:460.7pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">225-230</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">.</span></p>
<p style="top:471.7pt;left:306.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">37.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> Aiyegbusi AI, Duru FI, Akinbo SR. The morphology of the</span></p>
<p style="top:482.6pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">healing tendon: A comparison of the effects of intrasound</span></p>
<p style="top:493.6pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">therapy and therapeutic pulsed ultrasound.</span><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac"> Connect Tissue</span></p>
<p style="top:504.5pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac">Res</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> 2012;53:478-484</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">.</span></p>
<p style="top:515.5pt;left:306.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">38.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> Fu SC, Hung LK, Shum WT, et al. In vivo low-intensity</span></p>
<p style="top:526.5pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">pulsed ultrasound (LIPUS) following tendon injury pro-</span></p>
<p style="top:537.4pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">motes repair during granulation but suppresses decorin</span></p>
<p style="top:548.4pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">and biglycan expression during remodeling.</span><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac"> J Orthop</span></p>
<p style="top:559.4pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac">Sports Phys Ther</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> 2010;40:422-429</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">.</span></p>
<p style="top:570.3pt;left:306.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">39.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> Fu SC, Shum WT, Hung LK, Wong MW, Qin L, Chan KM.</span></p>
<p style="top:581.3pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">Low-intensity pulsed ultrasound on tendon healing: A</span></p>
<p style="top:592.2pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">study of the effect of treatment duration and treatment</span></p>
<p style="top:603.2pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">initiation.</span><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac"> Am J Sports Med</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> 2008;36:1742-1749</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">.</span></p>
<p style="top:614.2pt;left:306.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">40.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> Sparrow KJ, Finucane SD, Owen JR, Wayne JS. The ef-</span></p>
<p style="top:625.1pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">fects of low-intensity ultrasound on medial collateral lig-</span></p>
<p style="top:636.1pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">ament healing in the rabbit model.</span><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac"> Am J Sports Med</span></p>
<p style="top:647.0pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">2005;33:1048-1056</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">.</span></p>
<p style="top:658.0pt;left:306.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">41.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> Leung MC, Ng GY, Yip KK. Therapeutic ultrasound en-</span></p>
<p style="top:668.9pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">hances medial collateral ligament repair in rats.</span><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac"> Ultrasound</span></p>
<p style="top:679.9pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac">Med Biol</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> 2006;32:449-452</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">.</span></p>
<p style="top:690.9pt;left:306.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">42.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> Papatheodorou LK, Malizos KN, Poultsides LA, et al. Ef-</span></p>
<p style="top:701.8pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">fect of transosseous application of low-intensity ultra-</span></p>
<p style="top:712.8pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">sound at the tendon graft-bone interface healing: Gene</span></p>
<p style="top:30.0pt;left:44.4pt;line-height:11.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:11.0pt">2332</span></p>
<p style="top:31.6pt;left:263.7pt;line-height:9.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt">W. C. LAI ET AL.</span></p>


<p style="top:55.2pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">expression and histological analysis in rabbits.</span><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac"> Ultrasound</span></p>
<p style="top:66.2pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac">Med Biol</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> 2009;35:576-584</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">.</span></p>
<p style="top:77.2pt;left:44.4pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">43.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> Lu H, Liu F, Chen H, et al. The effect of low-intensity</span></p>
<p style="top:88.1pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">pulsed ultrasound on bone-tendon junction healing:</span></p>
<p style="top:99.1pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">Initiating after in</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:9.0pt;color:#0a7fac">&#xfb02;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">ammation stage.</span><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac"> J Orthop Res</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> 2016;34:</span></p>
<p style="top:110.0pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">1697-1706</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">.</span></p>
<p style="top:121.0pt;left:44.4pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">44.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> Lu H, Qin L, Fok P, et al. Low-intensity pulsed ultrasound</span></p>
<p style="top:132.0pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">accelerates</span></p>
<p style="top:132.0pt;left:110.2pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">bone-tendon</span></p>
<p style="top:132.0pt;left:169.1pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">junction</span></p>
<p style="top:132.0pt;left:209.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">healing:</span></p>
<p style="top:132.0pt;left:248.8pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">A</span></p>
<p style="top:132.0pt;left:262.9pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">partial</span></p>
<p style="top:142.9pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">patellectomy model in rabbits.</span><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac"> Am J Sports Med</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> 2006;34:</span></p>
<p style="top:153.9pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">1287-1296</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">.</span></p>
<p style="top:164.8pt;left:44.4pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">45.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> Hu J, Qu J, Xu D, Zhang T, Qin L, Lu H. Combined</span></p>
<p style="top:175.8pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">application of low-intensity pulsed ultrasound and func-</span></p>
<p style="top:186.8pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">tional</span></p>
<p style="top:186.8pt;left:90.7pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">electrical</span></p>
<p style="top:186.8pt;left:133.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">stimulation</span></p>
<p style="top:186.8pt;left:186.3pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">accelerates</span></p>
<p style="top:186.8pt;left:236.9pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">bone-tendon</span></p>
<p style="top:197.7pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">junction healing in a rabbit model.</span><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac"> J Orthop Res</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> 2014;32:</span></p>
<p style="top:208.7pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">204-209</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">.</span></p>
<p style="top:219.7pt;left:44.4pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">46.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> Lu H, Liu F, Chen C, et al. Low-intensity pulsed ultra-</span></p>
<p style="top:230.6pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">sound stimulation for tendon-bone healing: A dose-</span></p>
<p style="top:241.5pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">dependent</span></p>
<p style="top:241.5pt;left:109.4pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">study.</span></p>
<p style="top:241.5pt;left:140.5pt;line-height:9.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac">Am</span></p>
<p style="top:241.5pt;left:160.7pt;line-height:9.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac">J</span></p>
<p style="top:241.5pt;left:171.9pt;line-height:9.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac">Phys</span></p>
<p style="top:241.5pt;left:196.0pt;line-height:9.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac">Med</span></p>
<p style="top:241.5pt;left:218.6pt;line-height:9.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac">Rehabil</span></p>
<p style="top:241.5pt;left:253.5pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">2018;97:</span></p>
<p style="top:252.5pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">270-277</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">.</span></p>
<p style="top:263.5pt;left:44.4pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">47.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> Lu MH, Zheng YP, Huang QH, Lu HB, Qin L. Low in-</span></p>
<p style="top:274.4pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">tensity pulsed ultrasound increases the mechanical prop-</span></p>
<p style="top:285.4pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">erties of the healing tissues at bone-tendon junction.</span><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac"> Conf</span></p>
<p style="top:296.4pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac">Proc IEEE Eng Med Biol Soc</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> 2009;2009:2141-2144</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">.</span></p>
<p style="top:307.3pt;left:44.4pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">48.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> Chen C, Zhang T, Liu F, et al. Effect of low-intensity</span></p>
<p style="top:318.2pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">pulsed ultrasound after autologous adipose-derived stro-</span></p>
<p style="top:329.2pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">mal cell transplantation for bone-tendon healing in a</span></p>
<p style="top:340.2pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">rabbit model.</span><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac"> Am J Sports Med</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> 2019;47:942-953</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">.</span></p>
<p style="top:351.1pt;left:44.4pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">49.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> Lu CC, Liu YC, Cheng YM, Chih TT, Tien YC. Augmen-</span></p>
<p style="top:362.1pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">tation of tendon-bone interface healing with low-in-</span></p>
<p style="top:373.1pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">tensity pulsed ultrasound.</span><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac"> Orthopedics</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> 2009;32:173</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">.</span></p>
<p style="top:384.0pt;left:44.4pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">50.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> Lu H, Chen C, Qu J, et al. Initiation timing of low-in-</span></p>
<p style="top:394.9pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">tensity pulsed ultrasound stimulation for tendon-bone</span></p>
<p style="top:405.9pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">healing in a rabbit model.</span><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac"> Am J Sports Med</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> 2016;44:</span></p>
<p style="top:416.9pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">2706-2715</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">.</span></p>
<p style="top:427.8pt;left:44.4pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">51.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> Suzuki A, Takayama T, Suzuki N, et al. Daily low-intensity</span></p>
<p style="top:438.8pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">pulsed</span></p>
<p style="top:438.8pt;left:95.5pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">ultrasound</span></p>
<p style="top:438.8pt;left:148.1pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">stimulates</span></p>
<p style="top:438.8pt;left:197.8pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">production</span></p>
<p style="top:438.8pt;left:250.9pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">of</span></p>
<p style="top:438.8pt;left:268.4pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">bone</span></p>
<p style="top:449.8pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">morphogenetic protein in ROS 17/2.8 cells.</span><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac"> J Oral Sci</span></p>
<p style="top:460.7pt;left:60.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">2009;51:29-36</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">.</span></p>
<p style="top:55.2pt;left:306.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">52.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> Doan N, Reher P, Meghji S, Harris M. In vitro effects of</span></p>
<p style="top:66.2pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">therapeutic ultrasound on cell proliferation, protein syn-</span></p>
<p style="top:77.2pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">thesis, and cytokine production by human</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:9.0pt;color:#0a7fac"> &#xfb01;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">broblasts,</span></p>
<p style="top:88.1pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">osteoblasts, and monocytes.</span><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac"> J Oral Maxillofac Surg</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> 1999;57:</span></p>
<p style="top:99.1pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">409-420</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">.</span></p>
<p style="top:110.0pt;left:306.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">53.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> Sun JS, Hong RC, Chang WH, Chen LT, Lin FH, Liu HC.</span></p>
<p style="top:121.0pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">In vitro effects of low-intensity ultrasound stimulation on</span></p>
<p style="top:131.9pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">the bone cells.</span><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac"> J Biomed Mater Res</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> 2001;57:449-456</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">.</span></p>
<p style="top:142.9pt;left:306.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">54.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> Cohen DB, Kawamura S, Ehteshami JR, Rodeo SA.</span></p>
<p style="top:153.9pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">Indomethacin and celecoxib impair rotator cuff tendon-</span></p>
<p style="top:164.8pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">to-bone healing.</span><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac"> Am J Sports Med</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> 2006;34:362-369</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">.</span></p>
<p style="top:175.8pt;left:306.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">55.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> Ferry ST, Dahners LE, Afshari HM, Weinhold PS. The</span></p>
<p style="top:186.8pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">effects of common anti-in</span><span style="font-family:AdvOTf93bf98f+fb,serif;font-size:9.0pt;color:#0a7fac">&#xfb02;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">ammatory drugs on the heal-</span></p>
<p style="top:197.7pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">ing rat patellar tendon.</span><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac"> Am J Sports Med</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> 2007;35:</span></p>
<p style="top:208.7pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">1326-1333</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">.</span></p>
<p style="top:219.7pt;left:306.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">56.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> Wong MW, Qin L, Lee KM, Leung KS. Articular cartilage</span></p>
<p style="top:230.6pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">increases transition zone regeneration in bone-tendon</span></p>
<p style="top:241.5pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">junction</span></p>
<p style="top:241.5pt;left:363.5pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">healing.</span></p>
<p style="top:241.5pt;left:404.0pt;line-height:9.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac">Clin</span></p>
<p style="top:241.5pt;left:427.7pt;line-height:9.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac">Orthop</span></p>
<p style="top:241.5pt;left:462.0pt;line-height:9.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac">Relat</span></p>
<p style="top:241.5pt;left:489.2pt;line-height:9.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac">Res</span></p>
<p style="top:241.5pt;left:510.1pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">2009;467:</span></p>
<p style="top:252.5pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">1092-1100</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">.</span></p>
<p style="top:263.5pt;left:306.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">57.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> Rodeo</span></p>
<p style="top:263.5pt;left:355.7pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">SA,</span></p>
<p style="top:263.5pt;left:378.4pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">Arnoczky</span></p>
<p style="top:263.5pt;left:425.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">SP,</span></p>
<p style="top:263.5pt;left:446.1pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">Torzilli</span></p>
<p style="top:263.5pt;left:481.9pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">PA,</span></p>
<p style="top:263.5pt;left:504.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">Hidaka</span></p>
<p style="top:263.5pt;left:541.1pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">C,</span></p>
<p style="top:274.4pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">Warren RF. Tendon-healing in a bone tunnel: A biome-</span></p>
<p style="top:285.4pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">chanical and histological study in the dog.</span><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac"> J Bone Joint Surg</span></p>
<p style="top:296.4pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac">Am</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> 1993;75:1795-1803</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">.</span></p>
<p style="top:307.3pt;left:306.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">58.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> Mihelic R, Pecina M, Jelic M, et al. Bone morphogenetic</span></p>
<p style="top:318.2pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">protein-7 (osteogenic protein-1) promotes tendon graft</span></p>
<p style="top:329.2pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">integration in anterior cruciate ligament reconstruction in</span></p>
<p style="top:340.2pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">sheep.</span><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac"> Am J Sports Med</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> 2004;32:1619-1625</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">.</span></p>
<p style="top:351.1pt;left:306.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">59.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> Hsu AR, Holmes GB. Preliminary treatment of achilles</span></p>
<p style="top:362.1pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">tendinopathy using low-intensity pulsed ultrasound.</span><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac"> Foot</span></p>
<p style="top:373.1pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac">Ankle Spec</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> 2016;9:52-57</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">.</span></p>
<p style="top:384.0pt;left:306.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">60.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> Weber B, Lackner I, Haffner-Luntzer M, et al. Modeling</span></p>
<p style="top:394.9pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">trauma in rats: Similarities to humans and potential pit-</span></p>
<p style="top:405.9pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">falls to consider.</span><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac"> J Transl Med</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> 2019;17:305</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">.</span></p>
<p style="top:416.9pt;left:306.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">61.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> Rodeo SA. Translational animal models in orthopaedic</span></p>
<p style="top:427.8pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">research.</span><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac"> Am J Sports Med</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> 2017;45:1487-1489</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">.</span></p>
<p style="top:438.8pt;left:306.0pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">62.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> Xin Z, Lin G, Lei H, Lue TF, Guo Y. Clinical applications of</span></p>
<p style="top:449.8pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">low-intensity pulsed ultrasound and its potential role in</span></p>
<p style="top:460.7pt;left:321.6pt;line-height:9.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac">urology.</span><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt;color:#0a7fac"> Transl Androl Urol</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt;color:#0a7fac"> 2016;5:255-266</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">.</span></p>
<p style="top:31.6pt;left:184.5pt;line-height:9.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt">LIPUS FOR MUSCULOSKELETAL SOFT TISSUE HEALING</span></p>
<p style="top:30.0pt;left:525.4pt;line-height:11.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:11.0pt">2333</span></p>


<p style="top:55.0pt;left:57.5pt;line-height:12.0pt"><span style="font-family:AdvOTd1f5cc91.B,serif;font-size:12.0pt">Appendix: Risk of Bias for Human and</span></p>
<p style="top:68.9pt;left:123.8pt;line-height:12.0pt"><span style="font-family:AdvOTd1f5cc91.B,serif;font-size:12.0pt">Animal Studies</span></p>
<p style="top:96.1pt;left:44.4pt;line-height:9.0pt"><span style="font-family:AdvOTc307558e.B,serif;font-size:9.0pt">Appendix Table 1.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt"> Risk of Bias for Human Studies</span></p>
<p style="top:148.7pt;left:64.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Risk of Bias</span></p>
<p style="top:115.4pt;left:181.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Selection</span></p>
<p style="top:115.4pt;left:272.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Performance</span></p>
<p style="top:115.4pt;left:334.0pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Detection</span></p>
<p style="top:115.4pt;left:392.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Attrition</span></p>
<p style="top:115.4pt;left:455.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Reporting</span></p>
<p style="top:115.4pt;left:520.6pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Other</span></p>
<p style="top:138.8pt;left:135.9pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Random Sequence</span></p>
<p style="top:148.7pt;left:149.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Generation</span></p>
<p style="top:138.8pt;left:217.8pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Allocation</span></p>
<p style="top:148.7pt;left:212.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Concealment</span></p>
<p style="top:128.8pt;left:274.8pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Blinding of</span></p>
<p style="top:138.8pt;left:274.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Participants</span></p>
<p style="top:148.7pt;left:269.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">and Personnel</span></p>
<p style="top:128.8pt;left:336.0pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Blinding</span></p>
<p style="top:138.8pt;left:330.0pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">of Outcome</span></p>
<p style="top:148.7pt;left:330.6pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Assessment</span></p>
<p style="top:138.8pt;left:387.8pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Incomplete</span></p>
<p style="top:148.7pt;left:382.0pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Outcome Data</span></p>
<p style="top:138.8pt;left:443.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Free of Selective</span></p>
<p style="top:148.7pt;left:455.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Reporting</span></p>
<p style="top:148.7pt;left:512.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Other Bias</span></p>
<p style="top:159.9pt;left:44.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Warden et al. (2008)</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:5.6pt;color:#0a7fac">34</span></sup></p>
<p style="top:159.9pt;left:161.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:159.9pt;left:228.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:159.9pt;left:286.8pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:159.9pt;left:343.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:159.9pt;left:399.9pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:159.9pt;left:464.9pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:159.9pt;left:523.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:169.9pt;left:44.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">D</span><span style="font-family:AdvOTf93bf98f+20,serif;font-size:8.0pt">&#x2019;</span><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Vaz et al. (2006)</span><sup><span style="font-family:AdvOTf93bf98f,serif;font-size:5.6pt;color:#0a7fac">33</span></sup></p>
<p style="top:169.9pt;left:161.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:169.9pt;left:228.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:169.9pt;left:286.8pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:169.9pt;left:343.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:169.9pt;left:399.9pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:169.9pt;left:464.9pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:169.9pt;left:523.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:30.0pt;left:44.4pt;line-height:11.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:11.0pt">2333.e1</span></p>
<p style="top:31.6pt;left:263.7pt;line-height:9.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt">W. C. LAI ET AL.</span></p>


<p style="top:713.5pt;left:93.8pt;line-height:9.0pt"><span style="font-family:AdvOTc307558e.B,serif;font-size:9.0pt">Appendix Table 2.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt"> Risk of Bias for Tendon Studies</span></p>
<p style="top:680.5pt;left:136.9pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Risk of Bias</span></p>
<p style="top:530.2pt;left:113.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Selection</span></p>
<p style="top:408.0pt;left:113.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Performance</span></p>
<p style="top:300.7pt;left:113.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Detection</span></p>
<p style="top:209.0pt;left:113.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Attrition</span></p>
<p style="top:145.1pt;left:113.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Reporting</span></p>
<p style="top:78.6pt;left:113.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Other</span></p>
<p style="top:591.1pt;left:126.9pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Sequence</span></p>
<p style="top:593.9pt;left:136.9pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Generation</span></p>
<p style="top:532.4pt;left:126.9pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Baseline</span></p>
<p style="top:543.0pt;left:136.9pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Characteristics</span></p>
<p style="top:475.6pt;left:126.9pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Allocation</span></p>
<p style="top:481.0pt;left:136.9pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Concealment</span></p>
<p style="top:423.1pt;left:126.9pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Random</span></p>
<p style="top:422.7pt;left:136.9pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Housing</span></p>
<p style="top:381.9pt;left:126.9pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Caregiver</span></p>
<p style="top:379.9pt;left:136.9pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Blinding</span></p>
<p style="top:336.8pt;left:126.9pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Random Outcome</span></p>
<p style="top:324.5pt;left:136.9pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Assessment</span></p>
<p style="top:260.6pt;left:136.9pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Blinding</span></p>
<p style="top:213.6pt;left:126.9pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Incomplete</span></p>
<p style="top:219.5pt;left:136.9pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Outcome Data</span></p>
<p style="top:157.1pt;left:126.9pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Free of Selective</span></p>
<p style="top:145.2pt;left:136.9pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Reporting</span></p>
<p style="top:87.2pt;left:136.9pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Other Bias</span></p>
<p style="top:714.2pt;left:146.8pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Aiyegbusi et al. (2012)</span><span style="font-family:AdvOTf93bf98f,serif;font-size:5.6pt;color:#0a7fac">37</span></p>
<p style="top:581.8pt;left:148.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:525.3pt;left:148.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:465.4pt;left:148.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:421.8pt;left:148.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Unclear</span></p>
<p style="top:378.6pt;left:148.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Unclear</span></p>
<p style="top:318.0pt;left:148.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Unclear</span></p>
<p style="top:259.3pt;left:148.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Unclear</span></p>
<p style="top:201.6pt;left:148.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:135.5pt;left:148.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:76.1pt;left:148.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:714.2pt;left:156.8pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Jeremias J&#xfa;nior et al. (2011)</span><span style="font-family:AdvOTf93bf98f,serif;font-size:5.6pt;color:#0a7fac">19</span></p>
<p style="top:581.8pt;left:158.0pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:525.3pt;left:158.0pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:465.4pt;left:158.0pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:415.8pt;left:158.0pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:372.6pt;left:158.0pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:312.0pt;left:158.0pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:253.4pt;left:158.0pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:201.6pt;left:158.0pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:135.5pt;left:158.0pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:76.1pt;left:158.0pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:714.2pt;left:166.7pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Kosaka et al. (2011)</span><span style="font-family:AdvOTf93bf98f,serif;font-size:5.6pt;color:#0a7fac">14</span></p>
<p style="top:581.8pt;left:168.0pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:525.3pt;left:168.0pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:471.4pt;left:168.0pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Unclear</span></p>
<p style="top:421.8pt;left:168.0pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Unclear</span></p>
<p style="top:378.6pt;left:168.0pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Unclear</span></p>
<p style="top:312.0pt;left:168.0pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:259.3pt;left:168.0pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Unclear</span></p>
<p style="top:201.6pt;left:168.0pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:135.5pt;left:168.0pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:76.1pt;left:168.0pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:714.2pt;left:176.7pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Fu et al. (2010)</span><span style="font-family:AdvOTf93bf98f,serif;font-size:5.6pt;color:#0a7fac">38</span></p>
<p style="top:581.8pt;left:177.9pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:531.3pt;left:177.9pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Unclear</span></p>
<p style="top:471.4pt;left:177.9pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Unclear</span></p>
<p style="top:421.8pt;left:177.9pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Unclear</span></p>
<p style="top:378.6pt;left:177.9pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Unclear</span></p>
<p style="top:312.0pt;left:177.9pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:259.3pt;left:177.9pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Unclear</span></p>
<p style="top:201.6pt;left:177.9pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:135.5pt;left:177.9pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:76.1pt;left:177.9pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:714.2pt;left:186.6pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Fu et al. (2008)</span><span style="font-family:AdvOTf93bf98f,serif;font-size:5.6pt;color:#0a7fac">39</span></p>
<p style="top:581.8pt;left:187.9pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:531.3pt;left:187.9pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Unclear</span></p>
<p style="top:471.4pt;left:187.9pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Unclear</span></p>
<p style="top:421.8pt;left:187.9pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Unclear</span></p>
<p style="top:378.6pt;left:187.9pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Unclear</span></p>
<p style="top:312.0pt;left:187.9pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:259.3pt;left:187.9pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Unclear</span></p>
<p style="top:201.6pt;left:187.9pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:135.5pt;left:187.9pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:76.1pt;left:187.9pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:714.2pt;left:196.6pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Yeung et al. (2006)</span><span style="font-family:AdvOTf93bf98f,serif;font-size:5.6pt;color:#0a7fac">18</span></p>
<p style="top:581.8pt;left:197.8pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:531.3pt;left:197.8pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Unclear</span></p>
<p style="top:471.4pt;left:197.8pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Unclear</span></p>
<p style="top:421.8pt;left:197.8pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Unclear</span></p>
<p style="top:378.6pt;left:197.8pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Unclear</span></p>
<p style="top:312.0pt;left:197.8pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:259.3pt;left:197.8pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Unclear</span></p>
<p style="top:201.6pt;left:197.8pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:135.5pt;left:197.8pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:76.1pt;left:197.8pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:714.2pt;left:206.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Larsen et al. (2005)</span><span style="font-family:AdvOTf93bf98f,serif;font-size:5.6pt;color:#0a7fac">36</span></p>
<p style="top:581.8pt;left:207.8pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:531.3pt;left:207.8pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Unclear</span></p>
<p style="top:471.4pt;left:207.8pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Unclear</span></p>
<p style="top:415.8pt;left:207.8pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:378.6pt;left:207.8pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Unclear</span></p>
<p style="top:312.0pt;left:207.8pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:259.3pt;left:207.8pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Unclear</span></p>
<p style="top:201.6pt;left:207.8pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:135.5pt;left:207.8pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:76.1pt;left:207.8pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:714.2pt;left:216.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">da Cunha et al. (2001)</span><span style="font-family:AdvOTf93bf98f,serif;font-size:5.6pt;color:#0a7fac">16</span></p>
<p style="top:581.8pt;left:217.8pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:531.3pt;left:217.8pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Unclear</span></p>
<p style="top:471.4pt;left:217.8pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Unclear</span></p>
<p style="top:421.8pt;left:217.8pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Unclear</span></p>
<p style="top:378.6pt;left:217.8pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Unclear</span></p>
<p style="top:312.0pt;left:217.8pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:259.3pt;left:217.8pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Unclear</span></p>
<p style="top:201.6pt;left:217.8pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:135.5pt;left:217.8pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:76.1pt;left:217.8pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:714.2pt;left:226.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Roberts et al. (1982)</span><span style="font-family:AdvOTf93bf98f,serif;font-size:5.6pt;color:#0a7fac">35</span></p>
<p style="top:581.8pt;left:227.7pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:531.3pt;left:227.7pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Unclear</span></p>
<p style="top:471.4pt;left:227.7pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Unclear</span></p>
<p style="top:421.8pt;left:227.7pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Unclear</span></p>
<p style="top:378.6pt;left:227.7pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Unclear</span></p>
<p style="top:312.0pt;left:227.7pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:259.3pt;left:227.7pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Unclear</span></p>
<p style="top:201.6pt;left:227.7pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:135.5pt;left:227.7pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:76.1pt;left:227.7pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:713.5pt;left:380.2pt;line-height:9.0pt"><span style="font-family:AdvOTc307558e.B,serif;font-size:9.0pt">Appendix Table 3.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt"> Risk of Bias for Ligament Studies</span></p>
<p style="top:681.5pt;left:423.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Study</span></p>
<p style="top:548.6pt;left:399.8pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Selection</span></p>
<p style="top:420.6pt;left:399.8pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Performance</span></p>
<p style="top:308.7pt;left:399.8pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Detection</span></p>
<p style="top:213.6pt;left:399.8pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Attrition</span></p>
<p style="top:147.5pt;left:399.8pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Reporting</span></p>
<p style="top:78.7pt;left:399.8pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Other</span></p>
<p style="top:611.8pt;left:413.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Sequence</span></p>
<p style="top:614.6pt;left:423.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Generation</span></p>
<p style="top:550.9pt;left:413.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Baseline</span></p>
<p style="top:561.5pt;left:423.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Characteristics</span></p>
<p style="top:491.8pt;left:413.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Allocation</span></p>
<p style="top:497.2pt;left:423.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Concealment</span></p>
<p style="top:437.0pt;left:413.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Random</span></p>
<p style="top:436.5pt;left:423.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Housing</span></p>
<p style="top:393.4pt;left:413.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Caregiver</span></p>
<p style="top:391.4pt;left:423.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Blinding</span></p>
<p style="top:346.0pt;left:413.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Random Outcome</span></p>
<p style="top:333.8pt;left:423.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Assessment</span></p>
<p style="top:267.6pt;left:423.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Blinding</span></p>
<p style="top:218.2pt;left:413.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Incomplete</span></p>
<p style="top:224.1pt;left:423.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Outcome Data</span></p>
<p style="top:159.3pt;left:413.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Free of Selective</span></p>
<p style="top:147.5pt;left:423.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Reporting</span></p>
<p style="top:87.2pt;left:423.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Other Bias</span></p>
<p style="top:714.2pt;left:433.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Warden et al. (2006)</span><span style="font-family:AdvOTf93bf98f,serif;font-size:5.6pt;color:#0a7fac">19</span></p>
<p style="top:602.6pt;left:434.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:543.8pt;left:434.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:487.5pt;left:434.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Unclear</span></p>
<p style="top:435.6pt;left:434.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Unclear</span></p>
<p style="top:390.1pt;left:434.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Unclear</span></p>
<p style="top:321.3pt;left:434.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:266.3pt;left:434.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Unclear</span></p>
<p style="top:206.2pt;left:434.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:137.8pt;left:434.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:76.1pt;left:434.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:714.2pt;left:443.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Leung et al. (2005)</span><span style="font-family:AdvOTf93bf98f,serif;font-size:5.6pt;color:#0a7fac">41</span></p>
<p style="top:602.6pt;left:444.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:543.8pt;left:444.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:487.5pt;left:444.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Unclear</span></p>
<p style="top:435.6pt;left:444.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Unclear</span></p>
<p style="top:390.1pt;left:444.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Unclear</span></p>
<p style="top:321.3pt;left:444.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:266.3pt;left:444.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Unclear</span></p>
<p style="top:206.2pt;left:444.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:137.8pt;left:444.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:76.1pt;left:444.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:714.2pt;left:453.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Sparrow et al. (2004)</span><span style="font-family:AdvOTf93bf98f,serif;font-size:5.6pt;color:#0a7fac">40</span></p>
<p style="top:602.6pt;left:454.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:543.8pt;left:454.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:487.5pt;left:454.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Unclear</span></p>
<p style="top:429.6pt;left:454.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:390.1pt;left:454.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Unclear</span></p>
<p style="top:321.3pt;left:454.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:266.3pt;left:454.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Unclear</span></p>
<p style="top:206.2pt;left:454.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:137.8pt;left:454.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:76.1pt;left:454.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:714.2pt;left:463.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Takakura et al. (2002)</span><span style="font-family:AdvOTf93bf98f,serif;font-size:5.6pt;color:#0a7fac">12</span></p>
<p style="top:602.6pt;left:464.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:543.8pt;left:464.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:487.5pt;left:464.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Unclear</span></p>
<p style="top:435.6pt;left:464.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Unclear</span></p>
<p style="top:390.1pt;left:464.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Unclear</span></p>
<p style="top:321.3pt;left:464.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:266.3pt;left:464.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Unclear</span></p>
<p style="top:206.2pt;left:464.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:137.8pt;left:464.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:76.1pt;left:464.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:31.6pt;left:184.5pt;line-height:9.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt">LIPUS FOR MUSCULOSKELETAL SOFT TISSUE HEALING</span></p>
<p style="top:30.0pt;left:510.9pt;line-height:11.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:11.0pt">2333.e2</span></p>


<p style="top:713.5pt;left:194.3pt;line-height:9.0pt"><span style="font-family:AdvOTc307558e.B,serif;font-size:9.0pt">Appendix Table 4.</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt"> Risk of Bias for Bone</span><span style="font-family:AdvPS44A44B,serif;font-size:9.0pt">e</span><span style="font-family:AdvOTf93bf98f,serif;font-size:9.0pt">Soft Tissue Studies</span></p>
<p style="top:671.2pt;left:237.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Study</span></p>
<p style="top:534.1pt;left:213.9pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Selection</span></p>
<p style="top:413.7pt;left:213.9pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Performance</span></p>
<p style="top:307.9pt;left:213.9pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Detection</span></p>
<p style="top:217.2pt;left:213.9pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Attrition</span></p>
<p style="top:149.3pt;left:213.9pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Reporting</span></p>
<p style="top:78.6pt;left:213.9pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Other</span></p>
<p style="top:594.3pt;left:227.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Sequence</span></p>
<p style="top:597.1pt;left:237.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Generation</span></p>
<p style="top:536.4pt;left:227.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Baseline</span></p>
<p style="top:547.1pt;left:237.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Characteristics</span></p>
<p style="top:480.3pt;left:227.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Allocation</span></p>
<p style="top:485.7pt;left:237.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Concealment</span></p>
<p style="top:428.6pt;left:227.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Random</span></p>
<p style="top:428.1pt;left:237.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Housing</span></p>
<p style="top:388.0pt;left:227.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Caregiver</span></p>
<p style="top:386.0pt;left:237.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Blinding</span></p>
<p style="top:343.6pt;left:227.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Random Outcome</span></p>
<p style="top:331.4pt;left:237.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Assessment</span></p>
<p style="top:268.2pt;left:237.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Blinding</span></p>
<p style="top:221.9pt;left:227.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Incomplete</span></p>
<p style="top:227.8pt;left:237.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Outcome Data</span></p>
<p style="top:144.4pt;left:227.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Free of</span></p>
<p style="top:166.0pt;left:237.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Selective Reporting</span></p>
<p style="top:87.2pt;left:237.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Other Bias</span></p>
<p style="top:714.2pt;left:247.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Chen et al. (2019)</span><span style="font-family:AdvOTf93bf98f,serif;font-size:5.6pt;color:#0a7fac">48</span></p>
<p style="top:585.0pt;left:248.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:529.3pt;left:248.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:476.0pt;left:248.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Unclear</span></p>
<p style="top:427.2pt;left:248.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Unclear</span></p>
<p style="top:384.7pt;left:248.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Unclear</span></p>
<p style="top:318.9pt;left:248.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:266.9pt;left:248.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Unclear</span></p>
<p style="top:209.9pt;left:248.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:139.6pt;left:248.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:76.1pt;left:248.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:714.2pt;left:257.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Lu et al. (2018)</span><span style="font-family:AdvOTf93bf98f,serif;font-size:5.6pt;color:#0a7fac">46</span></p>
<p style="top:585.0pt;left:258.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:529.3pt;left:258.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:476.0pt;left:258.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Unclear</span></p>
<p style="top:427.2pt;left:258.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Unclear</span></p>
<p style="top:384.7pt;left:258.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Unclear</span></p>
<p style="top:318.9pt;left:258.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:266.9pt;left:258.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Unclear</span></p>
<p style="top:209.9pt;left:258.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:139.6pt;left:258.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:76.1pt;left:258.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:714.2pt;left:267.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Lu et al. (2016)</span><span style="font-family:AdvOTf93bf98f,serif;font-size:5.6pt;color:#0a7fac">50</span></p>
<p style="top:585.0pt;left:268.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:529.3pt;left:268.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:476.0pt;left:268.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Unclear</span></p>
<p style="top:427.2pt;left:268.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Unclear</span></p>
<p style="top:384.7pt;left:268.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Unclear</span></p>
<p style="top:318.9pt;left:268.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:266.9pt;left:268.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Unclear</span></p>
<p style="top:209.9pt;left:268.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:139.6pt;left:268.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:76.1pt;left:268.5pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:714.2pt;left:277.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Lu et al. (2016)</span><span style="font-family:AdvOTf93bf98f,serif;font-size:5.6pt;color:#0a7fac">43</span></p>
<p style="top:585.0pt;left:278.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:529.3pt;left:278.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:476.0pt;left:278.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Unclear</span></p>
<p style="top:427.2pt;left:278.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Unclear</span></p>
<p style="top:384.7pt;left:278.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Unclear</span></p>
<p style="top:318.9pt;left:278.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:266.9pt;left:278.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Unclear</span></p>
<p style="top:209.9pt;left:278.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:139.6pt;left:278.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:76.1pt;left:278.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:714.2pt;left:287.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Lu et al. (2015)</span><span style="font-family:AdvOTf93bf98f,serif;font-size:5.6pt;color:#0a7fac">24</span></p>
<p style="top:585.0pt;left:288.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:529.3pt;left:288.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:476.0pt;left:288.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Unclear</span></p>
<p style="top:427.2pt;left:288.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Unclear</span></p>
<p style="top:384.7pt;left:288.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Unclear</span></p>
<p style="top:318.9pt;left:288.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:266.9pt;left:288.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Unclear</span></p>
<p style="top:209.9pt;left:288.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:139.6pt;left:288.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:76.1pt;left:288.4pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:714.2pt;left:297.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Hu et al. (2013)</span><span style="font-family:AdvOTf93bf98f,serif;font-size:5.6pt;color:#0a7fac">45</span></p>
<p style="top:585.0pt;left:298.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:529.3pt;left:298.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:476.0pt;left:298.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Unclear</span></p>
<p style="top:427.2pt;left:298.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Unclear</span></p>
<p style="top:384.7pt;left:298.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Unclear</span></p>
<p style="top:318.9pt;left:298.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:266.9pt;left:298.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Unclear</span></p>
<p style="top:209.9pt;left:298.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:139.6pt;left:298.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:76.1pt;left:298.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:714.2pt;left:307.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Lovric et al. (2013)</span><span style="font-family:AdvOTf93bf98f,serif;font-size:5.6pt;color:#0a7fac">22</span></p>
<p style="top:585.0pt;left:308.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:535.3pt;left:308.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Unclear</span></p>
<p style="top:476.0pt;left:308.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Unclear</span></p>
<p style="top:421.3pt;left:308.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:384.7pt;left:308.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Unclear</span></p>
<p style="top:318.9pt;left:308.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:266.9pt;left:308.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Unclear</span></p>
<p style="top:209.9pt;left:308.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:139.6pt;left:308.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:76.1pt;left:308.3pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:714.2pt;left:317.0pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Lu et al. (2009)</span><span style="font-family:AdvOTf93bf98f,serif;font-size:5.6pt;color:#0a7fac">49</span></p>
<p style="top:585.0pt;left:318.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:535.3pt;left:318.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Unclear</span></p>
<p style="top:476.0pt;left:318.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Unclear</span></p>
<p style="top:427.2pt;left:318.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Unclear</span></p>
<p style="top:384.7pt;left:318.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Unclear</span></p>
<p style="top:318.9pt;left:318.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:266.9pt;left:318.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Unclear</span></p>
<p style="top:209.9pt;left:318.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:139.6pt;left:318.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:76.1pt;left:318.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:714.2pt;left:326.9pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Lu et al. (2009)</span><span style="font-family:AdvOTf93bf98f,serif;font-size:5.6pt;color:#0a7fac">47</span></p>
<p style="top:585.0pt;left:328.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:529.3pt;left:328.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:476.0pt;left:328.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Unclear</span></p>
<p style="top:427.2pt;left:328.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Unclear</span></p>
<p style="top:384.7pt;left:328.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Unclear</span></p>
<p style="top:318.9pt;left:328.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:266.9pt;left:328.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Unclear</span></p>
<p style="top:209.9pt;left:328.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:139.6pt;left:328.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:76.1pt;left:328.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:714.2pt;left:336.9pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Papatheodorou et al. (2009)</span><span style="font-family:AdvOTf93bf98f,serif;font-size:5.6pt;color:#0a7fac">42</span></p>
<p style="top:585.0pt;left:338.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:529.3pt;left:338.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:476.0pt;left:338.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Unclear</span></p>
<p style="top:421.3pt;left:338.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:384.7pt;left:338.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Unclear</span></p>
<p style="top:318.9pt;left:338.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:260.9pt;left:338.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:209.9pt;left:338.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:139.6pt;left:338.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:76.1pt;left:338.2pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:714.2pt;left:346.9pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Lu et al. (2008)</span><span style="font-family:AdvOTf93bf98f,serif;font-size:5.6pt;color:#0a7fac">13</span></p>
<p style="top:585.0pt;left:348.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:529.3pt;left:348.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:476.0pt;left:348.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Unclear</span></p>
<p style="top:421.3pt;left:348.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:384.7pt;left:348.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Unclear</span></p>
<p style="top:318.9pt;left:348.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:266.9pt;left:348.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Unclear</span></p>
<p style="top:209.9pt;left:348.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:139.6pt;left:348.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:76.1pt;left:348.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:714.2pt;left:356.9pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Walsh et al. (2007)</span><span style="font-family:AdvOTf93bf98f,serif;font-size:5.6pt;color:#0a7fac">20</span></p>
<p style="top:585.0pt;left:358.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:535.3pt;left:358.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Unclear</span></p>
<p style="top:476.0pt;left:358.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Unclear</span></p>
<p style="top:427.2pt;left:358.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Unclear</span></p>
<p style="top:384.7pt;left:358.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Unclear</span></p>
<p style="top:318.9pt;left:358.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:266.9pt;left:358.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Unclear</span></p>
<p style="top:209.9pt;left:358.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:139.6pt;left:358.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:76.1pt;left:358.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:714.2pt;left:366.8pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Lu et al. (2006)</span><span style="font-family:AdvOTf93bf98f,serif;font-size:5.6pt;color:#0a7fac">44</span></p>
<p style="top:585.0pt;left:368.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:529.3pt;left:368.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:476.0pt;left:368.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Unclear</span></p>
<p style="top:427.2pt;left:368.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Unclear</span></p>
<p style="top:384.7pt;left:368.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Unclear</span></p>
<p style="top:318.9pt;left:368.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:266.9pt;left:368.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Unclear</span></p>
<p style="top:209.9pt;left:368.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:139.6pt;left:368.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:76.1pt;left:368.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:714.2pt;left:376.8pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Qin et al. (2006)</span><span style="font-family:AdvOTf93bf98f,serif;font-size:5.6pt;color:#0a7fac">23</span></p>
<p style="top:585.0pt;left:378.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:535.3pt;left:378.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Unclear</span></p>
<p style="top:476.0pt;left:378.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Unclear</span></p>
<p style="top:427.2pt;left:378.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Unclear</span></p>
<p style="top:384.7pt;left:378.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Unclear</span></p>
<p style="top:318.9pt;left:378.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:266.9pt;left:378.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Unclear</span></p>
<p style="top:209.9pt;left:378.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:139.6pt;left:378.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:76.1pt;left:378.1pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:714.2pt;left:386.8pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Qin et al. (2006)</span><span style="font-family:AdvOTf93bf98f,serif;font-size:5.6pt;color:#0a7fac">21</span></p>
<p style="top:585.0pt;left:388.0pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:535.3pt;left:388.0pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Unclear</span></p>
<p style="top:476.0pt;left:388.0pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Unclear</span></p>
<p style="top:427.2pt;left:388.0pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Unclear</span></p>
<p style="top:384.7pt;left:388.0pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Unclear</span></p>
<p style="top:318.9pt;left:388.0pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:266.9pt;left:388.0pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Unclear</span></p>
<p style="top:209.9pt;left:388.0pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:139.6pt;left:388.0pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:76.1pt;left:388.0pt;line-height:8.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:8.0pt">Low</span></p>
<p style="top:30.0pt;left:44.4pt;line-height:11.0pt"><span style="font-family:AdvOTf93bf98f,serif;font-size:11.0pt">2333.e3</span></p>
<p style="top:31.6pt;left:263.7pt;line-height:9.0pt"><span style="font-family:AdvOTc548c603.I,serif;font-size:9.0pt">W. C. LAI ET AL.</span></p>

</div>
